细胞株Cell Lines 57-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net
- 价 格：¥19200
- 货 号：NTCC-CV57
- 产 地：北京
- BioVector NTCC典型培养物保藏中心
- 联系人：Dr.Xu, Biovector NTCC Inc.
电话：400-800-2947 工作QQ:1843439339 (微信同号)
邮件：Biovector@163.com
手机：18901268599
地址：北京
- 已注册
细胞株Cell Lines-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
ID IMO-3C3
AC CVCL_D797
SY IMO3C3
RX PubMed=12382283;
RX PubMed=15517566;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID IMO-3C6
AC CVCL_D809
SY IMO3C6
RX PubMed=10654599;
RX PubMed=12382283;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID IMO-3D1
AC CVCL_D798
SY IMO3D1
RX PubMed=12382283;
RX PubMed=15517566;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID iMPD183.C1
AC CVCL_D178
SY iPS MPD183 clone 1; iPS MPD 183 clone 1
DR ISCR; 1441
DR SKIP; SKIP000522
RX PubMed=19797525;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D179 ! iMPD183.C2
OI CVCL_D180 ! iMPD183.C3
OI CVCL_D181 ! iMPD183.C5
OI CVCL_D182 ! iMPD183.C6
OI CVCL_D183 ! iMPD183.C7
OI CVCL_D184 ! iMPD183.C8
OI CVCL_D185 ! iMPD183.C10
OI CVCL_D186 ! iMPD183.C11
SX Female
CA Induced pluripotent stem cell
//
ID iMPD183.C10
AC CVCL_D185
SY iPS MPD183 clone 10; iPS MPD 183 clone 10
DR ISCR; 1442
DR SKIP; SKIP000528
RX PubMed=19797525;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D178 ! iMPD183.C1
OI CVCL_D179 ! iMPD183.C2
OI CVCL_D180 ! iMPD183.C3
OI CVCL_D181 ! iMPD183.C5
OI CVCL_D182 ! iMPD183.C6
OI CVCL_D183 ! iMPD183.C7
OI CVCL_D184 ! iMPD183.C8
OI CVCL_D186 ! iMPD183.C11
SX Female
CA Induced pluripotent stem cell
//
ID iMPD183.C11
AC CVCL_D186
SY iPS MPD183 clone 11; iPS MPD 183 clone 11
DR ISCR; 1443
DR SKIP; SKIP000529
RX PubMed=19797525;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D178 ! iMPD183.C1
OI CVCL_D179 ! iMPD183.C2
OI CVCL_D180 ! iMPD183.C3
OI CVCL_D181 ! iMPD183.C5
OI CVCL_D182 ! iMPD183.C6
OI CVCL_D183 ! iMPD183.C7
OI CVCL_D184 ! iMPD183.C8
OI CVCL_D185 ! iMPD183.C10
SX Female
CA Induced pluripotent stem cell
//
ID iMPD183.C2
AC CVCL_D179
SY iPS MPD183 clone 2; iPS MPD 183 clone 2
DR ISCR; 1444
DR SKIP; SKIP000523
RX PubMed=19797525;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D178 ! iMPD183.C1
OI CVCL_D180 ! iMPD183.C3
OI CVCL_D181 ! iMPD183.C5
OI CVCL_D182 ! iMPD183.C6
OI CVCL_D183 ! iMPD183.C7
OI CVCL_D184 ! iMPD183.C8
OI CVCL_D185 ! iMPD183.C10
OI CVCL_D186 ! iMPD183.C11
SX Female
CA Induced pluripotent stem cell
//
ID iMPD183.C3
AC CVCL_D180
SY iPS MPD183 clone 3; iPS MPD 183 clone 3
DR ISCR; 1445
DR SKIP; SKIP000524
RX PubMed=19797525;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D178 ! iMPD183.C1
OI CVCL_D179 ! iMPD183.C2
OI CVCL_D181 ! iMPD183.C5
OI CVCL_D182 ! iMPD183.C6
OI CVCL_D183 ! iMPD183.C7
OI CVCL_D184 ! iMPD183.C8
OI CVCL_D185 ! iMPD183.C10
OI CVCL_D186 ! iMPD183.C11
SX Female
CA Induced pluripotent stem cell
//
ID iMPD183.C5
AC CVCL_D181
SY iPS MPD183 clone 5; iPS MPD 183 clone 5
DR ISCR; 1446
DR SKIP; SKIP000525
RX PubMed=19797525;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D178 ! iMPD183.C1
OI CVCL_D179 ! iMPD183.C2
OI CVCL_D180 ! iMPD183.C3
OI CVCL_D182 ! iMPD183.C6
OI CVCL_D183 ! iMPD183.C7
OI CVCL_D184 ! iMPD183.C8
OI CVCL_D185 ! iMPD183.C10
OI CVCL_D186 ! iMPD183.C11
SX Female
CA Induced pluripotent stem cell
//
ID iMPD183.C6
AC CVCL_D182
SY iPS MPD183 clone 6
DR ISCR; 1447
RX PubMed=19797525;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D178 ! iMPD183.C1
OI CVCL_D179 ! iMPD183.C2
OI CVCL_D180 ! iMPD183.C3
OI CVCL_D181 ! iMPD183.C5
OI CVCL_D183 ! iMPD183.C7
OI CVCL_D184 ! iMPD183.C8
OI CVCL_D185 ! iMPD183.C10
OI CVCL_D186 ! iMPD183.C11
SX Female
CA Induced pluripotent stem cell
//
ID iMPD183.C7
AC CVCL_D183
SY iPS MPD183 clone 7; iPS MPD 183 clone 7
DR ISCR; 1448
DR SKIP; SKIP000526
RX PubMed=19797525;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D178 ! iMPD183.C1
OI CVCL_D179 ! iMPD183.C2
OI CVCL_D180 ! iMPD183.C3
OI CVCL_D181 ! iMPD183.C5
OI CVCL_D182 ! iMPD183.C6
OI CVCL_D184 ! iMPD183.C8
OI CVCL_D185 ! iMPD183.C10
OI CVCL_D186 ! iMPD183.C11
SX Female
CA Induced pluripotent stem cell
//
ID iMPD183.C8
AC CVCL_D184
SY iPS MPD183 clone 8; iPS MPD 183 clone 8
DR ISCR; 1449
DR SKIP; SKIP000527
RX PubMed=19797525;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D178 ! iMPD183.C1
OI CVCL_D179 ! iMPD183.C2
OI CVCL_D180 ! iMPD183.C3
OI CVCL_D181 ! iMPD183.C5
OI CVCL_D182 ! iMPD183.C6
OI CVCL_D183 ! iMPD183.C7
OI CVCL_D185 ! iMPD183.C10
OI CVCL_D186 ! iMPD183.C11
SX Female
CA Induced pluripotent stem cell
//
ID iMPD562.C2
AC CVCL_D187
SY iPS MPD562 clone 2; iPS MPD 562 clone 2
DR ISCR; 1451
DR SKIP; SKIP000530
RX PubMed=19797525;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D188 ! iMPD562.C3
SX Female
CA Induced pluripotent stem cell
//
ID iMPD562.C3
AC CVCL_D188
SY iMPD562.C.3; iPS MPD562 clone 3; iPS MPD 562 clone 3
DR ISCR; 1450
DR SKIP; SKIP000531
RX PubMed=19797525;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D187 ! iMPD562.C2
SX Female
CA Induced pluripotent stem cell
//
ID IMR-31
AC CVCL_2527
SY IMR 31; IMR31; IMR 31 Bu; Bu (IMR-31); Bu; Institute for Medical Research-31
DR CLO; CLO_0002049
DR CLO; CLO_0006947
DR CLDB; cl503
DR CLDB; cl504
DR CLDB; cl5211
DR ATCC; CCL-40
DR ECACC; 89051704
DR IZSLER; BS CL 52
RX PubMed=7065527;
CC Discontinued: ATCC; CCL-40; true.
OX NCBI_TaxID=9901; ! Bison bison
SX Female
CA Finite cell line
//
ID IMR-32
AC CVCL_0346
SY IMR 32; IMR32; Institute for Medical Research-32; GM03320
DR BTO; BTO:0000934
DR CLO; CLO_0006948
DR CLO; CLO_0016777
DR EFO; EFO_0001195
DR MCCL; MCC:0000242
DR CLDB; cl2878
DR CLDB; cl2879
DR CLDB; cl2880
DR CLDB; cl2881
DR CLDB; cl2882
DR CLDB; cl2883
DR CLDB; cl2885
DR CLDB; cl2886
DR CLDB; cl2887
DR CLDB; cl2888
DR ATCC; CCL-127
DR BCRC; 60014
DR BCRJ; 0377
DR BioSample; SAMN03472412
DR BioSample; SAMN03473082
DR CCLE; IMR32_AUTONOMIC_GANGLIA
DR CCRID; 3111C0001CCC000282
DR CCRID; 3131C0001000700145
DR CGH-DB; 78-1
DR CGH-DB; 9095-4
DR ChEMBL-Cells; CHEMBL3307656
DR ChEMBL-Targets; CHEMBL614585
DR CLS; 300148/p666_IMR-32
DR Coriell; GM03320
DR Cosmic; 688067
DR Cosmic; 759892
DR Cosmic; 801746
DR Cosmic; 920239
DR Cosmic; 922658
DR Cosmic; 947702
DR Cosmic; 1019944
DR Cosmic; 1037352
DR Cosmic; 1099149
DR Cosmic; 1109111
DR Cosmic; 1237544
DR Cosmic; 1518066
DR Cosmic; 1526626
DR Cosmic; 2058113
DR Cosmic; 2131590
DR Cosmic; 2301580
DR Cosmic; 2393630
DR Cosmic; 2485944
DR DSMZ; ACC-165
DR ECACC; 86041809
DR GEO; GSM453632
DR GEO; GSM563362
DR GEO; GSM692859
DR GEO; GSM887162
DR GEO; GSM888234
DR GEO; GSM1366406
DR GEO; GSM1669934
DR ICLC; HTL96021
DR IFO; IFO50283
DR IZSLER; BS TCL 29
DR JCRB; JCRB9050
DR KCB; KCB 2011100YJ
DR KCLB; 10127
DR Lonza; 971
DR PRIDE; PXD000589
DR RCB; RCB1895
DR TKG; TKG 0207
RX DOI=10.1007/0-306-46872-7_2;
RX DOI=10.1007/978-1-4757-1647-4_13;
RX DOI=10.1016/B978-0-12-333530-2.50006-X;
RX PubMed=62055;
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=922665;
RX PubMed=2535691;
RX PubMed=5459762;
RX PubMed=6888561;
RX PubMed=6935474;
RX PubMed=7037175;
RX PubMed=7139592;
RX PubMed=7459858;
RX PubMed=7838528;
RX PubMed=8221663;
RX PubMed=9516836;
RX PubMed=11550280;
RX PubMed=12702577;
RX PubMed=22213050;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=25894527;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/i/cell-lines-detail-508.html
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~40-50 hours (DSMZ).
CC Omics: Cell surface proteome.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: Occasionally 'IMR-92'.
CC Discontinued: RCB; RCB1895; true.
ST Source(s): ATCC; CLS; COG; DSMZ; JCRB; KCLB; PubMed=25877200; RCB; TKG
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 9
ST D16S539: 8,10 (CLS)
ST D16S539: 8 (ATCC; COG; DSMZ; JCRB; PubMed=25877200; RCB; TKG)
ST D18S51: 12,15
ST D19S433: 14,15
ST D21S11: 30,31
ST D2S1338: 23,24
ST D3S1358: 16
ST D5S818: 11,12
ST D7S820: 9,10
ST D8S1179: 13
ST FGA: 21,24
ST Penta D: 11,12
ST Penta E: 7,15
ST TH01: 7,9.3 (CLS; COG; DSMZ; JCRB_IFO50283; KCLB; PubMed=25877200; RCB; TKG)
ST TH01: 7,10 (JCRB_JCRB9050)
ST TPOX: 11
ST vWA: 15
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID IMR-32 SimpleCell O-GalNAc
AC CVCL_S028
SY IMR32 SimpleCell; IMR32 SC
RX PubMed=23584533;
CC Characteristics: Cell engineered to produce only truncated GalNAc or NeuAc-alpha-2-6-GalNAc O-glycans.
CC Knockout cell: Method=ZFN; HGNC; 24338; C1GALT1C1.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0346 ! IMR-32
SX Male
CA Cancer cell line
//
ID IMR-32_pCMV-DPP3
AC CVCL_ER17
DR GEO; GSM148455
DR GEO; GSM148456
RX PubMed=17360324;
CC Transfected with: HGNC; 3008; DPP3.
CC Omics: Transcriptome analysis.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0346 ! IMR-32
SX Male
CA Cancer cell line
//
ID IMR-32_pCMV-SQSTM1
AC CVCL_ER18
DR GEO; GSM148457
DR GEO; GSM148458
RX PubMed=17360324;
CC Transfected with: HGNC; 11280; SQSTM1.
CC Omics: Transcriptome analysis.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0346 ! IMR-32
SX Male
CA Cancer cell line
//
ID IMR-33
AC CVCL_2528
SY IMR 33; IMR33; Institute for Medical Research-33
DR CLO; CLO_0006949
DR ATCC; CCL-146
DR ECACC; 96020931
RX PubMed=5554453;
OX NCBI_TaxID=10047; ! Meriones unguiculatus
SX Male
CA Cancer cell line
//
ID IMR-5
AC CVCL_1306
SY IMR 5; IMR5
DR BTO; BTO:0005846
DR CLO; CLO_0006950
DR CLDB; cl5097
DR ChEMBL-Cells; CHEMBL3308201
DR ChEMBL-Targets; CHEMBL2366209
DR Cosmic; 907170
DR Cosmic; 1019939
DR Cosmic; 1109364
DR Cosmic; 1161989
DR Cosmic; 1167417
DR Cosmic; 1890113
DR Cosmic-CLP; 907170
DR GDSC; 907170
DR GEO; GSM1669935
DR ICLC; HTL00009
RX PubMed=6160155;
RX PubMed=12536080;
RX PubMed=15150091;
RX PubMed=23202128;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 9
ST D16S539: 8
ST D5S818: 11,12
ST D7S820: 9,10
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 15
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0346 ! IMR-32
SX Male
CA Cancer cell line
//
ID IMR-5/75
AC CVCL_M473
SY IMR-5-75; IMR5/75; IMR5-75
DR Cosmic; 2393631
RX PubMed=16216448;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1306 ! IMR-5
SX Male
CA Cancer cell line
//
ID IMR-5/M-1
AC CVCL_M472
SY M-1
RX PubMed=3898405;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1306 ! IMR-5
SX Male
CA Cancer cell line
//
ID IMR-6
AC CVCL_5421
SY IMR 6; IMR6
DR BTO; BTO:0003535
DR Cosmic; 922657
CC From: Kennett R.; Department of Genetics; University of Pennsylvania; Philadelphia; USA.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID IMR-90
AC CVCL_0347
SY IMR 90; IMR90; Institute for Medical Research-90; I90
DR BTO; BTO:0001229
DR CLO; CLO_0006951
DR CLO; CLO_0029276
DR CLO; CLO_0029279
DR CLO; CLO_0029284
DR CLO; CLO_0029291
DR CLO; CLO_0029294
DR CLO; CLO_0029328
DR CLO; CLO_0029330
DR CLO; CLO_0029331
DR CLO; CLO_0029332
DR CLO; CLO_0029336
DR EFO; EFO_0001196
DR MCCL; MCC:0000243
DR CLDB; cl2889
DR CLDB; cl2890
DR ATCC; CCL-186
DR ATCC; CRL-7931
DR BCRC; 60204
DR BCRJ; 0118
DR BioSample; SAMN03471461
DR BioSample; SAMN03472414
DR ChEMBL-Cells; CHEMBL3307985
DR ChEMBL-Targets; CHEMBL612577
DR Coriell; I90-10
DR Coriell; I90-15
DR Coriell; I90-19
DR Coriell; I90-24
DR Coriell; I90-26
DR Coriell; I90-33
DR Coriell; I90-40
DR Coriell; I90-52
DR Coriell; I90-53
DR Coriell; I90-78
DR Coriell; I90-79
DR Coriell; I90-83
DR ECACC; 85020204
DR ENCODE; ENCBS007TVF
DR ENCODE; ENCBS048GPK
DR ENCODE; ENCBS048TNH
DR ENCODE; ENCBS073JZM
DR ENCODE; ENCBS192DLO
DR ENCODE; ENCBS357USI
DR ENCODE; ENCBS364NFD
DR ENCODE; ENCBS368ENC
DR ENCODE; ENCBS369ENC
DR ENCODE; ENCBS370ENC
DR ENCODE; ENCBS371ENC
DR ENCODE; ENCBS371NWL
DR ENCODE; ENCBS372ENC
DR ENCODE; ENCBS373ENC
DR ENCODE; ENCBS379ENC
DR ENCODE; ENCBS410ENC
DR ENCODE; ENCBS411ENC
DR ENCODE; ENCBS412ENC
DR ENCODE; ENCBS412SDE
DR ENCODE; ENCBS413ENC
DR ENCODE; ENCBS414ENC
DR ENCODE; ENCBS415ENC
DR ENCODE; ENCBS416ENC
DR ENCODE; ENCBS460CLV
DR ENCODE; ENCBS472JFT
DR ENCODE; ENCBS486FIC
DR ENCODE; ENCBS598YLQ
DR ENCODE; ENCBS648SCY
DR ENCODE; ENCBS683AVF
DR ENCODE; ENCBS754TWW
DR ENCODE; ENCBS780OTZ
DR ENCODE; ENCBS981IKS
DR ENCODE; ENCBS981UBX
DR ENCODE; ENCBS982GUC
DR ENCODE; ENCBS992YMT
DR GEO; GSM432687
DR GEO; GSM432688
DR GEO; GSM432689
DR GEO; GSM432690
DR GEO; GSM432691
DR GEO; GSM432692
DR GEO; GSM438363
DR GEO; GSM438364
DR GEO; GSM468792
DR GEO; GSM468801
DR GEO; GSM469965
DR GEO; GSM469966
DR GEO; GSM469967
DR GEO; GSM469968
DR GEO; GSM469970
DR GEO; GSM469973
DR GEO; GSM469974
DR GEO; GSM469975
DR GEO; GSM521866
DR GEO; GSM521868
DR GEO; GSM521869
DR GEO; GSM521870
DR GEO; GSM521871
DR GEO; GSM521873
DR GEO; GSM521874
DR GEO; GSM521875
DR GEO; GSM521877
DR GEO; GSM521878
DR GEO; GSM521879
DR GEO; GSM521880
DR GEO; GSM521881
DR GEO; GSM521883
DR GEO; GSM521884
DR GEO; GSM521885
DR GEO; GSM521886
DR GEO; GSM521887
DR GEO; GSM521889
DR GEO; GSM521890
DR GEO; GSM521892
DR GEO; GSM521893
DR GEO; GSM521894
DR GEO; GSM521895
DR GEO; GSM521897
DR GEO; GSM521898
DR GEO; GSM521899
DR GEO; GSM521900
DR GEO; GSM521901
DR GEO; GSM521902
DR GEO; GSM521903
DR GEO; GSM521904
DR GEO; GSM521906
DR GEO; GSM521907
DR GEO; GSM521908
DR GEO; GSM521909
DR GEO; GSM521911
DR GEO; GSM521912
DR GEO; GSM521913
DR GEO; GSM521914
DR GEO; GSM521915
DR GEO; GSM521917
DR GEO; GSM521918
DR GEO; GSM521919
DR GEO; GSM521921
DR GEO; GSM521922
DR GEO; GSM521923
DR GEO; GSM521924
DR GEO; GSM521925
DR GEO; GSM521926
DR GEO; GSM521927
DR GEO; GSM521928
DR GEO; GSM521929
DR GEO; GSM521930
DR GEO; GSM521931
DR GEO; GSM521932
DR GEO; GSM521933
DR GEO; GSM530665
DR GEO; GSM530666
DR GEO; GSM541279
DR GEO; GSM541280
DR GEO; GSM604470
DR GEO; GSM604471
DR GEO; GSM723024
DR GEO; GSM752986
DR GEO; GSM752987
DR GEO; GSM818007
DR GEO; GSM818008
DR GEO; GSM818012
DR GEO; GSM818013
DR GEO; GSM818017
DR GEO; GSM827198
DR GEO; GSM832837
DR GEO; GSM832838
DR GEO; GSM909321
DR GEO; GSM909338
DR GEO; GSM909339
DR GEO; GSM959044
DR GEO; GSM1008586
DR GEO; GSM1068140
DR GEO; GSM1068141
DR GEO; GSM1186664
DR GEO; GSM1296454
DR GEO; GSM1463270
DR IMGT/HLA; 11782
DR IZSLER; BS CL 107
DR JCRB; JCRB0516
DR JCRB; JCRB9054
DR KCLB; 10186
DR Lonza; 745
DR PRIDE; PXD000134
RX PubMed=738322;
RX PubMed=841339;
RX PubMed=7065527;
RX PubMed=22108792;
RX PubMed=23325432;
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/IMR90_Stam_protocol.pdf
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/i/cell-lines-detail-246.html
CC Part of: ENCODE project common cell types; tier 2.
CC Part of: International Histocompatibility Workshop cell lines.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Omics: Deep proteome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Genome sequenced.
CC Omics: H2AK5ac ChIP-seq epigenome analysis.
CC Omics: H2AK9ac ChIP-seq epigenome analysis.
CC Omics: H2BK120ac ChIP-seq epigenome analysis.
CC Omics: H2BK12ac ChIP-seq epigenome analysis.
CC Omics: H2BK15ac ChIP-seq epigenome analysis.
CC Omics: H2BK20ac ChIP-seq epigenome analysis.
CC Omics: H2BK5ac ChIP-seq epigenome analysis.
CC Omics: H3K14ac ChIP-seq epigenome analysis.
CC Omics: H3K18ac ChIP-seq epigenome analysis.
CC Omics: H3K23ac ChIP-seq epigenome analysis.
CC Omics: H3K27ac ChIP-seq epigenome analysis.
CC Omics: H3K27me3 ChIP-seq epigenome analysis.
CC Omics: H3K36me3 ChIP-seq epigenome analysis.
CC Omics: H3K4ac ChIP-seq epigenome analysis.
CC Omics: H3K4me1 ChIP-seq epigenome analysis.
CC Omics: H3K4me2 ChIP-seq epigenome analysis.
CC Omics: H3K4me3 ChIP-seq epigenome analysis.
CC Omics: H3K56ac ChIP-seq epigenome analysis.
CC Omics: H3K79me1 ChIP-seq epigenome analysis.
CC Omics: H3K79me2 ChIP-seq epigenome analysis.
CC Omics: H3K9ac ChIP-seq epigenome analysis.
CC Omics: H3K9me1 ChIP-seq epigenome analysis.
CC Omics: H3K9me3 ChIP-seq epigenome analysis.
CC Omics: H4K20me1 ChIP-seq epigenome analysis.
CC Omics: H4K5ac ChIP-seq epigenome analysis.
CC Omics: H4K8ac ChIP-seq epigenome analysis.
CC Omics: H4K91ac ChIP-seq epigenome analysis.
CC Discontinued: ATCC; CRL-7931; true.
CC Discontinued: Coriell; I90-52; probable.
CC Discontinued: Coriell; I90-78; probable.
ST Source(s): ATCC; JCRB; KCLB; PubMed=11416159
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 11,13
ST D16S539: 10,13
ST D18S51: 17
ST D21S11: 30.2,31
ST D3S1358: 14,15
ST D5S818: 12,13
ST D7S820: 9,12
ST D8S1179: 13,14
ST FGA: 25,26
ST TH01: 8,9.3 (ATCC; KCLB; PubMed=11416159)
ST TH01: 8,10 (JCRB)
ST TPOX: 8,9
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID IMR-90-40
AC CVCL_2963
DR JCRB; JCRB0519
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0347 ! IMR-90
SX Female
CA Finite cell line
//
ID IMR-90-50
AC CVCL_2964
DR JCRB; JCRB0520
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0347 ! IMR-90
SX Female
CA Finite cell line
//
ID IMR-90-SV
AC CVCL_6269
SY IMR90-SV
DR CLO; CLO_0050033
DR BioSample; SAMN03472209
DR RCB; RCB1024
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 11,13
ST D16S539: 10,13
ST D5S818: 12,13
ST D7S820: 9,12
ST TH01: 8
ST TPOX: 8,9
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0347 ! IMR-90
SX Female
CA Transformed cell line
//
ID IMR-90/GFPdeltaRaf-1[YY]:ER
AC CVCL_HA48
RX PubMed=9765202;
CC Characteristics: Transfected with a construct that is composed of EGFP at the N-terminus, the catalytic domain of RAF1 (with 340-DD-341) in the middle and the hormone-binding domain of ESR1 at the C-terminus. Protein kinase activity is activated by estrogen or analogs such as 4-hydroxy-tamoxifen.
CC Transfected with: HGNC; 9829; RAF1 (catalytic domain with D-340 and D-341).
CC Transfected with: HGNC; 3467; ESR1 (hormone-binding domain).
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0347 ! IMR-90
SX Female
CA Finite cell line
//
ID IMR-91
AC CVCL_5420
SY IMR 91; IMR91; IMR-91L; IMR-91 Lung; Institute for Medical Research-91 Lung; I91L
DR CLO; CLO_0029259
DR CLO; CLO_0029261
DR CLO; CLO_0029282
DR CLO; CLO_0029303
DR CLO; CLO_0029304
DR CLO; CLO_0029305
DR CLO; CLO_0029306
DR Coriell; I91L-07
DR Coriell; I91L-12
DR Coriell; I91L-13
DR Coriell; I91L-15
DR Coriell; I91L-16
DR Coriell; I91L-17
DR Coriell; I91L-18
RX PubMed=738322;
RX PubMed=6629383;
ST Source(s): PubMed=11416159
ST Amelogenin: X,Y
ST D18S51: 15,16
ST D21S11: 27,31.2
ST D8S1179: 13,14
ST FGA: 23,24
ST TH01: 9
ST vWA: 14,19
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_CX66 ! IMR-91S
SX Male
CA Finite cell line
//
ID IMR-91S
AC CVCL_CX66
SY IMR-91 Skin; Institute for Medical Research-91 Skin; I91S
DR CLO; CLO_0029246
DR CLO; CLO_0029248
DR CLO; CLO_0029250
DR CLO; CLO_0029252
DR CLO; CLO_0029256
DR Coriell; I91S-04
DR Coriell; I91S-05
DR Coriell; I91S-06
DR Coriell; I91S-07
DR Coriell; I91S-08
RX PubMed=738322;
RX PubMed=6629383;
CC Discontinued: Coriell; I91S-06; probable.
CC Discontinued: Coriell; I91S-07; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5420 ! IMR-91
SX Male
CA Finite cell line
//
ID IMS/M1
AC CVCL_A623
SY IMS-M1; IMS/MI; IMS-MI
DR Cosmic; 787437
DR Cosmic; 975256
DR Cosmic; 996321
DR Cosmic; 1037672
DR Cosmic; 1281319
DR Cosmic; 2089654
DR Cosmic; 2378128
RX PubMed=23955599;
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ImST
AC CVCL_HE73
SY Stom-WT
RX PubMed=12878595;
WW https://www.abmgood.com/Immortalized-(Conditionally)-Mouse-Stomach-Epithelial-Cells-(ImSt)-T0569.html
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID IMT 9
AC CVCL_4348
SY IMT9
DR ECACC; 95060901
CC Selected for resistance to: ChEBI; CHEBI:48775; Cadmium(2+).
CC Transformant: ChEBI; CHEBI:82373; N-nitroso-N-methylurethane.
CC Discontinued: ECACC; 95060901; probable.
OX NCBI_TaxID=9888; ! Muntiacus muntjak
HI CVCL_4349 ! SCR5
SX Male
CA Transformed cell line
//
ID IMT-1
AC CVCL_L785
RX PubMed=22273270;
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0560 ! TIG-1
SX Female
CA Telomerase immortalized cell line
//
ID imWilms10
AC CVCL_DF34
RX PubMed=27213811;
CC Characteristics: Has a homozygous deletion of WT1 nested within a heterozygous 11p13 deletion.
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Omics: SNP array analysis.
DI NCIt; C40407; Renal Wilms tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Conditionally immortalized cell line
//
ID iMycEmu-1
AC CVCL_0348
SY iMycEmu1
DR MCCL; MCC:0000498
RX PubMed=16277667;
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID iMycEmu-2
AC CVCL_0349
SY iMycEmu2
DR MCCL; MCC:0000499
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID IN-1
AC CVCL_W473
RX PubMed=1964585;
DI NCIt; C3211; Non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID In-111-R1
AC CVCL_GR54
SY In-111 R1
RX PubMed=221713;
CC Transformant: NCBI_TaxID; 1891762; BK polyomavirus (BKPyV).
OX NCBI_TaxID=10029; ! Cricetulus griseus
CA Cancer cell line
//
ID In-R1-G9
AC CVCL_0353
SY InR1-G9; InRIG9; INR1G9; InR1G9
DR BTO; BTO:0002740
DR MCCL; MCC:0000247
DR TOKU-E; 3993
RX PubMed=2834160;
RX PubMed=2869020;
CC Transformant: NCBI_TaxID; 1891762; BK polyomavirus (BKPyV).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_GR54 ! In-111-R1
CA Cancer cell line
//
ID IN157
AC CVCL_0350
SY IN-157; IN/157; IN 157
DR MCCL; MCC:0000244
RX PubMed=1620276;
CC Problematic cell line: Contaminated. Shown to be a RD derivative (PubMed=1620276).
DI NCIt; C8971; Embryonal rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1649 ! RD
SX Female
CA Cancer cell line
//
ID in203-3Y1-19
AC CVCL_K111
DR RCB; RCB0336
RX PubMed=2961438;
CC Transformant: NCBI_TaxID; 28282; Adenovirus 12 [in203S].
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID in203-3Y1-23
AC CVCL_K112
DR RCB; RCB0337
RX PubMed=2961438;
CC Transformant: NCBI_TaxID; 28282; Adenovirus 12 [in203S].
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID in203-3Y1-7
AC CVCL_K113
DR RCB; RCB0335
RX PubMed=2961438;
CC Transformant: NCBI_TaxID; 28282; Adenovirus 12 [in203S].
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID IN24
AC CVCL_F501
RX PubMed=3210476;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
CA Cancer cell line
//
ID IN699
AC CVCL_AU96
RX PubMed=22741033;
RX PubMed=23340741;
RX PubMed=24335698;
ST Source(s): PubMed=24335698
ST Amelogenin: X,Y
ST CSF1PO: 9,11
ST D13S317: 10,11
ST D16S539: 10,13
ST D21S11: 28
ST D5S818: 12
ST D7S820: 9,10
ST TH01: 7,9
ST TPOX: 8
ST vWA: 19
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID INA-6
AC CVCL_5209
SY INA6
DR BTO; BTO:0004745
DR EFO; EFO_0005386
DR Cosmic; 1424216
DR Cosmic; 1483075
DR Cosmic; 2081383
RX CelloPub=CLPUB00060;
RX PubMed=10936422;
RX PubMed=11920233;
RX PubMed=19621390;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=INA-6
CC Characteristics: IL6 dependent.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID INA-6.Tu1
AC CVCL_0C40
SY Tu1
RX PubMed=19621390;
CC Characteristics: IL6 dependent.
CC Characteristics: INA-6 cells derived from a tumor that grew in a SCID mouse.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5209 ! INA-6
SX Male
CA Cancer cell line
//
ID INBL
AC CVCL_5140
DR BTO; BTO:0003112
DR SKY/M-FISH/CGH; 2650
RX PubMed=12659655;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID INC-2
AC CVCL_3902
SY INC2
DR BTO; BTO:0004264
RX PubMed=9227903;
CC Breed/subspecies: C3H.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0188 ! C2C12
SX Female
CA Spontaneously immortalized cell line
//
ID INEM-1
AC CVCL_R976
SY INconnu EMbryonic-1
RX DOI=10.1577/1548-8667(1990)002<0061:COACLD>2.3.CO;2;
CC Group: Fish cell line.
OX NCBI_TaxID=59296; ! Stenodus leucichthys
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID INER-37
AC CVCL_5621
DR BTO; BTO:0002558
RX PubMed=16271071;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID INER-51
AC CVCL_5531
DR BTO; BTO:0002559
RX PubMed=16001980;
RX PubMed=16271071;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID INER-51/PSC-1
AC CVCL_5622
SY INER-51 PSC-1 clone; PSC-1
DR BTO; BTO:0002567
RX PubMed=16001980;
RX PubMed=16271071;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5531 ! INER-51
CA Cancer cell line
//
ID INER-51/VP-1
AC CVCL_5623
SY INER-51 VP-1 clone; VP-1
RX PubMed=16271071;
CC Selected for resistance to: ChEBI; CHEBI:4911; Etoposide (VP-16).
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5531 ! INER-51
CA Cancer cell line
//
ID INF-3A
AC CVCL_S482
RX PubMed=2778838;
WW http://www.infarktforschung.de/macrophages_cell_lines.html
CC Transformant: Recombinant retrovirus J2.
CC Breed/subspecies: C3H/HeN.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID Ingles
AC CVCL_L358
DR BTO; BTO:0005357
RX PubMed=21552385;
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID INOF2
AC CVCL_0T67
SY INOF
RX PubMed=20360942;
WW http://www.e-lucid.com/i/materials/cell_lines/INOF2.html
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Telomerase immortalized cell line
//
ID INS-1
AC CVCL_0352
SY INS1
DR BTO; BTO:0002135
DR EFO; EFO_0002529
DR MCCL; MCC:0000246
DR CCRID; 3111C0001CCC000378
DR ChEMBL-Cells; CHEMBL3308040
DR ChEMBL-Targets; CHEMBL613545
DR Lonza; 301
DR TOKU-E; 3996
RX PubMed=1370150;
RX PubMed=22538498;
WW http://www.addexbio.com/productdetail?pid=371
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/i/cell-lines-detail-31.html
CC Breed/subspecies: NEDH.
DI NCIt; C121566; Rat insulinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_J993 ! INS-2
CA Cancer cell line
//
ID INS-1 832/1
AC CVCL_EG57
SY INS-1 (832/1); 832/1
DR BCGO; BCGO_0000113
RX PubMed=10868964;
CC Transfected with: HGNC; 6081; INS.
CC Breed/subspecies: NEDH.
DI NCIt; C121566; Rat insulinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0352 ! INS-1
CA Cancer cell line
//
ID INS-1 832/13
AC CVCL_7226
SY INS1 832/13; INS-1 (832/13); INS 832/13 ; 832/13; 832/13 INS-1
DR BCGO; BCGO_0000115
DR BTO; BTO:0003318
DR Lonza; 11
DR TOKU-E; 4125
RX PubMed=10868964;
RX PubMed=23555872;
CC Transfected with: HGNC; 6081; INS.
CC Misspelling: Occasionally '823/13'.
CC Misspelling: Occasionally 'INS-1 823/13'.
CC Breed/subspecies: NEDH.
DI NCIt; C121566; Rat insulinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0352 ! INS-1
CA Cancer cell line
//
ID INS-1 832/2
AC CVCL_EG56
SY INS-1 (832/2); 832/2
DR BCGO; BCGO_0000116
RX PubMed=10868964;
CC Transfected with: HGNC; 6081; INS.
CC Breed/subspecies: NEDH.
DI NCIt; C121566; Rat insulinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0352 ! INS-1
CA Cancer cell line
//
ID INS-1 833/117
AC CVCL_2G79
SY INS-1 (833/117); 833/117
DR BCGO; BCGO_0000117
RX PubMed=10871193;
CC Transfected with: HGNC; 6081; INS.
CC Breed/subspecies: NEDH.
DI NCIt; C121566; Rat insulinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0352 ! INS-1
CA Cancer cell line
//
ID INS-1 833/15
AC CVCL_2G78
SY INS-1 (833/15); 833/15
DR BCGO; BCGO_0000118
RX PubMed=10871193;
CC Transfected with: HGNC; 6081; INS.
CC Breed/subspecies: NEDH.
DI NCIt; C121566; Rat insulinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0352 ! INS-1
CA Cancer cell line
//
ID INS-1 834/40
AC CVCL_2G77
SY 834/40
DR BCGO; BCGO_0000119
RX PubMed=10871193;
CC Transfected with: HGNC; 6081; INS.
CC Breed/subspecies: NEDH.
DI NCIt; C121566; Rat insulinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0352 ! INS-1
CA Cancer cell line
//
ID INS-1E
AC CVCL_0351
SY INS1-E; INS1E
DR BCGO; BCGO_0000120
DR BTO; BTO:0003317
DR MCCL; MCC:0000245
DR Lonza; 1137
RX PubMed=14592952;
WW http://www.addexbio.com/productdetail?pid=4675
CC Breed/subspecies: NEDH.
DI NCIt; C121566; Rat insulinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0352 ! INS-1
CA Cancer cell line
//
ID INS-2
AC CVCL_J993
SY INS2
RX PubMed=1370150;
CC Breed/subspecies: NEDH.
DI NCIt; C121566; Rat insulinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_0352 ! INS-1
CA Cancer cell line
//
ID INS-r3
AC CVCL_W945
SY INSr3
RX PubMed=9113996;
RX PubMed=18708196;
CC Breed/subspecies: NEDH.
DI NCIt; C121566; Rat insulinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0352 ! INS-1
CA Cancer cell line
//
ID INS-r3-GK27
AC CVCL_W946
RX PubMed=9113996;
RX PubMed=9325299;
CC Transfected with: RGD; 2670; Gck.
CC Breed/subspecies: NEDH.
DI NCIt; C121566; Rat insulinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_W945 ! INS-r3
CA Cancer cell line
//
ID Int-3LL
AC CVCL_8358
DR JCRB; JCRB1351
RX PubMed=10408901;
CC Breed/subspecies: C57BL/6.
DI NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5653 ! 3LL
CA Cancer cell line
//
ID INT.Ov1
AC CVCL_DF86
RX PubMed=9334822;
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID INT.Ov2
AC CVCL_DF87
SY INTOV2
DR GEO; GSM313674
RX PubMed=9334822;
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID INT.Ov3
AC CVCL_DF88
RX PubMed=9334822;
CC Derived from metastatic site: Ascites.
DI NCIt; C5243; Ovarian mucinous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID INT.Ov4
AC CVCL_DF89
RX PubMed=9334822;
DI NCIt; C5243; Ovarian mucinous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID INT.Ov5
AC CVCL_DF90
RX PubMed=9334822;
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID INT.Ov6
AC CVCL_DF91
RX PubMed=9334822;
CC Derived from metastatic site: Ascites.
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID INT.Ov7
AC CVCL_DF92
RX PubMed=9334822;
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID INT.Ov8
AC CVCL_DF93
RX PubMed=9334822;
DI NCIt; C5243; Ovarian mucinous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID INT.Ov9
AC CVCL_DF94
RX PubMed=9334822;
DI NCIt; C9192; Ovarian carcinosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Intestine 407
AC CVCL_1907
SY intestine 407; Intestine-407; intestine-407; INT 407; Int 407; INT-407; Int-407; Int407; INT407; HEI
DR BTO; BTO:0000633
DR CLO; CLO_0006953
DR CLO; CLO_0006954
DR CLO; CLO_0006955
DR CLDB; cl2895
DR CLDB; cl2896
DR CLDB; cl2897
DR CLDB; cl2898
DR ATCC; CCL-6
DR BioSample; SAMN03151723
DR ECACC; 85051004
DR IZSLER; BS CL 53
DR RCB; RCB0553
RX PubMed=566722;
RX PubMed=1246601;
RX PubMed=13475808;
RX PubMed=20143388;
RX PubMed=23925245;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=566722, PubMed=1246601, PubMed=20143388). Was originally thought to originate from embryonic intestinal cells (jejunum/ileum).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Omics: Genome sequenced (low read coverage).
CC Discontinued: RCB; RCB0553; true.
ST Source(s): ATCC; PubMed=11416159
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 12,13.3
ST D16S539: 9,10
ST D18S51: 16
ST D21S11: 27,28
ST D5S818: 11,12
ST D7S820: 8,12
ST D8S1179: 12,13
ST FGA: 18,21
ST TH01: 7
ST TPOX: 8,12
ST vWA: 16,18
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID INV-3
AC CVCL_0C65
SY inv-3
DR Cosmic; 1037662
DR Cosmic; 2089661
RX PubMed=23955599;
DI NCIt; C3171; Acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID IOBA-NHC
AC CVCL_9Y68
SY Instituto de OftalmoBiologia Aplicada - Normal Human Conjunctiva
RX PubMed=14507870;
RX PubMed=19630270;
RX PubMed=26260330;
CC Omics: Deep proteome analysis.
CC Omics: Metabolome analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Spontaneously immortalized cell line
//
ID iOECHHN
AC CVCL_0P76
SY immortalized Oral Epithelial Cells from HIV+ HAART Naive subject
WW https://www.kerafast.com/product/1796/oral-epithelial-hiv-cell-line
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID IOMM-Lee
AC CVCL_5779
SY IOMM-LEE; Iomm-Lee; IOMM Lee; IOMMLEE
DR BTO; BTO:0004464
DR CCLE; IOMMLEE_CENTRAL_NERVOUS_SYSTEM
DR Cosmic; 2516047
RX PubMed=2234331;
RX PubMed=18261772;
RX PubMed=25984343;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 18 hours (PubMed=25984343).
CC Omics: shRNA library screening.
DI NCIt; C3230; Meningioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID IOMM-Lee-LucNeo
AC CVCL_HA67
RX PubMed=18240927;
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
DI NCIt; C3230; Meningioma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5779 ! IOMM-Lee
SX Male
CA Cancer cell line
//
ID IOR-CEA1
AC CVCL_HA36
SY IOR-ANTI CEA
DR BCRJ; 0119
CC Discontinued: BCRJ; 0119; probable.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID IOR/BER
AC CVCL_H723
RX PubMed=11891184;
CC From: Laboratorio di Ricerca Oncologica; Istituti Ortopedici Rizzoli; Bologna; Italy.
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID IOR/BRZ
AC CVCL_H724
SY IOR-BRZ
RX PubMed=11891184;
CC From: Laboratorio di Ricerca Oncologica; Istituti Ortopedici Rizzoli; Bologna; Italy.
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID IOR/CAR
AC CVCL_H725
RX PubMed=11891184;
CC From: Laboratorio di Ricerca Oncologica; Istituti Ortopedici Rizzoli; Bologna; Italy.
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID IOR/CLB
AC CVCL_H726
SY IOR-CLB
RX PubMed=11891184;
CC From: Laboratorio di Ricerca Oncologica; Istituti Ortopedici Rizzoli; Bologna; Italy.
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID IOR/EW4
AC CVCL_A624
SY IOR-EW4
DR Cosmic; 1082510
RX PubMed=8617485;
CC From: Laboratorio di Ricerca Oncologica; Istituti Ortopedici Rizzoli; Bologna; Italy.
DI NCIt; C35871; Ewing sarcoma/peripheral primitive neuroectodermal tumor of bone
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID IOR/MOS
AC CVCL_9986
SY IOR-MOS; MOS
DR Cosmic; 1082495
DR Cosmic; 1529896
DR GEO; GSM879214
RX PubMed=8617485;
RX PubMed=9935160;
RX PubMed=19787792;
RX PubMed=21519327;
CC From: Laboratorio di Ricerca Oncologica; Istituti Ortopedici Rizzoli; Bologna; Italy.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID IOR/NGR
AC CVCL_H727
SY IOR-NGR
RX PubMed=11891184;
CC From: Laboratorio di Ricerca Oncologica; Istituti Ortopedici Rizzoli; Bologna; Italy.
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID IOR/OS10
AC CVCL_9989
SY IOR-OS10; OS-10; OS10
DR Cosmic; 1082498
DR Cosmic; 1529913
DR GEO; GSM879210
RX PubMed=8617485;
RX PubMed=9935160;
RX PubMed=19787792;
RX PubMed=21519327;
CC From: Laboratorio di Ricerca Oncologica; Istituti Ortopedici Rizzoli; Bologna; Italy.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID IOR/OS14
AC CVCL_9990
SY IOR-OS14; OS-14; OS14
DR Cosmic; 1082499
DR GEO; GSM879211
RX PubMed=8617485;
RX PubMed=9935160;
RX PubMed=19787792;
RX PubMed=21519327;
CC From: Laboratorio di Ricerca Oncologica; Istituti Ortopedici Rizzoli; Bologna; Italy.
DI NCIt; C4023; Small cell osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID IOR/OS15
AC CVCL_9991
SY IOR-OS15; OS-15; OS15
DR Cosmic; 1082500
DR Cosmic; 1529907
DR GEO; GSM879212
RX PubMed=8617485;
RX PubMed=9935160;
RX PubMed=19787792;
RX PubMed=21519327;
CC From: Laboratorio di Ricerca Oncologica; Istituti Ortopedici Rizzoli; Bologna; Italy.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID IOR/OS17
AC CVCL_9992
SY OS-17
DR Cosmic; 1082501
RX PubMed=8617485;
RX PubMed=9935160;
CC From: Laboratorio di Ricerca Oncologica; Istituti Ortopedici Rizzoli; Bologna; Italy.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID IOR/OS18
AC CVCL_9993
SY IOR-OS18; OS-18; OS18
DR Cosmic; 1082502
DR Cosmic; 1529899
DR GEO; GSM879213
RX PubMed=8617485;
RX PubMed=9935160;
RX PubMed=19787792;
RX PubMed=21519327;
CC From: Laboratorio di Ricerca Oncologica; Istituti Ortopedici Rizzoli; Bologna; Italy.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID IOR/OS19
AC CVCL_9994
SY OS-19
DR Cosmic; 1082503
RX PubMed=8617485;
RX PubMed=9935160;
CC From: Laboratorio di Ricerca Oncologica; Istituti Ortopedici Rizzoli; Bologna; Italy.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID IOR/OS7
AC CVCL_9987
SY OS-7
DR Cosmic; 1082496
RX PubMed=8617485;
RX PubMed=9935160;
CC From: Laboratorio di Ricerca Oncologica; Istituti Ortopedici Rizzoli; Bologna; Italy.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID IOR/OS9
AC CVCL_9988
SY IOR-OS9; OS-9; OS9
DR Cosmic; 1082497
DR Cosmic; 1529911
DR GEO; GSM879209
RX PubMed=8617485;
RX PubMed=9935160;
RX PubMed=19787792;
RX PubMed=21519327;
CC From: Laboratorio di Ricerca Oncologica; Istituti Ortopedici Rizzoli; Bologna; Italy.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID IOR/RCH
AC CVCL_H728
SY IOR-RCH
RX PubMed=11891184;
CC From: Laboratorio di Ricerca Oncologica; Istituti Ortopedici Rizzoli; Bologna; Italy.
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID IOR/SARG
AC CVCL_9995
SY IOR-SARG; SARG
DR Cosmic; 1082494
DR Cosmic; 1529897
DR GEO; GSM879215
RX PubMed=1622859;
RX PubMed=8617485;
RX PubMed=9935160;
RX PubMed=19787792;
RX PubMed=21519327;
CC From: Laboratorio di Ricerca Oncologica; Istituti Ortopedici Rizzoli; Bologna; Italy.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID IOSE-10
AC CVCL_5532
SY IOSE10
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID IOSE-120
AC CVCL_E240
SY IOSE 120; IOSE120; NFHIOSE-120
RX PubMed=10329039;
CC From: Canadian Ovarian Tissue Bank; University of British Columbia; Vancouver; Canada.
CC Doubling time: 45.9 hours (PubMed=10329039).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID IOSE-121
AC CVCL_E228
SY IOSE 121; IOSE121; NFHIOSE-121; IOSE-Low
RX PubMed=10329039;
CC From: Canadian Ovarian Tissue Bank; University of British Columbia; Vancouver; Canada.
CC Doubling time: 35.3 hours (PubMed=10329039).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID IOSE-144
AC CVCL_5533
SY IOSE144; IOSE 144; NFHIOSE-144
RX PubMed=10329039;
CC From: Canadian Ovarian Tissue Bank; University of British Columbia; Vancouver; Canada.
CC Doubling time: 28 hours (PubMed=10329039).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID IOSE-144RZ
AC CVCL_5534
SY IOSE 144RZ; I-144RZ
RX PubMed=17266044;
CC Transfected with: HGNC; 13009; ZNF217.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5533 ! IOSE-144
SX Female
CA Transformed cell line
//
ID IOSE-29
AC CVCL_5535
SY IOSE 29; IOSE29; NFHIOSE-29; IOSE-Mar; IOSE-MAR
DR BTO; BTO:0004132
DR Lonza; 12
RX PubMed=1326894;
RX PubMed=7967506;
RX PubMed=10329039;
RX PubMed=23415752;
CC From: Canadian Ovarian Tissue Bank; University of British Columbia; Vancouver; Canada.
CC Doubling time: 33.7 hours (PubMed=10329039).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID IOSE-29EC
AC CVCL_5536
RX PubMed=10652437;
CC Transfected with: MGI; MGI:88354; Cdh1.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5535 ! IOSE-29
SX Female
CA Transformed cell line
//
ID IOSE-29EC/T4
AC CVCL_5537
RX PubMed=10652437;
CC Transfected with: MGI; MGI:88354; Cdh1.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5536 ! IOSE-29EC
SX Female
CA Transformed cell line
//
ID IOSE-29EC/T5
AC CVCL_5538
RX PubMed=10652437;
CC Transfected with: MGI; MGI:88354; Cdh1.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5536 ! IOSE-29EC
SX Female
CA Transformed cell line
//
ID IOSE-2Ap2
AC CVCL_5539
DR BTO; BTO:0004134
RX PubMed=16585202;
CC From: Katabuchi H.; Kumamoto University School of Medicine; Kumamoto; Japan.
CC Transformant: Unknown.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID IOSE-364
AC CVCL_5540
SY IOSE 364; IOSE364; IOSE-364(-)
DR GDSC; 1479991
DR GEO; GSM1669936
CC From: Canadian Ovarian Tissue Bank; University of British Columbia; Vancouver; Canada.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Omics: DNA methylation analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID IOSE-385
AC CVCL_E229
SY IOSE 385; IOSE385
CC From: Canadian Ovarian Tissue Bank; University of British Columbia; Vancouver; Canada.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID IOSE-386
AC CVCL_E230
SY IOSE 386; IOSE386
CC From: Canadian Ovarian Tissue Bank; University of British Columbia; Vancouver; Canada.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID IOSE-397
AC CVCL_5541
SY IOSE 397; IOSE397
DR BTO; BTO:0004131
DR GDSC; 1479992
DR GEO; GSM1669937
RX PubMed=27561551;
CC From: Canadian Ovarian Tissue Bank; University of British Columbia; Vancouver; Canada.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Omics: Deep proteome analysis.
CC Omics: DNA methylation analysis.
CC Misspelling: 'IOSE379' in PubMed=20332224.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID IOSE-398
AC CVCL_5542
SY IOSE 398; IOSE398
DR BTO; BTO:0004135
DR TOKU-E; 4059
RX PubMed=15531506;
CC From: Canadian Ovarian Tissue Bank; University of British Columbia; Vancouver; Canada.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID IOSE-4p2
AC CVCL_5543
DR BTO; BTO:0004133
RX PubMed=16585202;
CC From: Katabuchi H.; Kumamoto University School of Medicine; Kumamoto; Japan.
CC Transformant: Unknown.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID IOSE-523
AC CVCL_E234
SY IOSE 523; IOSE523; IOSE-523(-)
DR GDSC; 1479993
DR GEO; GSM1669938
CC From: Canadian Ovarian Tissue Bank; University of British Columbia; Vancouver; Canada.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Omics: DNA methylation analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID IOSE-53
AC CVCL_E270
SY IOSE 53; IOSE53; IOSE-Heff; IOSE-HEFF
RX PubMed=1326894;
RX PubMed=7967506;
CC From: Canadian Ovarian Tissue Bank; University of British Columbia; Vancouver; Canada.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID IOSE-592F
AC CVCL_5544
SY IOSE 592F; IOSE592F
CC From: Canadian Ovarian Tissue Bank; University of British Columbia; Vancouver; Canada.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID IOSE-7
AC CVCL_5545
SY IOSE7
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID IOSE-75-16SV40
AC CVCL_EQ74
DR GDSC; 1479994
DR GEO; GSM1669939
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Omics: DNA methylation analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID IOSE-7576
AC CVCL_E227
SY IOSE 7576; IOSE7576
RX PubMed=27561551;
CC From: Canadian Ovarian Tissue Bank; University of British Columbia; Vancouver; Canada.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Omics: Deep proteome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID IOSE-80
AC CVCL_5546
SY IOSE 80; IOSE80; NFHIOSE-80; IOSE80UBC; IOSE-Van; IOSE-VAN
DR Lonza; 13
RX PubMed=1326894;
RX PubMed=7967506;
RX PubMed=10329039;
RX PubMed=15947112;
RX PubMed=23415752;
CC From: Canadian Ovarian Tissue Bank; University of British Columbia; Vancouver; Canada.
CC Doubling time: 26.2 hours (PubMed=10329039).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID IOSE-80PC
AC CVCL_5547
SY IOSE-80pc; IOSE 80pc; IOSE80pc; IOSE-80 post-crisis
DR TOKU-E; 4058
RX PubMed=15947112;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5546 ! IOSE-80
SX Female
CA Transformed cell line
//
ID IOSE-80RZ
AC CVCL_5548
SY I-80RZ
RX PubMed=17266044;
CC Transfected with: HGNC; 13009; ZNF217.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5546 ! IOSE-80
SX Female
CA Transformed cell line
//
ID IOSE11
AC CVCL_0T68
SY IOE11
RX PubMed=20360942;
RX PubMed=21859834;
WW http://www.e-lucid.com/i/materials/cell_lines/IOSE11.html
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Telomerase immortalized cell line
//
ID IOSE19
AC CVCL_0T69
SY IOE19
RX PubMed=20360942;
RX PubMed=21859834;
WW http://www.e-lucid.com/i/materials/cell_lines/IOSE19.html
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Telomerase immortalized cell line
//
ID IOSE4
AC CVCL_0T70
RX PubMed=20360942;
WW http://www.e-lucid.com/i/materials/cell_lines/ISOE4.html
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Telomerase immortalized cell line
//
ID iOTC2
AC CVCL_Y695
SY A000054#2; A000054# 2
DR RCB; HPS0086
DR SKIP; SKIP000034
DI NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L557 ! OTCD1TKB
SX Male
CA Induced pluripotent stem cell
//
ID iOTC4
AC CVCL_T828
SY A000054#4; A000054# 4
DR RCB; HPS0087
DR SKIP; SKIP000035
DR SKIP; SKIP000270
DI NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L557 ! OTCD1TKB
SX Male
CA Induced pluripotent stem cell
//
ID iOTC6
AC CVCL_Y696
SY A000054#6; A000054# 6
DR RCB; HPS0088
DR SKIP; SKIP000036
DI NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L557 ! OTCD1TKB
SX Male
CA Induced pluripotent stem cell
//
ID IOWA-1T
AC CVCL_6G16
DR ATCC; CRL-3292
RX PubMed=25326397;
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 11
ST D5S818: 12
ST D7S820: 10,11
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID IOZCAS-Ha-1
AC CVCL_Z303
SY IOZCAS-Ha-I
RX CelloPub=CLPUB00225;
RX Patent=CN101070533A;
RX PubMed=17316061;
CC Group: Insect cell line.
CC Registration: International Depositary Authority, China General Microbiological Culture Collection Center (CGMCC); CGMCC No.1690.
CC Doubling time: 65 hours (CelloPub=CLPUB00225).
OX NCBI_TaxID=29058; ! Helicoverpa armigera
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IOZCAS-Osfu-1
AC CVCL_Z302
RX PubMed=24163160;
CC Group: Insect cell line.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=93504; ! Ostrinia furnacalis
SX Female
CA Transformed cell line
//
ID IOZCAS-Spex-12
AC CVCL_9U10
SY IOZCAS-Spex 12
RX PubMed=22549336;
CC Group: Insect cell line.
CC Doubling time: 71 hours (PubMed=22549336).
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=7107; ! Spodoptera exigua
SX Female
CA Transformed cell line
//
ID IOZCAS-Spex-II
AC CVCL_0A49
RX CelloPub=CLPUB00225;
RX CelloPub=CLPUB00304;
RX PubMed=16376374;
RX PubMed=19252957;
CC Group: Insect cell line.
CC Doubling time: 108.8 hours (CelloPub=CLPUB00225).
OX NCBI_TaxID=7107; ! Spodoptera exigua
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IOZCAS-Spex-II-A
AC CVCL_0A50
SY IOZCAS-Spex II-A
RX PubMed=19252957;
CC Group: Insect cell line.
OX NCBI_TaxID=7107; ! Spodoptera exigua
HI CVCL_0A49 ! IOZCAS-Spex-II
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IOZCAS-Spex-III
AC CVCL_0A51
RX CelloPub=CLPUB00225;
RX CelloPub=CLPUB00304;
RX PubMed=16376374;
CC Group: Insect cell line.
OX NCBI_TaxID=7107; ! Spodoptera exigua
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IOZCAS-Spex-IV
AC CVCL_0A52
RX CelloPub=CLPUB00225;
RX CelloPub=CLPUB00304;
CC Group: Insect cell line.
OX NCBI_TaxID=7107; ! Spodoptera exigua
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IOZCAS-Spex-V
AC CVCL_0A53
RX CelloPub=CLPUB00225;
CC Group: Insect cell line.
OX NCBI_TaxID=7107; ! Spodoptera exigua
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IOZCAS-Spex-VI
AC CVCL_0A54
RX CelloPub=CLPUB00225;
RX CelloPub=CLPUB00304;
CC Group: Insect cell line.
OX NCBI_TaxID=7107; ! Spodoptera exigua
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IOZCAS-Spex-VII
AC CVCL_0A55
RX CelloPub=CLPUB00225;
RX CelloPub=CLPUB00304;
CC Group: Insect cell line.
OX NCBI_TaxID=7107; ! Spodoptera exigua
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IOZCAS-Spex-X
AC CVCL_AV28
SY IOZCAS-Spex X
RX Patent=CN102807968A;
CC Group: Insect cell line.
CC Registration: International Depositary Authority, China General Microbiological Culture Collection Center (CGMCC); CGMCC No.4505.
OX NCBI_TaxID=7107; ! Spodoptera exigua
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IOZCAS-Spex-XI
AC CVCL_AV29
SY IOZCAS-Spex XI
RX DOI=10.1111/j.1439-0418.2011.01689.x;
CC Group: Insect cell line.
OX NCBI_TaxID=7107; ! Spodoptera exigua
SX Female
CA Spontaneously immortalized cell line
//
ID IP
AC CVCL_F561
SY 23411; TER273
DR IMGT/HLA; 11850
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID IP-1B
AC CVCL_6485
DR CLO; CLO_0006956
DR ATCC; CRL-2162
RX PubMed=8496612;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C3H/HeJ.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID IP15
AC CVCL_Y655
RX PubMed=12164867;
RX PubMed=17180447;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID IP2-E4
AC CVCL_6486
DR CLO; CLO_0006958
DR ATCC; CRL-2171
RX PubMed=8496612;
CC Breed/subspecies: C3H/HeJ.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID IPAT-1
AC CVCL_0G01
DR CGH-DB; 9032-4
RX PubMed=9738977;
RX PubMed=10570904;
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID IPC-209
AC CVCL_M213
SY IPC 209
RX PubMed=8325707;
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID IPC-211
AC CVCL_M215
SY IPC 211
RX PubMed=8325707;
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID IPC-217E
AC CVCL_M216
SY IPC 217e
RX PubMed=8325707;
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M217 ! IPC-217F
SX Female
CA Cancer cell line
//
ID IPC-217F
AC CVCL_M217
SY IPC 217F
RX PubMed=8325707;
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M216 ! IPC-217E
SX Female
CA Cancer cell line
//
ID IPC-281
AC CVCL_M218
SY IPC 281
RX PubMed=8325707;
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID IPC-285
AC CVCL_M214
SY IPC 285
RX PubMed=8325707;
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID IPC-292
AC CVCL_M219
SY IPC 292
RX PubMed=8325707;
DI NCIt; C4550; Conjunctival melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID IPC-298
AC CVCL_1307
SY IPC 298; IPC298
DR BTO; BTO:0005774
DR CLO; CLO_0006961
DR EFO; EFO_0006447
DR CLDB; cl2901
DR BioSample; SAMN03471908
DR CCLE; IPC298_SKIN
DR ChEMBL-Cells; CHEMBL3308797
DR ChEMBL-Targets; CHEMBL1075480
DR Cosmic; 907171
DR Cosmic; 928731
DR Cosmic-CLP; 907171
DR DSMZ; ACC-251
DR GDSC; 907171
DR GEO; GSM887163
DR GEO; GSM888235
DR GEO; GSM1669940
RX PubMed=8325707;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~30 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 12,14
ST D18S51: 13
ST D21S11: 29,31
ST D3S1358: 18
ST D5S818: 10,11
ST D7S820: 11,12
ST D8S1179: 13,15
ST FGA: 23,24
ST Penta D: 11,14
ST Penta E: 5,10
ST TH01: 6,9
ST TPOX: 10,12
ST vWA: 18,22
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID IPC-366
AC CVCL_0Q77
RX PubMed=25807360;
RX PubMed=26495931;
CC Doubling time: ~24 hours (PubMed=25807360).
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID IPC-501
AC CVCL_GR48
SY IPC 501
RX PubMed=405430;
RX PubMed=6929009;
CC Derived from metastatic site: Axillary lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_GR49 ! IPC-502
SX Male
CA Cancer cell line
//
ID IPC-502
AC CVCL_GR49
SY IPC 502
RX PubMed=405430;
RX PubMed=6929009;
CC Derived from metastatic site: Axillary lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_GR48 ! IPC-501
SX Male
CA Cancer cell line
//
ID IPC-clone 13
AC CVCL_2H29
SY Immortalized Pituitary Cells-clone 13
RX PubMed=26086106;
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
CC Breed/subspecies: ICR.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID IPC-clone 2
AC CVCL_2H30
SY Immortalized Pituitary Cells-clone 2
RX PubMed=26086106;
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
CC Breed/subspecies: ICR.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID IPDDC-A2
AC CVCL_7169
SY IPDDCA2
DR BioSample; SAMN03152016
DR ECACC; 99050529
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Misidentified. Originally thought to be of human origin but found to be from rat (PubMed=20143388).
CC Discontinued: ECACC; 99050529; probable.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Sex undetermined
CA Undefined cell line type
//
ID IPEC
AC CVCL_6C42
RX PubMed=22193509;
CC Problematic cell line: Misidentified/contaminated. Originally thought to be of pig origin but found to be a bovine cell (PubMed=22193509).
OX NCBI_TaxID=9913; ! Bos taurus
CA Undefined cell line type
//
ID IPEC-1
AC CVCL_2245
SY IPEC1; Intestinal Porcine Epithelial Cell line-1
DR DSMZ; ACC-705
DR GEO; GSM1646395
DR GEO; GSM1646396
DR GEO; GSM1646397
RX DOI=10.1016/S0016-5085(89)80002-2;
RX PubMed=8770040;
RX PubMed=22193509;
RX PubMed=26147118;
CC Doubling time: ~30 hours (DSMZ).
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9823; ! Sus scrofa
CA Spontaneously immortalized cell line
//
ID IPEC-J2
AC CVCL_2246
SY IPECJ2; Intestinal Porcine Epithelial Cell line-J2
DR DSMZ; ACC-701
DR GEO; GSM1646398
DR GEO; GSM1646399
DR GEO; GSM1646400
DR IZSLER; BS CL 205
RX DOI=10.1016/S0016-5085(89)80002-2;
RX DOI=10.1155/2013/980651;
RX PubMed=16215741;
RX PubMed=21626283;
RX PubMed=22074860;
RX PubMed=22193509;
RX PubMed=24260272;
RX PubMed=26147118;
RX PubMed=26975772;
CC Doubling time: ~40-60 hours (DSMZ).
CC Omics: Deep proteome analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9823; ! Sus scrofa
CA Spontaneously immortalized cell line
//
ID IPEC-J2 MDR1
AC CVCL_6C41
RX PubMed=26651362;
WW http://healthsciences.ku.dk/news/new-2016/copenhagen-researchers-develop-novel-cell-line-for-screening-of-brain-drugs/
CC Transfected with: HGNC; 40; ABCB1.
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_2246 ! IPEC-J2
CA Spontaneously immortalized cell line
//
ID IPEC-J2-3
AC CVCL_6C22
RX PubMed=20444515;
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_2246 ! IPEC-J2
CA Spontaneously immortalized cell line
//
ID IPEC-J2-9
AC CVCL_6C23
RX PubMed=20444515;
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_2246 ! IPEC-J2
CA Spontaneously immortalized cell line
//
ID IPH-926
AC CVCL_A625
DR Cosmic; 1179081
RX PubMed=19191266;
DI NCIt; C7950; Invasive lobular breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID IPI-1
AC CVCL_3825
SY Immortal Pig Intestinal-1
DR CLO; CLO_0006962
DR CLDB; cl2902
DR ECACC; 93100621
RX PubMed=8269973;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
CC Breed/subspecies: Miniature boar (d/d haplotype).
OX NCBI_TaxID=9823; ! Sus scrofa
OI CVCL_3826 ! IPI-2I
SX Male
CA Transformed cell line
//
ID IPI-2I
AC CVCL_3826
SY Immortal Pig Intestinal-2I
DR CLO; CLO_0006963
DR CLDB; cl2903
DR ECACC; 93100622
RX PubMed=8269973;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
CC Breed/subspecies: Miniature boar (d/d haplotype).
OX NCBI_TaxID=9823; ! Sus scrofa
OI CVCL_3825 ! IPI-1
SX Male
CA Transformed cell line
//
ID IPLB-AiE1611S
AC CVCL_Z441
SY AiE1611S
RX PubMed=18395741;
CC Group: Insect cell line.
OX NCBI_TaxID=56364; ! Agrotis ipsilon
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-AiE1611T
AC CVCL_Z442
SY AiE1611T
RX PubMed=18395741;
CC Group: Insect cell line.
OX NCBI_TaxID=56364; ! Agrotis ipsilon
HI CVCL_Z441 ! IPLB-AiE1611S
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-AiEd6T
AC CVCL_Z443
SY AiEd6T
RX PubMed=18395741;
CC Group: Insect cell line.
OX NCBI_TaxID=56364; ! Agrotis ipsilon
HI CVCL_Z442 ! IPLB-AiE1611T
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-CPB2
AC CVCL_Z435
RX PubMed=7735572;
CC Group: Insect cell line.
OX NCBI_TaxID=7539; ! Leptinotarsa decemlineata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-DnEa3
AC CVCL_Z444
SY IPLB DnEa3; IPLB-DnEA3
RX DOI=10.3954/1523-5475-25.2.81;
RX PubMed=18395741;
CC Group: Insect cell line.
CC Misspelling: 'IPLB-DmEA3' in PubMed=18395741.
OX NCBI_TaxID=1140737; ! Diaphania nitidalis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-DnEa4
AC CVCL_AV83
RX DOI=10.3954/1523-5475-25.2.81;
CC Group: Insect cell line.
OX NCBI_TaxID=1140737; ! Diaphania nitidalis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-DnEs1
AC CVCL_Z445
SY IPLB DnEs1; IPLB-DnES1
RX DOI=10.3954/1523-5475-25.2.81;
RX PubMed=18395741;
CC Group: Insect cell line.
CC Misspelling: 'IPLB-DmES1' in PubMed=18395741.
OX NCBI_TaxID=1140737; ! Diaphania nitidalis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-DnEs2
AC CVCL_AV84
RX DOI=10.3954/1523-5475-25.2.81;
CC Group: Insect cell line.
OX NCBI_TaxID=1140737; ! Diaphania nitidalis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-DU182A
AC CVCL_Z376
RX DOI=10.1007/BF02619580;
WW http://www.ars.usda.gov/sp2userfiles/person/3489/DU182A-ExC.pdf
CC Group: Insect cell line.
OX NCBI_TaxID=50387; ! Diabrotica undecimpunctata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-DU182E
AC CVCL_Z377
RX DOI=10.1007/BF02619580;
CC Group: Insect cell line.
OX NCBI_TaxID=50387; ! Diabrotica undecimpunctata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-Ek-x4T
AC CVCL_Z097
SY IPLB-Ekx4T; Ek-x4T
RX PubMed=15861225;
WW http://www.ars.usda.gov/sp2userfiles/person/3489/ekx4t.pdf
CC Group: Insect cell line.
OX NCBI_TaxID=40079; ! Ephestia kuehniella
OI CVCL_Z098 ! IPLB-Ek-x4V
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-Ek-x4V
AC CVCL_Z098
SY IPLB-Ekx4V; Ek-x4V; IPLB-Ek-x4S; IPLB-Ekx4S
RX PubMed=15861225;
WW http://www.ars.usda.gov/SP2UserFiles/person/3489/Ekx4S.pdf
CC Group: Insect cell line.
OX NCBI_TaxID=40079; ! Ephestia kuehniella
OI CVCL_Z097 ! IPLB-Ek-x4T
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-HvE1a
AC CVCL_Z110
SY IPLB-HvE1A; IPLB HvE1A; HvE1a
RX PubMed=9784351;
RX PubMed=12623313;
RX PubMed=15926859;
CC Group: Insect cell line.
OX NCBI_TaxID=7102; ! Heliothis virescens
OI CVCL_Z112 ! IPLB-HvE1s
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-HvE1a-lt
AC CVCL_Z111
RX PubMed=9784351;
CC Group: Insect cell line.
OX NCBI_TaxID=7102; ! Heliothis virescens
HI CVCL_Z110 ! IPLB-HvE1a
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-HvE1s
AC CVCL_Z112
SY HvE1s
RX PubMed=9784351;
CC Group: Insect cell line.
OX NCBI_TaxID=7102; ! Heliothis virescens
OI CVCL_Z110 ! IPLB-HvE1a
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-HvE6a
AC CVCL_Z113
SY IPLB-HvE6A; IPLB HvE6A; HvE6a
RX PubMed=9784351;
RX PubMed=12623313;
WW http://www.ars.usda.gov/SP2UserFiles/person/3489/HvE6a.pdf
CC Group: Insect cell line.
OX NCBI_TaxID=7102; ! Heliothis virescens
OI CVCL_Z574 ! IPLB-HvE6s
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-HvE6a-lt
AC CVCL_Z114
RX PubMed=9784351;
CC Group: Insect cell line.
OX NCBI_TaxID=7102; ! Heliothis virescens
HI CVCL_Z113 ! IPLB-HvE6a
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-HvE6s
AC CVCL_Z574
RX PubMed=9784351;
RX PubMed=12623313;
RX PubMed=15926859;
CC Group: Insect cell line.
OX NCBI_TaxID=7102; ! Heliothis virescens
OI CVCL_Z113 ! IPLB-HvE6a
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-HvT1
AC CVCL_Z101
RX CelloPub=CLPUB00162;
RX PubMed=1367489;
RX PubMed=12623313;
WW http://www.ars.usda.gov/SP2UserFiles/person/3489/hvt1.pdf
CC Group: Insect cell line.
OX NCBI_TaxID=7102; ! Heliothis virescens
SX Male
CA Spontaneously immortalized cell line
//
ID IPLB-HZ-1074
AC CVCL_AV49
RX DOI=10.1007/BF02796325;
CC Group: Insect cell line.
OX NCBI_TaxID=7113; ! Helicoverpa zea
SX Female
CA Spontaneously immortalized cell line
//
ID IPLB-HZ-1075
AC CVCL_Z209
SY IPLB-Hz-1075; IPLB-HZ 1075; IPLB-HZ1075; IPLB-1075; Hz 1075
RX DOI=10.1007/BF02620965;
RX DOI=10.1007/BF02796325;
RX DOI=10.1111/j.1550-7408.1983.tb05338.x;
RX PubMed=16593348;
CC Group: Insect cell line.
OX NCBI_TaxID=7113; ! Helicoverpa zea
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-HZ-1075/UND-B
AC CVCL_Z210
SY UND-B
RX DOI=10.1007/BF02620965;
RX PubMed=2685005;
CC Group: Insect cell line.
OX NCBI_TaxID=7113; ! Helicoverpa zea
HI CVCL_Z209 ! IPLB-HZ-1075
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-HZ-1075/UND-C
AC CVCL_Z211
SY UND-C
RX DOI=10.1007/BF02620965;
RX PubMed=2685005;
CC Group: Insect cell line.
OX NCBI_TaxID=7113; ! Helicoverpa zea
HI CVCL_Z209 ! IPLB-HZ-1075
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-HZ-1075/UND-F
AC CVCL_Z212
SY UND-F
RX DOI=10.1007/BF02620965;
RX PubMed=2685005;
CC Group: Insect cell line.
OX NCBI_TaxID=7113; ! Helicoverpa zea
HI CVCL_Z209 ! IPLB-HZ-1075
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-HZ-1075/UND-G
AC CVCL_Z213
SY UND-G
RX DOI=10.1007/BF02620965;
RX PubMed=2685005;
CC Group: Insect cell line.
OX NCBI_TaxID=7113; ! Helicoverpa zea
HI CVCL_Z209 ! IPLB-HZ-1075
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-HZ-1075/UND-H
AC CVCL_Z214
SY UND-H
RX DOI=10.1007/BF02620965;
CC Group: Insect cell line.
OX NCBI_TaxID=7113; ! Helicoverpa zea
HI CVCL_Z209 ! IPLB-HZ-1075
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-HZ-1075/UND-I
AC CVCL_Z215
SY UND-I
RX DOI=10.1007/BF02620965;
RX PubMed=2685005;
CC Group: Insect cell line.
OX NCBI_TaxID=7113; ! Helicoverpa zea
HI CVCL_Z209 ! IPLB-HZ-1075
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-HZ-1075/UND-K
AC CVCL_Z216
SY IPLB-HZ1075/UND-K; Hz 1075/UND-K; UND-K
RX DOI=10.1007/BF02620965;
RX PubMed=2685005;
CC Group: Insect cell line.
OX NCBI_TaxID=7113; ! Helicoverpa zea
HI CVCL_Z209 ! IPLB-HZ-1075
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-HZ-1075/UND-L
AC CVCL_Z217
SY UND-L
RX DOI=10.1007/BF02620965;
RX PubMed=2685005;
CC Group: Insect cell line.
OX NCBI_TaxID=7113; ! Helicoverpa zea
HI CVCL_Z209 ! IPLB-HZ-1075
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-HZ-1075/UND-O
AC CVCL_Z218
SY UND-O
RX DOI=10.1007/BF02620965;
RX PubMed=2685005;
CC Group: Insect cell line.
OX NCBI_TaxID=7113; ! Helicoverpa zea
HI CVCL_Z209 ! IPLB-HZ-1075
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-HZ-1075/UND-R
AC CVCL_Z219
SY UND-R
RX DOI=10.1007/BF02620965;
RX PubMed=2685005;
CC Group: Insect cell line.
OX NCBI_TaxID=7113; ! Helicoverpa zea
HI CVCL_Z209 ! IPLB-HZ-1075
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-HZ-1075/UND-U
AC CVCL_Z220
SY UND-U
RX DOI=10.1007/BF02620965;
RX PubMed=2685005;
CC Group: Insect cell line.
OX NCBI_TaxID=7113; ! Helicoverpa zea
HI CVCL_Z209 ! IPLB-HZ-1075
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-HZ-1075/UND-V
AC CVCL_Z221
SY UND-V
RX DOI=10.1007/BF02620965;
RX PubMed=2685005;
CC Group: Insect cell line.
OX NCBI_TaxID=7113; ! Helicoverpa zea
HI CVCL_Z209 ! IPLB-HZ-1075
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-HZ-1079
AC CVCL_AV50
RX DOI=10.1007/BF02796325;
CC Group: Insect cell line.
OX NCBI_TaxID=7113; ! Helicoverpa zea
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-HZ-110
AC CVCL_AV51
RX DOI=10.1007/BF02796325;
CC Group: Insect cell line.
OX NCBI_TaxID=7113; ! Helicoverpa zea
SX Female
CA Spontaneously immortalized cell line
//
ID IPLB-HZ-124Q
AC CVCL_AV52
RX DOI=10.1007/BF02796325;
CC Group: Insect cell line.
OX NCBI_TaxID=7113; ! Helicoverpa zea
SX Female
CA Spontaneously immortalized cell line
//
ID IPLB-LD-64
AC CVCL_Z378
SY IPLB-Ld-64
RX PubMed=79542;
CC Group: Insect cell line.
OX NCBI_TaxID=13123; ! Lymantria dispar
SX Female
CA Spontaneously immortalized cell line
//
ID IPLB-LD-65
AC CVCL_Z379
SY IPLB-LD 65
RX PubMed=79542;
CC Group: Insect cell line.
OX NCBI_TaxID=13123; ! Lymantria dispar
SX Female
CA Spontaneously immortalized cell line
//
ID IPLB-LD-652
AC CVCL_Z380
RX PubMed=79542;
RX PubMed=16346059;
RX PubMed=24986084;
CC Group: Insect cell line.
OX NCBI_TaxID=13123; ! Lymantria dispar
HI CVCL_Z379 ! IPLB-LD-65
SX Female
CA Spontaneously immortalized cell line
//
ID IPLB-LD-652Y
AC CVCL_Z381
SY IPLB-Ld652Y; IPLBLd652Y; LD-652Y; Ld652Y
RX PubMed=79542;
RX PubMed=11549938;
RX PubMed=24986084;
CC Group: Insect cell line.
CC Caution: IPLB-LD-652Y is not explicitely mentioned in PubMed=79542, but almost all authors cite this publication as the source. PubMed=24986084 discuss the possibility that this is a typo for IPLB-LD-65Y, but this is not certain.
OX NCBI_TaxID=13123; ! Lymantria dispar
HI CVCL_Z379 ! IPLB-LD-65
SX Female
CA Spontaneously immortalized cell line
//
ID IPLB-LD-65Y
AC CVCL_Z382
SY IPL-LD-65Y; IPL-LD 65Y
DR CLO; CLO_0006965
DR CLDB; cl2904
DR DSMZ; ACC-181
RX PubMed=79542;
CC Group: Insect cell line.
OX NCBI_TaxID=13123; ! Lymantria dispar
HI CVCL_Z379 ! IPLB-LD-65
SX Female
CA Spontaneously immortalized cell line
//
ID IPLB-LD-65Z
AC CVCL_Z383
SY IPLB-Ld-65z
DR CLDB; cl2905
DR CLO; CLO_0006964
RX PubMed=79542;
CC Group: Insect cell line.
OX NCBI_TaxID=13123; ! Lymantria dispar
HI CVCL_Z379 ! IPLB-LD-65
SX Female
CA Spontaneously immortalized cell line
//
ID IPLB-LD-66
AC CVCL_Z384
SY IPLB-Ld-66
RX PubMed=79542;
CC Group: Insect cell line.
OX NCBI_TaxID=13123; ! Lymantria dispar
SX Female
CA Spontaneously immortalized cell line
//
ID IPLB-LD-67
AC CVCL_Z385
SY IPLB-Ld-67
RX PubMed=79542;
CC Group: Insect cell line.
OX NCBI_TaxID=13123; ! Lymantria dispar
SX Female
CA Spontaneously immortalized cell line
//
ID IPLB-LdEG
AC CVCL_Z405
SY LdEG
RX CelloPub=CLPUB00162;
CC Group: Insect cell line.
OX NCBI_TaxID=13123; ! Lymantria dispar
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-LdEI
AC CVCL_Z406
SY LdEI
RX CelloPub=CLPUB00162;
CC Group: Insect cell line.
OX NCBI_TaxID=13123; ! Lymantria dispar
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-LdEIt
AC CVCL_Z407
RX CelloPub=CLPUB00162;
CC Group: Insect cell line.
OX NCBI_TaxID=13123; ! Lymantria dispar
HI CVCL_Z406 ! IPLB-LdEI
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-LdEIta
AC CVCL_Z099
SY LdEIta
RX CelloPub=CLPUB00162;
RX PubMed=1367489;
RX PubMed=10475270;
RX PubMed=11549938;
RX PubMed=12623313;
RX PubMed=15926859;
WW http://www.ars.usda.gov/SP2UserFiles/person/3489/LDEITA.pdf
CC Group: Insect cell line.
OX NCBI_TaxID=13123; ! Lymantria dispar
HI CVCL_Z407 ! IPLB-LdEIt
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-LdEp
AC CVCL_Z102
SY IPLB-LdEP
RX CelloPub=CLPUB00162;
RX PubMed=11549938;
RX PubMed=12623313;
RX PubMed=15926859;
RX PubMed=24986084;
CC Group: Insect cell line.
OX NCBI_TaxID=13123; ! Lymantria dispar
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-LdFB
AC CVCL_Z100
SY LdFB
RX CelloPub=CLPUB00162;
RX PubMed=18220824;
WW http://www.ars.usda.gov/sp2userfiles/person/3489/ldfb.pdf
CC Group: Insect cell line.
OX NCBI_TaxID=13123; ! Lymantria dispar
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IBL-Sf-21AE-Cl 3
AC CVCL_Z451
DR ATCC; PTA-2207
RX Patent=US6379958;
CC Group: Insect cell line.
CC Group: Recombinant protein production insect cell line.
CC Discontinued: ATCC; PTA-2207; probable.
OX NCBI_TaxID=7108; ! Spodoptera frugiperda
HI CVCL_0518 ! Sf21
SX Female
CA Spontaneously immortalized cell line
//
ID IBL-Sf-21AE-Cl 5
AC CVCL_Z452
DR ATCC; PTA-2206
RX Patent=US6379958;
CC Group: Insect cell line.
CC Group: Recombinant protein production insect cell line.
CC Discontinued: ATCC; PTA-2206; probable.
OX NCBI_TaxID=7108; ! Spodoptera frugiperda
HI CVCL_0518 ! Sf21
SX Female
CA Spontaneously immortalized cell line
//
ID IBL-Sf-21AE-Cl 9
AC CVCL_Z453
DR ATCC; PTA-2205
RX Patent=US6379958;
CC Group: Insect cell line.
CC Group: Recombinant protein production insect cell line.
CC Discontinued: ATCC; PTA-2205; probable.
OX NCBI_TaxID=7108; ! Spodoptera frugiperda
HI CVCL_0518 ! Sf21
SX Female
CA Spontaneously immortalized cell line
//
ID IPLB-OlE505A
AC CVCL_9U11
RX PubMed=9282305;
CC Group: Insect cell line.
OX NCBI_TaxID=95259; ! Orgyia leucostigma
OI CVCL_9U12 ! IPLB-OlE505s
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-OlE505s
AC CVCL_9U12
RX PubMed=9282305;
CC Group: Insect cell line.
OX NCBI_TaxID=95259; ! Orgyia leucostigma
OI CVCL_9U11 ! IPLB-OlE505A
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-OlE7
AC CVCL_9U13
SY IPLB-OlE-7
RX PubMed=9282305;
CC Group: Insect cell line.
OX NCBI_TaxID=95259; ! Orgyia leucostigma
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-PiE
AC CVCL_AV30
RX PubMed=26820856;
CC Group: Insect cell line.
OX NCBI_TaxID=58824; ! Plodia interpunctella
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-PxE1
AC CVCL_Z575
CC Group: Insect cell line.
OX NCBI_TaxID=51655; ! Plutella xylostella
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-PxE2
AC CVCL_Z576
RX PubMed=12623313;
RX PubMed=15926859;
CC Group: Insect cell line.
OX NCBI_TaxID=51655; ! Plutella xylostella
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPLB-SF-1254
AC CVCL_Z439
RX PubMed=68913;
RX PubMed=1367489;
RX PubMed=16593348;
CC Group: Insect cell line.
CC Doubling time: 36 hours (PubMed=68913).
OX NCBI_TaxID=7108; ! Spodoptera frugiperda
SX Female
CA Spontaneously immortalized cell line
//
ID IPLB-Tcon1
AC CVCL_Z504
SY IPLB-Tcon-1; IPLB-Tcon 1
RX PubMed=1799679;
CC Group: Insect cell line.
OX NCBI_TaxID=238528; ! Trichogramma confusum
SX Female
CA Spontaneously immortalized cell line
//
ID IPLB-Tex2
AC CVCL_Z503
RX PubMed=1799679;
CC Group: Insect cell line.
CC Misspelling: Occasionally 'IPBL-Tex2'.
OX NCBI_TaxID=185872; ! Trichogramma exiguum
SX Female
CA Spontaneously immortalized cell line
//
ID IPLB-TN-R2
AC CVCL_Z096
SY IPLB-TNR2; IPLB-Tn-RR; IPLB-TN-R; IPLB-TNR; TN-R2
RX DOI=10.1007/BF02619626;
RX PubMed=1367489;
RX PubMed=1389161;
RX PubMed=12623313;
RX PubMed=15926859;
CC Group: Insect cell line.
OX NCBI_TaxID=7111; ! Trichoplusia ni
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID iPM1
AC CVCL_Y700
SY A000011#1; A000011# 1
DR RCB; HPS0066
DR SKIP; SKIP000019
DI NCIt; C75487; Pelizaeus-Merzbacher disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y701 ! iPM2
OI CVCL_Y702 ! iPM9
SX Male
CA Induced pluripotent stem cell
//
ID iPM2
AC CVCL_Y701
SY A000011#2; A000011# 2
DR RCB; HPS0067
DR SKIP; SKIP000020
DI NCIt; C75487; Pelizaeus-Merzbacher disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y700 ! iPM1
OI CVCL_Y702 ! iPM9
SX Male
CA Induced pluripotent stem cell
//
ID iPM9
AC CVCL_Y702
SY A000011#9; A000011# 9
DR RCB; HPS0068
DR SKIP; SKIP000021
DI NCIt; C75487; Pelizaeus-Merzbacher disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y700 ! iPM1
OI CVCL_Y701 ! iPM2
SX Male
CA Induced pluripotent stem cell
//
ID IPNN-8
AC CVCL_5G67
RX PubMed=7518347;
RX PubMed=7591247;
RX PubMed=9428346;
DI NCIt; C3222; Medulloblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID IPNT-H
AC CVCL_5G65
RX PubMed=7518347;
RX PubMed=7591247;
RX PubMed=8054266;
RX PubMed=9428346;
RX PubMed=21556643;
DI NCIt; C4047; Pilocytic astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID IPPS-11
AC CVCL_5G68
RX PubMed=7518347;
RX PubMed=7591247;
DI NCIt; C3017; Ependymoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID IPRB
AC CVCL_1R53
DR BioSample; SAMN03152017
RX PubMed=20951163;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Misidentified. Originally thought to be of human origin but found to be from rat (PubMed=20951163).
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Sex undetermined
CA Undefined cell line type
//
ID IPRI-CF-1
AC CVCL_Z473
SY IPRI-Cf-1; CF-1; FPMI-CF-1
RX DOI=10.1007/BF01947579;
RX DOI=10.1016/0022-1910(94)00139-8;
RX DOI=10.1139/z85-337;
RX PubMed=1367489;
CC Group: Insect cell line.
OX NCBI_TaxID=7141; ! Choristoneura fumiferana
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPRI-CF-10
AC CVCL_Z474
RX DOI=10.1139/z85-337;
CC Group: Insect cell line.
OX NCBI_TaxID=7141; ! Choristoneura fumiferana
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPRI-CF-12
AC CVCL_Z475
RX DOI=10.1139/z85-337;
CC Group: Insect cell line.
OX NCBI_TaxID=7141; ! Choristoneura fumiferana
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPRI-CF-124
AC CVCL_Z480
SY IPRI-Cf124; Cf124
RX DOI=10.1139/z76-180;
RX DOI=10.1139/z85-337;
RX PubMed=903169;
CC Group: Insect cell line.
CC Doubling time: 31 hours (PubMed=903169).
OX NCBI_TaxID=7141; ! Choristoneura fumiferana
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPRI-CF-124T
AC CVCL_Z481
SY Cf-124T; CF-124T
RX PubMed=903169;
CC Group: Insect cell line.
CC Doubling time: 25 hours (PubMed=903169).
OX NCBI_TaxID=7141; ! Choristoneura fumiferana
HI CVCL_Z480 ! IPRI-CF-124
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPRI-CF-16
AC CVCL_Z476
RX DOI=10.1139/z85-337;
CC Group: Insect cell line.
OX NCBI_TaxID=7141; ! Choristoneura fumiferana
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPRI-CF-5
AC CVCL_Z477
RX DOI=10.1139/z85-337;
CC Group: Insect cell line.
OX NCBI_TaxID=7141; ! Choristoneura fumiferana
SX Male
CA Spontaneously immortalized cell line
//
ID IPRI-CF-6
AC CVCL_Z478
RX DOI=10.1139/z85-337;
CC Group: Insect cell line.
OX NCBI_TaxID=7141; ! Choristoneura fumiferana
SX Male
CA Spontaneously immortalized cell line
//
ID IPRI-CF-8
AC CVCL_Z479
RX DOI=10.1139/z85-337;
CC Group: Insect cell line.
OX NCBI_TaxID=7141; ! Choristoneura fumiferana
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPRI-MD-108
AC CVCL_Z482
SY IPRI-Md-108; IPRI-108; Md108
RX CelloPub=CLPUB00188;
RX DOI=10.1139/z76-180;
RX PubMed=16346059;
RX PubMed=21907208;
CC Group: Insect cell line.
OX NCBI_TaxID=40071; ! Malacosoma disstria
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPRI-MD-109
AC CVCL_Z483
SY Md109
RX DOI=10.1139/z76-180;
CC Group: Insect cell line.
OX NCBI_TaxID=40071; ! Malacosoma disstria
SX Female
CA Spontaneously immortalized cell line
//
ID IPRI-MD-63
AC CVCL_Z484
SY Md63
RX DOI=10.1139/z76-180;
CC Group: Insect cell line.
OX NCBI_TaxID=40071; ! Malacosoma disstria
SX Female
CA Spontaneously immortalized cell line
//
ID IPRI-MD-66
AC CVCL_Z437
SY IPRI-Md-66; MD-66; Md66
DR BTO; BTO:0004106
RX CelloPub=CLPUB00188;
RX DOI=10.1016/0022-1910(94)00139-8;
RX DOI=10.1139/z71-202;
RX DOI=10.1139/z76-180;
RX DOI=10.1139/z85-337;
RX PubMed=21907208;
CC Group: Insect cell line.
OX NCBI_TaxID=40071; ! Malacosoma disstria
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPRI-OL-11
AC CVCL_Z489
RX DOI=10.1139/z85-337;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Group: Insect cell line.
CC Problematic cell line: Contaminated. Shown to probably be a IPRI-CF-124 derivative. Originate from Choristoneura fumiferana and not from Orgyia leucostigma (DOI 10.1139/z85-337).
OX NCBI_TaxID=7141; ! Choristoneura fumiferana
HI CVCL_Z480 ! IPRI-CF-124
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPRI-OL-12
AC CVCL_Z485
SY FPMI-OL-12
RX DOI=10.1139/z85-337;
RX DOI=10.1385/0-89603-272-8:397;
CC Group: Insect cell line.
OX NCBI_TaxID=95259; ! Orgyia leucostigma
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPRI-OL-13
AC CVCL_Z486
RX DOI=10.1139/z85-337;
CC Group: Insect cell line.
OX NCBI_TaxID=95259; ! Orgyia leucostigma
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPRI-OL-4
AC CVCL_Z487
RX DOI=10.1139/z85-337;
CC Group: Insect cell line.
OX NCBI_TaxID=95259; ! Orgyia leucostigma
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPRI-OL-7
AC CVCL_Z490
RX DOI=10.1139/z85-337;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Group: Insect cell line.
CC Problematic cell line: Contaminated. Shown to probably be a IPRI-CF-124 derivative. Originate from Choristoneura fumiferana and not from Orgyia leucostigma (DOI 10.1139/z85-337).
OX NCBI_TaxID=7141; ! Choristoneura fumiferana
HI CVCL_Z480 ! IPRI-CF-124
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPRI-OL-9
AC CVCL_Z488
RX DOI=10.1139/z85-337;
CC Group: Insect cell line.
OX NCBI_TaxID=95259; ! Orgyia leucostigma
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IPRM-5
AC CVCL_5G66
RX PubMed=7518347;
RX PubMed=7591247;
RX PubMed=8054266;
RX PubMed=21556643;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID iPS ADPKD 1
AC CVCL_V449
RX PubMed=24009235;
DI NCIt; C84578; Autosomal dominant polycystic kidney disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID iPS ADPKD 2
AC CVCL_V450
RX PubMed=24009235;
DI NCIt; C84578; Autosomal dominant polycystic kidney disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID iPS ADPKD 3
AC CVCL_V451
RX PubMed=24009235;
DI NCIt; C84578; Autosomal dominant polycystic kidney disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID iPS ARPKD 4
AC CVCL_V452
RX PubMed=24009235;
DI NCIt; C84579; Autosomal recessive polycystic kidney disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_V446 ! GM10287
SX Male
CA Induced pluripotent stem cell
//
ID iPS ARPKD 5
AC CVCL_V453
RX PubMed=24009235;
DI NCIt; C84579; Autosomal recessive polycystic kidney disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_V447 ! GM12607
SX Female
CA Induced pluripotent stem cell
//
ID iPS CWRU1
AC CVCL_W123
SY iPS_CWRU1
DR ENCODE; ENCBS334AAA
DR GEO; GSM1008570
CC Part of: ENCODE project common cell types; tier 3.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID iPS NIHi1
AC CVCL_AS22
SY NIH-i1; i1
DR GEO; GSM856734
RX PubMed=23117585;
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID iPS NIHi11
AC CVCL_W121
SY iPS_NIHi11; NIH-i11
DR ENCODE; ENCBS556ENC
DR GEO; GSM1008569
RX PubMed=23117585;
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/FibroP_Crawford_protocol.pdf
CC Part of: ENCODE project common cell types; tier 3.
CC Omics: Transcriptome analysis.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_N797 ! AG20443
SX Male
CA Induced pluripotent stem cell
//
ID iPS NIHi12
AC CVCL_AS26
SY NIH-i12; i12
DR GEO; GSM856741
RX PubMed=23117585;
CC Omics: Transcriptome analysis.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_N796 ! AG08396
SX Female
CA Induced pluripotent stem cell
//
ID iPS NIHi13
AC CVCL_AS27
SY NIH-i13
RX PubMed=23117585;
CC Omics: Transcriptome analysis.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_N796 ! AG08396
SX Female
CA Induced pluripotent stem cell
//
ID iPS NIHi2
AC CVCL_AS23
SY NIH-i2
RX PubMed=23117585;
CC Omics: Transcriptome analysis.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_N797 ! AG20443
SX Male
CA Induced pluripotent stem cell
//
ID iPS NIHi4
AC CVCL_AS24
SY NIH-i4; i4
DR GEO; GSM856740
RX PubMed=23117585;
CC Omics: Transcriptome analysis.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_N797 ! AG20443
SX Male
CA Induced pluripotent stem cell
//
ID iPS NIHi5
AC CVCL_AS25
SY NIH-i5; i5
DR GEO; GSM856739
RX PubMed=23117585;
CC Omics: Transcriptome analysis.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_N797 ! AG20443
SX Male
CA Induced pluripotent stem cell
//
ID iPS NIHi7
AC CVCL_W122
SY iPS_NIHi7; NIH-i7; i7
DR ENCODE; ENCBS041ENC
DR ENCODE; ENCBS557ENC
DR GEO; GSM856742
DR GEO; GSM1008600
RX PubMed=23117585;
CC Part of: ENCODE project common cell types; tier 3.
CC Omics: Transcriptome analysis.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_N795 ! AG08395
SX Female
CA Induced pluripotent stem cell
//
ID IPS-1
AC CVCL_B531
SY iPS1
DR ISCR; 259
RX PubMed=18287077;
CC From: University of California, Los Angeles; Los Angeles; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID IPS-18
AC CVCL_B532
SY iPS18
DR ISCR; 255
RX PubMed=18287077;
CC From: University of California, Los Angeles; Los Angeles; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID IPS-2
AC CVCL_B533
SY iPS2
DR ISCR; 258
RX PubMed=18287077;
CC From: University of California, Los Angeles; Los Angeles; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID IPS-24
AC CVCL_B534
SY iPS24
DR ISCR; 254
RX PubMed=18287077;
CC From: University of California, Los Angeles; Los Angeles; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID IPS-29
AC CVCL_B535
SY iPS29
DR ISCR; 253
RX PubMed=18287077;
CC From: University of California, Los Angeles; Los Angeles; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID IPS-5
AC CVCL_B536
SY iPS5
DR ISCR; 257
RX PubMed=18287077;
CC From: University of California, Los Angeles; Los Angeles; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID IPS-7
AC CVCL_B537
SY iPS7
DR ISCR; 256
RX PubMed=18287077;
CC From: University of California, Los Angeles; Los Angeles; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID iPS-DF19-9
AC CVCL_4T92
SY DF19-9
RX PubMed=19325077;
RX PubMed=21296996;
CC From: University of Wisconsin; Madison; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2337 ! CCD-1079Sk
SX Male
CA Induced pluripotent stem cell
//
ID iPS-DF19-9-11T.H
AC CVCL_K054
SY iPS DF19-9-11T.H; iPS-DF19-9-11T; DF19-9-11T; iPS DF 19.11; DF19.11
DR EFO; EFO_0007096
DR ENCODE; ENCBS068ICJ
DR ENCODE; ENCBS085RNG
DR ENCODE; ENCBS087RTK
DR ENCODE; ENCBS368AVD
DR ENCODE; ENCBS698JQZ
DR ENCODE; ENCBS972ZOZ
DR ISCR; 2124
RX PubMed=19325077;
RX PubMed=21296996;
RX PubMed=21983960;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/ips-df19-9-11t-h.cmsx
WW http://shared.eagle-i.net/i/00000144-8d86-ba25-5797-c9ee80000000
CC From: University of Wisconsin; Madison; USA.
CC Omics: Deep phosphoproteome analysis.
CC Omics: Deep proteome analysis.
CC Omics: H3K4me3 ChIP-seq epigenome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4T92 ! iPS-DF19-9
SX Male
CA Induced pluripotent stem cell
//
ID iPS-DF19-9-7T
AC CVCL_K055
SY iPS DF19-9-7T; DF19-9-7T; iPS DF 19.7; DF19.7
DR EFO; EFO_0007095
DR ENCODE; ENCBS858DVB
DR ISCR; 2125
RX PubMed=19325077;
RX PubMed=21296996;
RX PubMed=21983960;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/ips-df19-9-7t.cmsx
WW http://shared.eagle-i.net/i/00000144-8db5-6a69-5797-c9ee80000000
CC From: University of Wisconsin; Madison; USA.
CC Omics: Deep phosphoproteome analysis.
CC Omics: Deep proteome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4T92 ! iPS-DF19-9
SX Male
CA Induced pluripotent stem cell
//
ID iPS-DF4-3-7T.A
AC CVCL_K056
SY iPS DF4-3-7T.A; DF4-3-7T; iPS DF 4.7; DF4.7
DR EFO; EFO_0007097
DR ENCODE; ENCBS624PSN
DR ISCR; 2141
RX PubMed=21296996;
RX PubMed=21983960;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/ips-df4-3-7t-a.cmsx
WW http://shared.eagle-i.net/i/00000144-8db8-5302-5797-c9ee80000000
CC From: University of Wisconsin; Madison; USA.
CC Omics: Deep phosphoproteome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2337 ! CCD-1079Sk
SX Male
CA Induced pluripotent stem cell
//
ID iPS-DF6-9
AC CVCL_4T90
SY iPS DF 6.9; DF6-9
DR EFO; EFO_0007098
DR ENCODE; ENCBS011GNQ
DR ENCODE; ENCBS111INZ
DR ENCODE; ENCBS586ZNR
DR ENCODE; ENCBS757ZRB
RX PubMed=19325077;
RX PubMed=21296996;
CC From: University of Wisconsin; Madison; USA.
CC Omics: H3K4me3 ChIP-seq epigenome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2337 ! CCD-1079Sk
SX Male
CA Induced pluripotent stem cell
//
ID iPS-DF6-9-12T
AC CVCL_4T91
RX PubMed=19325077;
CC From: University of Wisconsin; Madison; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4T90 ! iPS-DF6-9
SX Male
CA Induced pluripotent stem cell
//
ID iPS-DF6-9-9T.B
AC CVCL_K057
SY iPS DF6-9-9T.B; iPS-DF6-9-9T; DF6-9-9T; DF6.9
DR ISCR; 2142
RX PubMed=19325077;
RX PubMed=21296996;
RX PubMed=21983960;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/ips-df6-9-9t-b.cmsx
WW http://shared.eagle-i.net/i/00000144-8dbe-b52c-5797-c9ee80000000
CC From: University of Wisconsin; Madison; USA.
CC Omics: Deep phosphoproteome analysis.
CC Omics: Deep proteome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4T90 ! iPS-DF6-9
SX Male
CA Induced pluripotent stem cell
//
ID iPS-DP31 3f-1
AC CVCL_DP82
RX PubMed=20554890;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DP75 ! DP31
SX Female
CA Induced pluripotent stem cell
//
ID iPS-DP31 3f-2
AC CVCL_DP83
RX PubMed=20554890;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
ST Source(s): PubMed=20554890
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,10
ST D16S539: 10
ST D18S51: 15
ST D21S11: 30
ST D3S1358: 16,17
ST D5S818: 11,12
ST D7S820: 10,12
ST D8S1179: 12,15
ST FGA: 21,23
ST Penta D: 12,14
ST Penta E: 16,19
ST TH01: 7
ST TPOX: 8,11
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DP75 ! DP31
SX Female
CA Induced pluripotent stem cell
//
ID iPS-DP31 3f-3
AC CVCL_DP84
RX PubMed=20554890;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DP75 ! DP31
SX Female
CA Induced pluripotent stem cell
//
ID iPS-DP31 4f-1
AC CVCL_DQ77
SY DP31-4f1
DR GEO; GSM1040268
DR GEO; GSM1040338
RX PubMed=20554890;
RX PubMed=24259714;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
CC Miscellaneous: Although not directly described in PubMed=20554890, was established at the same time as the other DP31 iPSCs described in that paper (personal communication Koyanagi-Aoi M.).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DP75 ! DP31
SX Female
CA Induced pluripotent stem cell
//
ID iPS-DP31 4f-3
AC CVCL_DP85
RX PubMed=20554890;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
ST Source(s): PubMed=20554890
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,10
ST D16S539: 10
ST D18S51: 15
ST D21S11: 30
ST D3S1358: 16,17
ST D5S818: 11,12
ST D7S820: 10,12
ST D8S1179: 12,15
ST FGA: 21,23
ST Penta D: 12,14
ST Penta E: 16,19
ST TH01: 7
ST TPOX: 8,11
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DP75 ! DP31
SX Female
CA Induced pluripotent stem cell
//
ID iPS-DP31 4f-5
AC CVCL_DP86
RX PubMed=20554890;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DP75 ! DP31
SX Female
CA Induced pluripotent stem cell
//
ID iPS-DP31 4f-6
AC CVCL_DP87
RX PubMed=20554890;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DP75 ! DP31
SX Female
CA Induced pluripotent stem cell
//
ID iPS-DP75 3f-1
AC CVCL_DP77
RX PubMed=20554890;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DP76 ! DP75
SX Male
CA Induced pluripotent stem cell
//
ID iPS-DP75 3f-2
AC CVCL_DP78
RX PubMed=20554890;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
ST Source(s): PubMed=20554890
ST Amelogenin: X,Y
ST CSF1PO: 9,11
ST D13S317: 9,11
ST D16S539: 8,11
ST D18S51: 13,16
ST D21S11: 28,29
ST D3S1358: 14
ST D5S818: 10,11
ST D7S820: 7,10
ST D8S1179: 13,14
ST FGA: 22,24
ST Penta D: 8,11
ST Penta E: 12,16
ST TH01: 5,8
ST TPOX: 8,11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DP76 ! DP75
SX Male
CA Induced pluripotent stem cell
//
ID iPS-DP75 4f-1
AC CVCL_DP79
RX PubMed=20554890;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
ST Source(s): PubMed=20554890
ST Amelogenin: X,Y
ST CSF1PO: 9,11
ST D13S317: 9,11
ST D16S539: 8,11
ST D18S51: 13,16
ST D21S11: 28,29
ST D3S1358: 14
ST D5S818: 10,11
ST D7S820: 7,10
ST D8S1179: 13,14
ST FGA: 22,24
ST Penta D: 8,11
ST Penta E: 12,16
ST TH01: 5,8
ST TPOX: 8,11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DP76 ! DP75
SX Male
CA Induced pluripotent stem cell
//
ID iPS-DP75 4f-2
AC CVCL_DP80
RX PubMed=20554890;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DP76 ! DP75
SX Male
CA Induced pluripotent stem cell
//
ID iPS-DP75 4f-3
AC CVCL_DP81
RX PubMed=20554890;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DP76 ! DP75
SX Male
CA Induced pluripotent stem cell
//
ID iPS-Hep-FB/Ng/gfp-103C-1
AC CVCL_T784
DR RCB; APS0007
RX PubMed=18276851;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Transfected with: UniProtKB; P42212; GFP.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Induced pluripotent stem cell
//
ID iPS-HHT
AC CVCL_Y541
SY HHT
DR SKIP; SKIP000532
RX PubMed=20111645;
DI NCIt; C35064; Hereditary hemorrhagic telangiectasia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID iPS-L1
AC CVCL_B969
DR RCB; APS0008
RX PubMed=20670936;
CC Breed/subspecies: Dutch Belted.
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
OI CVCL_B970 ! iPS-L2
OI CVCL_B967 ! iPS-S1
OI CVCL_B968 ! iPS-S2
SX Female
CA Induced pluripotent stem cell
//
ID iPS-L2
AC CVCL_B970
RX PubMed=20670936;
CC Breed/subspecies: Dutch Belted.
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
OI CVCL_B969 ! iPS-L1
OI CVCL_B967 ! iPS-S1
OI CVCL_B968 ! iPS-S2
SX Female
CA Induced pluripotent stem cell
//
ID iPS-MEF-Fb/Ng-440A-3
AC CVCL_T785
SY iPS-MEF-FB/NG-440A-3
DR RCB; APS0003
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Induced pluripotent stem cell
//
ID iPS-MEF-Ng-178B-5
AC CVCL_T786
DR RCB; APS0002
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Induced pluripotent stem cell
//
ID iPS-MEF-Ng-20D-17
AC CVCL_T787
SY 20D17; Nanog iPS 20D17
DR GEO; GSM1330515
DR RCB; APS0001
RX PubMed=17554338;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Induced pluripotent stem cell
//
ID iPS-MEF-Ng-492B-4
AC CVCL_T788
DR RCB; APS0004
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Induced pluripotent stem cell
//
ID iPS-MSC-H9
AC CVCL_GR22
RX PubMed=26938212;
CC From: Universite Paris-Sud 11; Paris; France.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9773 ! WA09
SX Female
CA Induced pluripotent stem cell
//
ID iPS-MSC-SA01
AC CVCL_GR21
RX PubMed=26938212;
CC From: Universite Paris-Sud 11; Paris; France.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B347 ! SA001
SX Male
CA Induced pluripotent stem cell
//
ID IPS-S
AC CVCL_C876
DR ISCR; 211
RX PubMed=18414447;
CC From: Shanghai Institutes for Biological Sciences; Shanghai; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID iPS-S1
AC CVCL_B967
DR RCB; APS0010
RX PubMed=20670936;
CC Breed/subspecies: Dutch Belted.
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
OI CVCL_B969 ! iPS-L1
OI CVCL_B970 ! iPS-L2
OI CVCL_B968 ! iPS-S2
SX Female
CA Induced pluripotent stem cell
//
ID iPS-S2
AC CVCL_B968
RX PubMed=20670936;
CC Breed/subspecies: Dutch Belted.
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
OI CVCL_B969 ! iPS-L1
OI CVCL_B970 ! iPS-L2
OI CVCL_B967 ! iPS-S1
SX Female
CA Induced pluripotent stem cell
//
ID iPS-SCU-CD34+ #1
AC CVCL_V199
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Linea_iPS_SCU_CD34_1.pdf
CC From: Andalusian Stem Cell Bank; Granada; Spain.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID iPS-SCU-CD34+ #2
AC CVCL_V200
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Solicitud_Deposito_iPS_SCU_CD34_2.pdf
CC From: Andalusian Stem Cell Bank; Granada; Spain.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID iPS-SMA-3.5
AC CVCL_C877
SY iPS SMA 3.5; IPS-SMA-3.5; iPS-SMA3.5; iPS-SMA clone 3.5
DR ISCR; 313
DR GEO; GSM347916
RX PubMed=19098894;
CC From: University of Wisconsin; Madison; USA.
CC Omics: Transcriptome analysis.
DI NCIt; C98670; Werdnig-Hoffmann disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_F172 ! GM03813
SX Male
CA Induced pluripotent stem cell
//
ID iPS-SMA-3.6
AC CVCL_C878
AS CVCL_BV18; CVCL_F171; CVCL_Y792
SY iPS SMA 3.6; IPS-SMA-3.6; iPS-SMA3.6; iPS-SMA clone 3.6; UW13iSMA-i.6; 13iSMA; GM23240
DR Coriell; GM23240
DR GEO; GSM347917
DR ISCR; 312
DR SKIP; SKIP000185
RX PubMed=19098894;
RX PubMed=23665875;
CC From: University of Wisconsin; Madison; USA.
CC Omics: CNV analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C98670; Werdnig-Hoffmann disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_F172 ! GM03813
SX Male
CA Induced pluripotent stem cell
//
ID iPS-SPG4-splice
AC CVCL_IJ21
RX PubMed=27789400;
DI NCIt; C129981; Spastic paraplegia 4
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID iPS-Stm-FB/gfp-99-1
AC CVCL_T789
SY iPS-Stm-99-1; Stm99-1
DR RCB; APS0005
RX PubMed=18276851;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Transfected with: UniProtKB; P42212; GFP.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Induced pluripotent stem cell
//
ID iPS-Stm-FB/gfp-99-3
AC CVCL_T790
SY iPS-Stm-99-3; Stm99-3
DR RCB; APS0006
RX PubMed=18276851;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Transfected with: UniProtKB; P42212; GFP.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Induced pluripotent stem cell
//
ID iPS-TIG103-4f4
AC CVCL_C710
SY iPS-TIG103-4F4; TIG103-4f4; TIG103-4F4
DR GEO; GSM1040253
DR GEO; GSM1040323
RX PubMed=24259714;
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3188 ! TIG-103
SX Female
CA Induced pluripotent stem cell
//
ID iPS-TIG107-3f1
AC CVCL_T840
SY iPS-TIG107-3F1; TIG107-3f1
DR GEO; GSM1040255
DR GEO; GSM1040325
DR JCRB; NIHS0612
DR SKIP; SKIP000003
RX PubMed=24259714;
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3192 ! TIG-107
SX Female
CA Induced pluripotent stem cell
//
ID iPS-TIG107-4f1
AC CVCL_C709
SY iPS-TIG107-4F1; iPS-TIG107-Slc-4F1; TIG107-4f1; TIG1074F1
DR GEO; GSM1040254
DR GEO; GSM1040324
DR GEO; GSM1489221
DR GEO; GSM1489253
DR GEO; GSM1489429
DR JCRB; NIHS0613
DR SKIP; SKIP000004
RX PubMed=24259714;
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3192 ! TIG-107
SX Female
CA Induced pluripotent stem cell
//
ID iPS-TIG108-4f3
AC CVCL_DP61
SY TIG108-4f3
DR GEO; GSM1040256
DR GEO; GSM1040326
RX PubMed=24259714;
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3193 ! TIG-108
SX Female
CA Induced pluripotent stem cell
//
ID iPS-TIG109-4f1
AC CVCL_DP62
SY TIG109-4f1
DR GEO; GSM1040257
DR GEO; GSM1040327
RX PubMed=24259714;
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3194 ! TIG-109
SX Female
CA Induced pluripotent stem cell
//
ID iPS-TIG114-4f1
AC CVCL_C711
SY iPS-TIG114-4F1; TIG114-4F1; TIG114-4f1
DR GEO; GSM1040258
DR GEO; GSM1040328
DR JCRB; JCRB1437
DR SKIP; SKIP000007
RX PubMed=24259714;
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 8
ST D16S539: 9,10
ST D5S818: 10,11
ST D7S820: 9,11
ST TH01: 7,9
ST TPOX: 10,11
ST vWA: 14,16
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3199 ! TIG-114
SX Male
CA Induced pluripotent stem cell
//
ID iPS-TIG118-4f1
AC CVCL_DP63
SY TIG118-4f1
DR GEO; GSM1040259
DR GEO; GSM1040329
RX PubMed=24259714;
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3200 ! TIG-118
SX Female
CA Induced pluripotent stem cell
//
ID iPS-TIG120-3f7
AC CVCL_C712
SY iPS-TIG120-3F7; TIG120-3F7
DR JCRB; JCRB1341
DR JCRB; NIHS0615
DR SKIP; SKIP000005
CC Discontinued: JCRB; NIHS0615; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10
ST D16S539: 12
ST D5S818: 9,11
ST D7S820: 10,12
ST TH01: 9,9.3
ST TPOX: 8,11
ST vWA: 14,20
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3202 ! TIG-120
SX Female
CA Induced pluripotent stem cell
//
ID iPS-TIG120-4f1
AC CVCL_C713
SY iPS-TIG120-4F1; TIG120-4F1; iPS-TIG120-Slc-4F1; vWT-TIG120-4f1; TIG120-4f1; TIG1204F1
DR GEO; GSM1040260
DR GEO; GSM1040330
DR GEO; GSM1489222
DR GEO; GSM1489254
DR GEO; GSM1489430
DR GEO; GSM1942574
DR JCRB; JCRB1363
DR JCRB; NIHS0616
DR SKIP; SKIP000006
DR SKIP; SKIP000535
RX PubMed=24259714;
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: JCRB; NIHS0616; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10
ST D16S539: 12
ST D5S818: 9,11
ST D7S820: 10,12
ST TH01: 9,9.3
ST TPOX: 8,11
ST vWA: 14,20
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3202 ! TIG-120
SX Female
CA Induced pluripotent stem cell
//
ID iPS-TIG121-4f4
AC CVCL_DP64
SY TIG121-4f4
DR GEO; GSM1040261
DR GEO; GSM1040331
RX PubMed=24259714;
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3203 ! TIG-121
SX Male
CA Induced pluripotent stem cell
//
ID iPS-WT 4.2
AC CVCL_C879
AS CVCL_F175
SY IPS-WT; iPS-WT4.2; iPS-WT clone 4.2; UW14iCTR-i.2; 14iCTR; GM23241; iPS SMA 4.2
DR Coriell; GM23241
DR GEO; GSM347918
DR ISCR; 311
DR SKIP; SKIP000186
RX PubMed=19098894;
RX PubMed=23665875;
CC From: University of Wisconsin; Madison; USA.
CC Omics: CNV analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: Coriell; GM23241; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_F173 ! GM03814
SX Female
CA Induced pluripotent stem cell
//
ID iPS.C2a
AC CVCL_D081
DR ISCR; 881
RX PubMed=19998274;
CC From: Medical College of Wisconsin; Milwaukee; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2337 ! CCD-1079Sk
SX Male
CA Induced pluripotent stem cell
//
ID iPS.C3a
AC CVCL_D090
RX PubMed=19998274;
CC From: Medical College of Wisconsin; Milwaukee; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2337 ! CCD-1079Sk
SX Male
CA Induced pluripotent stem cell
//
ID iPS.C6a
AC CVCL_D091
RX PubMed=19998274;
CC From: Medical College of Wisconsin; Milwaukee; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2337 ! CCD-1079Sk
SX Male
CA Induced pluripotent stem cell
//
ID iPS.II.1.1
AC CVCL_W241
RX PubMed=24319668;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W242 ! iPS.II.1.2
OI CVCL_W243 ! iPS.II.1.3
OI CVCL_W244 ! iPS.II.1.4
SX Male
CA Induced pluripotent stem cell
//
ID iPS.II.1.2
AC CVCL_W242
RX PubMed=24319668;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W241 ! iPS.II.1.1
OI CVCL_W243 ! iPS.II.1.3
OI CVCL_W244 ! iPS.II.1.4
SX Male
CA Induced pluripotent stem cell
//
ID iPS.II.1.3
AC CVCL_W243
RX PubMed=24319668;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W241 ! iPS.II.1.1
OI CVCL_W242 ! iPS.II.1.2
OI CVCL_W244 ! iPS.II.1.4
SX Male
CA Induced pluripotent stem cell
//
ID iPS.II.1.4
AC CVCL_W244
RX PubMed=24319668;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W241 ! iPS.II.1.1
OI CVCL_W242 ! iPS.II.1.2
OI CVCL_W243 ! iPS.II.1.3
SX Male
CA Induced pluripotent stem cell
//
ID iPS.II.6.1
AC CVCL_W245
RX PubMed=24319668;
DI NCIt; C36100; BRCA1 syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W246 ! iPS.II.6.2
OI CVCL_W247 ! iPS.II.6.3
SX Female
CA Induced pluripotent stem cell
//
ID iPS.II.6.2
AC CVCL_W246
RX PubMed=24319668;
DI NCIt; C36100; BRCA1 syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W245 ! iPS.II.6.1
OI CVCL_W247 ! iPS.II.6.3
SX Female
CA Induced pluripotent stem cell
//
ID iPS.II.6.3
AC CVCL_W247
RX PubMed=24319668;
DI NCIt; C36100; BRCA1 syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W245 ! iPS.II.6.1
OI CVCL_W246 ! iPS.II.6.2
SX Female
CA Induced pluripotent stem cell
//
ID iPS.III.1.1
AC CVCL_W248
RX PubMed=24319668;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W249 ! iPS.III.1.2
SX Male
CA Induced pluripotent stem cell
//
ID iPS.III.1.2
AC CVCL_W249
RX PubMed=24319668;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W248 ! iPS.III.1.1
SX Male
CA Induced pluripotent stem cell
//
ID iPS.III.3.1
AC CVCL_W250
RX PubMed=24319668;
DI NCIt; C36100; BRCA1 syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W251 ! iPS.III.3.2
OI CVCL_W252 ! iPS.III.3.3
SX Male
CA Induced pluripotent stem cell
//
ID iPS.III.3.2
AC CVCL_W251
RX PubMed=24319668;
DI NCIt; C36100; BRCA1 syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W250 ! iPS.III.3.1
OI CVCL_W252 ! iPS.III.3.3
SX Male
CA Induced pluripotent stem cell
//
ID iPS.III.3.3
AC CVCL_W252
RX PubMed=24319668;
DI NCIt; C36100; BRCA1 syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W250 ! iPS.III.3.1
OI CVCL_W251 ! iPS.III.3.2
SX Male
CA Induced pluripotent stem cell
//
ID iPS.III.4.1
AC CVCL_W253
RX PubMed=24319668;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W254 ! iPS.III.4.2
SX Female
CA Induced pluripotent stem cell
//
ID iPS.III.4.2
AC CVCL_W254
RX PubMed=24319668;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W253 ! iPS.III.4.1
SX Female
CA Induced pluripotent stem cell
//
ID iPS.III.7.1
AC CVCL_W255
RX PubMed=24319668;
DI NCIt; C36100; BRCA1 syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W256 ! iPS.III.7.2
OI CVCL_W257 ! iPS.III.7.3
OI CVCL_W258 ! iPS.III.7.4
SX Female
CA Induced pluripotent stem cell
//
ID iPS.III.7.2
AC CVCL_W256
RX PubMed=24319668;
DI NCIt; C36100; BRCA1 syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W255 ! iPS.III.7.1
OI CVCL_W257 ! iPS.III.7.3
OI CVCL_W258 ! iPS.III.7.4
SX Female
CA Induced pluripotent stem cell
//
ID iPS.III.7.3
AC CVCL_W257
RX PubMed=24319668;
DI NCIt; C36100; BRCA1 syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W255 ! iPS.III.7.1
OI CVCL_W256 ! iPS.III.7.2
OI CVCL_W258 ! iPS.III.7.4
SX Female
CA Induced pluripotent stem cell
//
ID iPS.III.7.4
AC CVCL_W258
RX PubMed=24319668;
DI NCIt; C36100; BRCA1 syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W255 ! iPS.III.7.1
OI CVCL_W256 ! iPS.III.7.2
OI CVCL_W257 ! iPS.III.7.3
SX Female
CA Induced pluripotent stem cell
//
ID iPS.IV.1.1
AC CVCL_W259
RX PubMed=24319668;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W260 ! iPS.IV.1.2
OI CVCL_W261 ! iPS.IV.1.3
CA Induced pluripotent stem cell
//
ID iPS.IV.1.2
AC CVCL_W260
RX PubMed=24319668;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W259 ! iPS.IV.1.1
OI CVCL_W261 ! iPS.IV.1.3
SX Female
CA Induced pluripotent stem cell
//
ID iPS.IV.1.3
AC CVCL_W261
RX PubMed=24319668;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W259 ! iPS.IV.1.1
OI CVCL_W260 ! iPS.IV.1.2
SX Female
CA Induced pluripotent stem cell
//
ID iPS.IV.3.1
AC CVCL_W262
RX PubMed=24319668;
DI NCIt; C36100; BRCA1 syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W263 ! iPS.IV.3.2
OI CVCL_W264 ! iPS.IV.3.3
SX Female
CA Induced pluripotent stem cell
//
ID iPS.IV.3.2
AC CVCL_W263
RX PubMed=24319668;
DI NCIt; C36100; BRCA1 syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W262 ! iPS.IV.3.1
OI CVCL_W264 ! iPS.IV.3.3
SX Female
CA Induced pluripotent stem cell
//
ID iPS.IV.3.3
AC CVCL_W264
RX PubMed=24319668;
DI NCIt; C36100; BRCA1 syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W262 ! iPS.IV.3.1
OI CVCL_W263 ! iPS.IV.3.2
SX Female
CA Induced pluripotent stem cell
//
ID IPS(Foreskin)-1
AC CVCL_C430
SY IPS(FORESKIN)-1; WISCi003-A
DR BioSamples; SAMEA7784668
DR hPSCreg; WISCi003-A
DR ISCR; 127
RX PubMed=18029452;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/ips-foreskin-1.cmsx
WW http://shared.eagle-i.net/i/00000144-8e77-a93b-5797-c9ee80000000
CC From: University of Wisconsin; Madison; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C431 ! IPS(Foreskin)-2
OI CVCL_C432 ! IPS(Foreskin)-3
OI CVCL_C433 ! IPS(Foreskin)-4
SX Male
CA Induced pluripotent stem cell
//
ID IPS(Foreskin)-2
AC CVCL_C431
SY IPS(FORESKIN)-2
DR ISCR; 128
RX PubMed=18029452;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/ips-foreskin-2.cmsx
WW http://shared.eagle-i.net/i/00000144-8e7c-4288-5797-c9ee80000000
CC From: University of Wisconsin; Madison; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C430 ! IPS(Foreskin)-1
OI CVCL_C432 ! IPS(Foreskin)-3
OI CVCL_C433 ! IPS(Foreskin)-4
SX Male
CA Induced pluripotent stem cell
//
ID IPS(Foreskin)-3
AC CVCL_C432
SY IPS(FORESKIN)-3
DR ISCR; 129
RX PubMed=18029452;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/ips-foreskin-3.cmsx
WW http://shared.eagle-i.net/i/00000144-8e7d-e38c-5797-c9ee80000000
CC From: University of Wisconsin; Madison; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C430 ! IPS(Foreskin)-1
OI CVCL_C431 ! IPS(Foreskin)-2
OI CVCL_C433 ! IPS(Foreskin)-4
SX Male
CA Induced pluripotent stem cell
//
ID IPS(Foreskin)-4
AC CVCL_C433
SY IPS(FORESKIN)-4
DR ISCR; 130
RX PubMed=18029452;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/ips-foreskin-4.cmsx
WW http://shared.eagle-i.net/i/00000144-8e7f-d2ca-5797-c9ee80000000
CC From: University of Wisconsin; Madison; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C430 ! IPS(Foreskin)-1
OI CVCL_C431 ! IPS(Foreskin)-2
OI CVCL_C432 ! IPS(Foreskin)-3
SX Male
CA Induced pluripotent stem cell
//
ID IPS(IMR90)-1
AC CVCL_C434
SY WISCi004-A
DR hPSCreg; WISCi004-A
DR ISCR; 131
RX PubMed=18029452;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/ips-imr90-1.cmsx
WW http://shared.eagle-i.net/i/00000144-8e04-49ed-5797-c9ee80000000
CC From: University of Wisconsin; Madison; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0347 ! IMR-90
SX Female
CA Induced pluripotent stem cell
//
ID IPS(IMR90)-2
AC CVCL_C435
DR ISCR; 132
RX PubMed=18029452;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/ips-imr90-2.cmsx
WW http://shared.eagle-i.net/i/00000144-8e02-cac7-5797-c9ee80000000
CC From: University of Wisconsin; Madison; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0347 ! IMR-90
SX Female
CA Induced pluripotent stem cell
//
ID IPS(IMR90)-3
AC CVCL_C436
DR ISCR; 133
RX PubMed=18029452;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/ips-imr90-3.cmsx
WW http://shared.eagle-i.net/i/00000144-8e01-130f-5797-c9ee80000000
CC From: University of Wisconsin; Madison; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0347 ! IMR-90
SX Female
CA Induced pluripotent stem cell
//
ID IPS(IMR90)-4
AC CVCL_C437
SY WISCi004-B
DR hPSCreg; WISCi004-B
DR ISCR; 134
RX PubMed=18029452;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/ips-imr90-4.cmsx
WW http://shared.eagle-i.net/i/00000144-8df2-8ded-5797-c9ee80000000
CC From: University of Wisconsin; Madison; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0347 ! IMR-90
SX Female
CA Induced pluripotent stem cell
//
ID iPS0826#6
AC CVCL_9S72
WW http://www.isciii.es/ISCIII/es/contenidos/fd-el-instituto/fd-organizacion/fd-estructura-directiva/fd-subdireccion-general-investigacion-terapia-celular-medicina-regenerativa/fd-centros-unidades/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Solicitud_iPS0826_6-m.pdf
CC From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.
DI NCIt; C84828; Limb-girdle muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID iPS0924#6
AC CVCL_9S73
WW http://www.isciii.es/ISCIII/es/contenidos/fd-el-instituto/fd-organizacion/fd-estructura-directiva/fd-subdireccion-general-investigacion-terapia-celular-medicina-regenerativa/fd-centros-unidades/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Solicitud_iPS0924_6-m.pdf
CC From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.
DI NCIt; C84828; Limb-girdle muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID IPSB-18
AC CVCL_5G64
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=1982895;
RX PubMed=7518347;
RX PubMed=7591247;
RX PubMed=8054266;
RX PubMed=21556643;
DI NCIt; C9477; Anaplastic astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID iPSC carrier 1 line 5
AC CVCL_Y957
SY Carrier1 #5
DR SKIP; SKIP000324
RX PubMed=23836290;
DI NCIt; C84719; Frontotemporal dementia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y958 ! iPSC carrier 1 line 6
SX Female
CA Induced pluripotent stem cell
//
ID iPSC carrier 1 line 6
AC CVCL_Y958
SY Carrier1 #6
DR SKIP; SKIP000325
RX PubMed=23836290;
DI NCIt; C84719; Frontotemporal dementia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y957 ! iPSC carrier 1 line 5
SX Female
CA Induced pluripotent stem cell
//
ID iPSC carrier 2 line 1
AC CVCL_Y959
SY Carrier2 #1
DR SKIP; SKIP000326
RX PubMed=23836290;
DI NCIt; C84719; Frontotemporal dementia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y960 ! iPSC carrier 2 line 11
SX Male
CA Induced pluripotent stem cell
//
ID iPSC carrier 2 line 11
AC CVCL_Y960
SY Carrier2 #11
DR SKIP; SKIP000327
RX PubMed=23836290;
DI NCIt; C84719; Frontotemporal dementia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y959 ! iPSC carrier 2 line 1
SX Male
CA Induced pluripotent stem cell
//
ID iPSC-1s
AC CVCL_D082
DR ISCR; 1452
RX PubMed=20139967;
CC From: Stanford University School of Medicine; Stanford; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID iPSC-2s
AC CVCL_D083
DR ISCR; 1453
RX PubMed=20139967;
CC From: Stanford University School of Medicine; Stanford; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID iPSC-3s
AC CVCL_D084
DR ISCR; 1454
RX PubMed=20139967;
CC From: Stanford University School of Medicine; Stanford; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID iPSC-CGD1.1
AC CVCL_V181
DR ISCR; 2269
DI NCIt; C26788; Chronic granulomatous disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V182 ! iPSC-CGD1.2
SX Male
CA Induced pluripotent stem cell
//
ID iPSC-CGD1.2
AC CVCL_V182
DR ISCR; 2270
DI NCIt; C26788; Chronic granulomatous disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V181 ! iPSC-CGD1.1
SX Male
CA Induced pluripotent stem cell
//
ID iPSC-CGD2
AC CVCL_V183
DR ISCR; 2271
DI NCIt; C26788; Chronic granulomatous disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID iPSC-CGD3
AC CVCL_V184
DR ISCR; 2272
DI NCIt; C26788; Chronic granulomatous disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID iPSC-FH2.1
AC CVCL_DQ93
RX PubMed=27345989;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID iPSc-GD-A8
AC CVCL_IN10
SY GD iPSC A8; Gaucher iPSC-A8; A8
DR GEO; GSM1012130
RX PubMed=23118351;
CC Characteristics: Has GBA p.Gly241Arg and p.Leu483Pro mutations.
CC Omics: Transcriptome analysis.
DI NCIt; C61268; Gaucher disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IN11 ! iPSc-GD-C21
SX Male
CA Induced pluripotent stem cell
//
ID iPSc-GD-C21
AC CVCL_IN11
SY GD iPSC C21; Gaucher iPSC-C21; C21; 21C
DR GEO; GSM1012128
RX PubMed=23118351;
CC Characteristics: Has GBA p.Gly241Arg and p.Leu483Pro mutations.
CC Omics: Transcriptome analysis.
DI NCIt; C61268; Gaucher disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IN10 ! iPSc-GD-A8
SX Male
CA Induced pluripotent stem cell
//
ID iPSC-HDF
AC CVCL_V185
DR ISCR; 2273
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID iPSC-MHF2 c1
AC CVCL_D089
DR ISCR; 1455
RX PubMed=20098701;
CC From: University of Washington; Seattle; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7421 ! GM05387
SX Male
CA Induced pluripotent stem cell
//
ID iPSC1
AC CVCL_D086
DR ISCR; 1456
RX PubMed=19763270;
CC From: University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID iPSC2
AC CVCL_D087
DR ISCR; 1457
RX PubMed=19763270;
CC From: University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID iPSC3
AC CVCL_D088
DR ISCR; 1458
RX PubMed=19763270;
CC From: University of California, San Diego; San Diego; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID iPWS1
AC CVCL_T948
SY A000041#1; A000041# 1
DR RCB; HPS0080
DR SKIP; SKIP000025
DI NCIt; C75463; Prader-Willi syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L556 ! PWS-Yamaguchi
SX Female
CA Induced pluripotent stem cell
//
ID iPWS3
AC CVCL_T949
SY A000041#3; A000041# 3
DR RCB; HPS0081
DR SKIP; SKIP000026
DI NCIt; C75463; Prader-Willi syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L556 ! PWS-Yamaguchi
SX Female
CA Induced pluripotent stem cell
//
ID iPWS5
AC CVCL_T947
SY A000041#5; A000041# 5
DR RCB; HPS0082
DR SKIP; SKIP000027
DR SKIP; SKIP000283
DI NCIt; C75463; Prader-Willi syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L556 ! PWS-Yamaguchi
SX Female
CA Induced pluripotent stem cell
//
ID IPTP/98
AC CVCL_7168
SY IPTP-98
DR BioSample; SAMN03152018
DR ECACC; 99050528
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Misidentified. Originally thought to be of human origin but found to be from rat (PubMed=20143388).
CC Discontinued: ECACC; 99050528; probable.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Sex undetermined
CA Undefined cell line type
//
ID IPTR-6
AC CVCL_5G69
RX PubMed=7518347;
RX PubMed=7591247;
DI NCIt; C3788; Ganglioglioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID IR983F
AC CVCL_7675
SY IR 983F
DR CCRID; 3111C0001CCC000221
RX PubMed=6678801;
CC Group: Hybridoma fusion partner cell line.
DI NCIt; C125416; Rat plasma cell myeloma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID IRB-1
AC CVCL_IU71
RX DOI=10.7287/peerj.preprints.2780v1;
CC Doubling time: 36 +- 4.6 hours (DOI=10.7287/peerj.preprints.2780v1).
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID IRC-1
AC CVCL_AR97
DR JCRB; NIHS0315
CC Discontinued: JCRB; NIHS0315; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 12
ST D16S539: 9,13
ST D5S818: 10,11
ST D7S820: 11,12
ST TH01: 7,9
ST TPOX: 9,11
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID IRC-2
AC CVCL_8359
DR BioSample; SAMN03472498
DR JCRB; JCRB1068
DR JCRB; NIHS0322
CC Discontinued: JCRB; JCRB1068; probable.
CC Discontinued: JCRB; NIHS0322; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 10,13
ST D16S539: 9,10
ST D5S818: 7,10
ST D7S820: 10,11
ST TH01: 9
ST TPOX: 8,11
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID IRE/CTVM18
AC CVCL_Z156
RX PubMed=15053931;
RX PubMed=17662657;
CC Group: Tick cell line.
OX NCBI_TaxID=34613; ! Ixodes ricinus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IRE/CTVM19
AC CVCL_Z157
DR TCB; 3021
RX PubMed=17662657;
RX PubMed=22743047;
CC Group: Tick cell line.
OX NCBI_TaxID=34613; ! Ixodes ricinus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IRE/CTVM20
AC CVCL_Z158
DR TCB; 3026
RX PubMed=17662657;
RX PubMed=20388200;
RX PubMed=21955214;
RX PubMed=22743047;
RX PubMed=23146170;
CC Group: Tick cell line.
OX NCBI_TaxID=34613; ! Ixodes ricinus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IRE11
AC CVCL_Z200
DR TCB; 3081
RX PubMed=12200314;
RX PubMed=17662657;
RX PubMed=22743047;
WW https://www.dsmz.de/fileadmin/Bereiche/Microbiology/Dateien/Kultivierungshinweise/TickCellCultureMethods-4.pdf
CC Group: Tick cell line.
OX NCBI_TaxID=34613; ! Ixodes ricinus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IREs-4
AC CVCL_W994
SY IFN resistant Eskol-4
RX PubMed=7694002;
DI NCIt; C7402; Hairy cell leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B398 ! ESKOL
SX Male
CA Cancer cell line
//
ID IRFMNi001-A
AC CVCL_IT61
SY iPS clone IV
DR BioSamples; SAMEA7614418
DR hPSCreg; IRFMNi001-A
RX PubMed=25744951;
CC From: Istituto di Ricerche Farmacologiche Mario Negri (IRCCS); Italy.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID IRKHBK
AC CVCL_9V28
SY Iran Razi Khedmati Bovine Kidney
DR NCBI_Iran; C541
RX DOI=10.7508/ari.2015.03.004;
CC Breed/subspecies: Holstein.
OX NCBI_TaxID=9913; ! Bos taurus
SX Male
CA Spontaneously immortalized cell line
//
ID IRM2
AC CVCL_AW96
SY IRM-2
DR Cosmic; 2297000
DR GEO; GSM119540
RX PubMed=16960149;
DI NCIt; C4337; Mantle cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID IRMC
AC CVCL_W170
SY Immortalized Rat Mesangial Cells
RX PubMed=9112121;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Miscellaneous: As no cell line name was given in the paper, we assigned the name based on the abbreviation of the cell description.
CC Breed/subspecies: Wistar.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Transformed cell line
//
ID IRNE
AC CVCL_C263
SY BB74-MEL
DR Cosmic; 972261
DR Cosmic; 2163787
DR ESTDAB; ESTDAB-038
RX PubMed=9894850;
RX PubMed=23493799;
CC From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC Discontinued: ESTDAB; ESTDAB-038; probable.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID irs1
AC CVCL_1N51
SY irs 1; irs-1
RX PubMed=2158612;
RX PubMed=3106801;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_2796 ! V79-4
SX Male
CA Spontaneously immortalized cell line
//
ID irs2
AC CVCL_1N52
SY irs 2
RX PubMed=2158612;
RX PubMed=3106801;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_2796 ! V79-4
SX Male
CA Spontaneously immortalized cell line
//
ID irs3
AC CVCL_1N53
SY irs 3
RX PubMed=3106801;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_2796 ! V79-4
SX Male
CA Spontaneously immortalized cell line
//
ID IS2258
AC CVCL_8X69
DR ECACC; 05060325
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID IS2259
AC CVCL_8X70
DR ECACC; 05060326
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID IS2260
AC CVCL_8X71
DR ECACC; 05060327
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ISE18
AC CVCL_Z168
DR TCB; 3111
RX Patent=US5869335;
RX PubMed=8057317;
RX PubMed=8064520;
RX PubMed=17662657;
RX PubMed=22743047;
WW https://www.dsmz.de/fileadmin/Bereiche/Microbiology/Dateien/Kultivierungshinweise/TickCellCultureMethods-4.pdf
WW https://www.vectorbase.org/data/ixodes-scapularis-ise18-cell-line-avcl
CC Group: Tick cell line.
CC Omics: Deep RNAseq analysis.
OX NCBI_TaxID=6945; ! Ixodes scapularis
SX Mixed sex
CA Spontaneously immortalized cell line
//
ID ISE5
AC CVCL_Z169
RX Patent=US5869335;
RX PubMed=8064520;
RX PubMed=8812616;
RX PubMed=17662657;
CC Group: Tick cell line.
CC Misspelling: 'ISE25' in PubMed=8812616.
OX NCBI_TaxID=6945; ! Ixodes scapularis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ISE6
AC CVCL_Z170
DR ATCC; CRL-11974
DR TCB; 3051
RX Patent=US5869335;
RX PubMed=8812616;
RX PubMed=16922866;
RX PubMed=17662657;
RX PubMed=19242658;
RX PubMed=22743047;
WW https://www.dsmz.de/fileadmin/Bereiche/Microbiology/Dateien/Kultivierungshinweise/TickCellCultureMethods-4.pdf
WW https://www.vectorbase.org/data/ixodes-scapularis-ise6-cell-line-avcl
CC Group: Tick cell line.
CC Omics: Deep RNAseq analysis.
OX NCBI_TaxID=6945; ! Ixodes scapularis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ISH/DDP
AC CVCL_IR24
RX PubMed=22041447;
CC Doubling time: 40.1 hours (PubMed=22041447).
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2529 ! Ishikawa
SX Female
CA Cancer cell line
//
ID ISH3
AC CVCL_E710
DR dbMHC; 48907
DR IHW; IHW9369
DR IMGT/HLA; 25980
CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ISH4
AC CVCL_E711
SY ENDO; TER281
DR dbMHC; 48908
DR IHW; IHW9371
DR IMGT/HLA; 25982
CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ISH5
AC CVCL_E712
DR dbMHC; 48909
DR IHW; IHW9372
DR IMGT/HLA; 25983
CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID Ishikawa
AC CVCL_2529
SY ISHIKAWA; ISHI
DR BTO; BTO:0003041
DR EFO; EFO_0005718
DR BCRJ; 0364
DR BioSample; SAMN03471030
DR ChEMBL-Cells; CHEMBL3307675
DR ChEMBL-Targets; CHEMBL614649
DR Cosmic; 713475
DR Cosmic; 713499
DR Cosmic; 809129
DR Cosmic; 846174
DR Cosmic; 1070811
DR Cosmic; 1152553
DR Cosmic; 1176597
DR Cosmic; 1177618
DR Cosmic; 1241344
DR Cosmic; 1622902
DR Cosmic; 1696753
DR Cosmic; 2030475
DR Cosmic; 2464666
DR ECACC; 99040201
DR ENCODE; ENCBS228AAA
DR ENCODE; ENCBS229AAA
DR ENCODE; ENCBS230AAA
DR GEO; GSM374972
DR GEO; GSM375431
DR GEO; GSM827370
DR GEO; GSM1008593
DR GEO; GSM1008594
DR GEO; GSM1669941
DR LINCS; 50018
DR TOKU-E; 3966
RX PubMed=4031568;
RX PubMed=12703541;
RX PubMed=22710073;
RX PubMed=23255909;
RX PubMed=27397505;
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/Ishikawa_Crawford_protocol.pdf
CC Part of: ENCODE project common cell types; tier 3.
CC Doubling time: 35.14 +- 2.68 hours (PubMed=23255909).
CC Misspelling: Occasionally 'Ischikawaa'.
ST Source(s): ECACC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 9,12
ST D16S539: 9
ST D18S51: 13,19
ST D19S433: 12.2,14
ST D21S11: 28
ST D2S1338: 20
ST D3S1358: 15,17
ST D5S818: 10,11
ST D7S820: 9,10
ST D8S1179: 12,16
ST FGA: 21
ST Penta D: 10,11
ST Penta E: 11,19
ST TH01: 9,10
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Ishikawa 1-A-12
AC CVCL_W420
RX PubMed=9183638;
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2529 ! Ishikawa
SX Female
CA Cancer cell line
//
ID Ishikawa 1-A-9
AC CVCL_W421
RX PubMed=9183638;
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2529 ! Ishikawa
SX Female
CA Cancer cell line
//
ID Ishikawa 1-C-10
AC CVCL_W422
RX PubMed=9183638;
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2529 ! Ishikawa
SX Female
CA Cancer cell line
//
ID Ishikawa 1-D-9
AC CVCL_W423
RX PubMed=9183638;
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2529 ! Ishikawa
SX Female
CA Cancer cell line
//
ID Ishikawa 1-E-8
AC CVCL_W424
RX PubMed=9183638;
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2529 ! Ishikawa
SX Female
CA Cancer cell line
//
ID Ishikawa 1-F-6
AC CVCL_W425
RX PubMed=9183638;
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2529 ! Ishikawa
SX Female
CA Cancer cell line
//
ID Ishikawa 1-H-6
AC CVCL_W426
RX PubMed=9183638;
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2529 ! Ishikawa
SX Female
CA Cancer cell line
//
ID Ishikawa 2-B-12
AC CVCL_W427
RX PubMed=9183638;
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2529 ! Ishikawa
SX Female
CA Cancer cell line
//
ID Ishikawa 2-C-3
AC CVCL_W428
RX PubMed=9183638;
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2529 ! Ishikawa
SX Female
CA Cancer cell line
//
ID Ishikawa 2-C-7
AC CVCL_W429
RX PubMed=9183638;
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2529 ! Ishikawa
SX Female
CA Cancer cell line
//
ID Ishikawa 2-E-7
AC CVCL_W430
RX PubMed=9183638;
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2529 ! Ishikawa
SX Female
CA Cancer cell line
//
ID Ishikawa 2-F-4
AC CVCL_W431
RX PubMed=9183638;
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2529 ! Ishikawa
SX Female
CA Cancer cell line
//
ID Ishikawa 3-D-7
AC CVCL_W432
RX PubMed=9183638;
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2529 ! Ishikawa
SX Female
CA Cancer cell line
//
ID Ishikawa 3-D-9
AC CVCL_W433
RX PubMed=9183638;
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2529 ! Ishikawa
SX Female
CA Cancer cell line
//
ID Ishikawa 3-H-12
AC CVCL_D199
SY Ishikawa-3H-12; Ishikawa-3H12; Ishikawa 3H12; Ishikawa 3 H 12; Ishikawa3-H-12; Ishikawa clone 3-H-12; Ishikawa-H-12
DR Cosmic; 871553
DR Cosmic; 889119
DR Cosmic; 1007163
DR Cosmic; 1066223
DR Cosmic; 1223489
DR JCRB; JCRB1505
RX PubMed=9183638;
RX PubMed=22710073;
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 9,12,13
ST D16S539: 9
ST D5S818: 10,11
ST D7S820: 9,10
ST TH01: 9,10
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2529 ! Ishikawa
SX Female
CA Cancer cell line
//
ID Ishikawa 3-H-3
AC CVCL_W434
RX PubMed=9183638;
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2529 ! Ishikawa
SX Female
CA Cancer cell line
//
ID Ishikawa 3-H-4
AC CVCL_W435
RX PubMed=9183638;
RX PubMed=22710073;
ST Source(s): PubMed=22710073;
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 9,12
ST D16S539: 9
ST D18S51: 13,21,22
ST D19S433: 12.2,14
ST D21S11: 28
ST D2S1338: 19,20
ST D3S1358: 16,17
ST D5S818: 10,11
ST D7S820: 9,10
ST D8S1179: 12,16
ST FGA: 21,22
ST TH01: 9,10
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2529 ! Ishikawa
SX Female
CA Cancer cell line
//
ID Ishikawa 3-H-7
AC CVCL_W436
RX PubMed=9183638;
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2529 ! Ishikawa
SX Female
CA Cancer cell line
//
ID Ishikawa (Heraklio) 02 ER-
AC CVCL_6543
SY Ishikawa(Heraklio)02ER-; ER-02 ISH
DR CLO; CLO_0006967
DR CCLE; ISHIKAWAHERAKLIO02ER_ENDOMETRIUM
DR ECACC; 98032302
DR GDSC; 1240156
DR GEO; GSM827371
DR GEO; GSM887164
DR GEO; GSM888236
DR LINCS; 50019
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ECACC; 98032302; probable.
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2529 ! Ishikawa
SX Female
CA Cancer cell line
//
ID Ishikawa (London) 02 ER+
AC CVCL_8783
DR CLO; CLO_0006968
DR ECACC; 98032301
CC Discontinued: ECACC; 98032301; probable.
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2529 ! Ishikawa
SX Female
CA Cancer cell line
//
ID Ishikawa-RP
AC CVCL_IJ14
SY Ishikawa-Resistant to Progestin
RX PubMed=23255909;
CC Doubling time: 34.18 +- 3.15 hours (PubMed=23255909).
CC Selected for resistance to: ChEBI; CHEBI:6716; Medroxyprogesterone acetate (MPA).
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2529 ! Ishikawa
SX Female
CA Cancer cell line
//
ID ISI-1
AC CVCL_A626
DR Cosmic; 1238081
RX CelloPub=CLPUB00135;
CC Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).
DI NCIt; C6915; Primary effusion lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ISO-HAS
AC CVCL_C516
SY ISO HAS
DR RCB; RCB3674
DR TKG; TKG 0593
RX PubMed=10188735;
RX PubMed=12453433;
CC Doubling time: 64 hours (PubMed=10188735).
ST Source(s): TKG
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 8
ST D16S539: 11
ST D5S818: 10
ST D7S820: 10,11
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 14
DI NCIt; C4489; Skin angiosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ISO-HAS-1
AC CVCL_C518
SY ISO-HAS.1
RX PubMed=12453433;
DI NCIt; C4489; Skin angiosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_C516 ! ISO-HAS
SX Male
CA Cancer cell line
//
ID ISO-HAS-B
AC CVCL_AS11
DR TKG; TKG 0715
ST Source(s): TKG
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 8
ST D16S539: 11
ST D5S818: 10
ST D7S820: 10,11
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 14
DI NCIt; C4489; Skin angiosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_C516 ! ISO-HAS
SX Male
CA Cancer cell line
//
ID ISOS-1
AC CVCL_C517
SY ISOS 1
DR RCB; RCB3670
DR TKG; TKG 0590
RX PubMed=9459120;
CC Discontinued: RCB; RCB3670; true.
CC Breed/subspecies: C.B-17/Icr-SCID Jcl.
DI NCIt; C24016; Mouse angiosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID Isreco-1
AC CVCL_A627
SY Isreco1; ISRECO1; IS-1; IS1
DR Cosmic; 711262
DR Cosmic; 887229
DR Cosmic; 902793
DR Cosmic; 1479579
RX PubMed=9000147;
RX PubMed=9000572;
RX PubMed=9205061;
RX PubMed=10766420;
RX PubMed=11414198;
RX PubMed=11526487;
RX PubMed=24042735;
CC Microsatellite instability: Stable (MSS) (PubMed=9000147; PubMed=24042735).
CC Miscellaneous: STR profile mentioned but not shown in PubMed=24042735; obtained by personal communication of Lind G.E.
ST Source(s): PubMed=24042735
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 12
ST D18S51: 10,20
ST D19S433: 13
ST D21S11: 31.2,32.2
ST D2S1338: 20
ST D3S1358: 16,18
ST D5S818: 12,13
ST D7S820: 9,10
ST D8S1179: 10,12
ST FGA: 21,22
ST TH01: 7
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A628 ! Isreco-2
OI CVCL_A629 ! Isreco-3
CA Cancer cell line
//
ID Isreco-2
AC CVCL_A628
SY Isreco2; ISRECO2; IS-2; IS2
DR Cosmic; 711263
DR Cosmic; 887237
DR Cosmic; 1479580
RX PubMed=9000147;
RX PubMed=9000572;
RX PubMed=9205061;
RX PubMed=10766420;
RX PubMed=11414198;
RX PubMed=11526487;
CC Microsatellite instability: Stable (MSS) (PubMed=9000147).
CC Derived from metastatic site: Liver.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A627 ! Isreco-1
OI CVCL_A629 ! Isreco-3
CA Cancer cell line
//
ID Isreco-3
AC CVCL_A629
SY Isreco3; ISRECO3; IS-3; IS3
DR Cosmic; 711264
DR Cosmic; 887239
DR Cosmic; 1479581
RX PubMed=9000147;
RX PubMed=9000572;
RX PubMed=9205061;
RX PubMed=10766420;
RX PubMed=11414198;
RX PubMed=11526487;
RX PubMed=24042735;
CC Microsatellite instability: Stable (MSS) (PubMed=9000147; PubMed=24042735).
CC Miscellaneous: STR profile mentioned but not shown in PubMed=24042735; obtained by personal communication of Lind G.E.
CC Derived from metastatic site: Peritoneum.
ST Source(s): PubMed=24042735
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 12
ST D18S51: 10
ST D19S433: 13
ST D21S11: 31.2,32.1
ST D2S1338: 20
ST D3S1358: 16,18
ST D5S818: 12,13
ST D7S820: 9,10
ST D8S1179: 10,12
ST FGA: 21,22
ST TH01: 7
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A627 ! Isreco-1
OI CVCL_A628 ! Isreco-2
CA Cancer cell line
//
ID Issac IV
AC CVCL_IU27
SY NK15d
RX PubMed=4174339;
RX PubMed=5021706;
RX PubMed=5786183;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ISt-1
AC CVCL_F645
SY Ist-1
DR GEO; GSM562416
RX PubMed=1716623;
RX PubMed=15767549;
CC Part of: JFCR45 cancer cell line panel.
DI NCIt; C4911; Gastric carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID IST-1
AC CVCL_F642
DR ATCC; CRL-2734
DR BioSample; SAMN03151922
DR BioSample; SAMN03471780
RX PubMed=9701564;
WW http://www.atcc.org/support/faqs/8093b/IST1%20ATCC%20CRL2734-1068.aspx
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a SK-OV-3 derivative. Originally thought to originate from and HPV16 immortalized first trimester placenta.
CC Discontinued: ATCC; CRL-2734; true.
CC Derived from metastatic site: Ascites.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11,12
ST D13S317: 8,11,12
ST D16S539: 10,12,13
ST D5S818: 11,12
ST D7S820: 9,10,13,14
ST TH01: 7,8,9,9.3
ST TPOX: 6,8,9,11
ST vWA: 16,17,18
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0532 ! SK-OV-3
SX Female
CA Cancer cell line
//
ID IST-EBV-TW1.1
AC CVCL_3903
DR CLDB; cl7144
DR ICLC; EBV03001
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Miscellaneous: Established from dizygotic twin of IST-EBV-TW1.2 (CVCL_3904).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID IST-EBV-TW1.2
AC CVCL_3904
DR CLDB; cl7145
DR ICLC; EBV03002
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Miscellaneous: Established from dizygotic twin of IST-EBV-TW1.1 (CVCL_3903).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID IST-EBV-TW2.1
AC CVCL_3905
DR CLDB; cl7146
DR ICLC; EBV03003
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Miscellaneous: Established from monozygotic twin of IST-EBV-TW2.2 (CVCL_3906).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID IST-EBV-TW2.2
AC CVCL_3906
DR CLDB; cl7147
DR ICLC; EBV03004
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Miscellaneous: Established from monozygotic twin of IST-EBV-TW2.1 (CVCL_3905).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID IST-EBV-TW3.1
AC CVCL_3907
DR CLDB; cl7148
DR ICLC; EBV03005
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Miscellaneous: Established from dizygotic twin of IST-EBV-TW3.2 (CVCL_3908).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID IST-EBV-TW3.2
AC CVCL_3908
DR CLDB; cl7149
DR ICLC; EBV03006
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Miscellaneous: Established from dizygotic twin of IST-EBV-TW3.1 (CVCL_3907).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID IST-EBV-TW4A
AC CVCL_3909
DR CLDB; cl7150
DR ICLC; EBV03007
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Miscellaneous: Established from monozygotic twin of IST-EBV-TW4B (CVCL_3909).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID IST-EBV-TW4B
AC CVCL_3910
DR CLDB; cl7151
DR ICLC; EBV03008
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Miscellaneous: Established from monozygotic twin of IST-EBV-TW4A (CVCL_3908).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID IST-EBV-TW5A
AC CVCL_3911
DR CLDB; cl7152
DR ICLC; EBV03009
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Miscellaneous: Established from dizygotic twin of IST-EBV-TW5B (CVCL_3912).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID IST-EBV-TW5B
AC CVCL_3912
DR CLDB; cl7153
DR ICLC; EBV03010
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Miscellaneous: Established from dizygotic twin of IST-EBV-TW5A (CVCL_3911).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID IST-EBV-TW6A
AC CVCL_3913
DR CLDB; cl7157
DR ICLC; EBV04001
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Miscellaneous: Established from dizygotic twin of IST-EBV-TW6B (CVCL_3914).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID IST-EBV-TW6B
AC CVCL_3914
DR CLDB; cl7158
DR ICLC; EBV04002
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Miscellaneous: Established from dizygotic twin of IST-EBV-TW6A (CVCL_3913).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID IST-MEL1
AC CVCL_1308
SY ISTMEL1
DR CLO; CLO_0006969
DR CLDB; cl5539
DR ChEMBL-Cells; CHEMBL3308290
DR ChEMBL-Targets; CHEMBL2366094
DR Cosmic; 907172
DR Cosmic-CLP; 907172
DR GDSC; 907172
DR GEO; GSM1669942
DR ICLC; HTL01006
DR LINCS; 50020
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 9,12
ST D16S539: 11,12
ST D5S818: 11,13
ST D7S820: 9,10
ST TH01: 9
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID IST-MEL2
AC CVCL_1309
DR CLO; CLO_0006970
DR CLDB; cl7047
DR ICLC; HTL01012
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID IST-MEL3
AC CVCL_1310
DR CLO; CLO_0006971
DR CLDB; cl7045
DR ICLC; HTL01011
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID IST-MELA 16
AC CVCL_F328
DR CLDB; cl7220
DR ICLC; HTL11007
CC Derived from metastatic site: Subcutaneous.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID IST-Mes1
AC CVCL_1311
SY IST-MES1; ISTMES1
DR CLO; CLO_0006972
DR CLDB; cl5540
DR CCLE; ISTMES1_PLEURA
DR ChEMBL-Cells; CHEMBL3308291
DR ChEMBL-Targets; CHEMBL2366194
DR Cosmic; 907173
DR Cosmic; 1995456
DR Cosmic-CLP; 907173
DR GDSC; 907173
DR GEO; GSM887165
DR GEO; GSM888237
DR GEO; GSM1669943
DR ICLC; HTL01005
RX PubMed=10232421;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 9
ST D16S539: 12
ST D5S818: 11,12
ST D7S820: 8,10
ST TH01: 8
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID IST-Mes2
AC CVCL_1312
SY IST-MES2; ISTMES2; IstMes2
DR CLO; CLO_0006973
DR CLDB; cl5544
DR CCLE; ISTMES2_PLEURA
DR GEO; GSM887166
DR GEO; GSM888238
DR GEO; GSM1029450
DR GEO; GSM1029451
DR GEO; GSM1029452
DR GEO; GSM1029453
DR GEO; GSM1029454
DR GEO; GSM1029455
DR GEO; GSM1029456
DR GEO; GSM1029457
DR GEO; GSM1029458
DR GEO; GSM1029459
DR ICLC; HTL01007
RX PubMed=10232421;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID IST-Mes3
AC CVCL_C312
SY IST-MES3
RX PubMed=10232421;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID IST-SL1
AC CVCL_1313
DR CLO; CLO_0006974
DR CLDB; cl2908
DR ChEMBL-Cells; CHEMBL3308263
DR ChEMBL-Targets; CHEMBL2366104
DR Cosmic; 753564
DR Cosmic; 1995457
DR Cosmic-CLP; 753564
DR GDSC; 753564
DR GEO; GSM1669944
DR ICLC; HTL97012
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8
ST D16S539: 10
ST D5S818: 13
ST D7S820: 8,11
ST TH01: 6,9
ST TPOX: 8
ST vWA: 15,17
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID IST-SL2
AC CVCL_1314
DR CLO; CLO_0006975
DR CLDB; cl2909
DR ChEMBL-Cells; CHEMBL3308871
DR ChEMBL-Targets; CHEMBL2366101
DR Cosmic; 753565
DR Cosmic; 1995458
DR Cosmic-CLP; 753565
DR GDSC; 753565
DR GEO; GSM1669945
DR ICLC; HTL97010
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 10,13
ST D16S539: 11,12
ST D5S818: 11
ST D7S820: 10,12
ST TH01: 6,9.3
ST TPOX: 10
ST vWA: 18
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID IT-25
AC CVCL_W522
RX PubMed=2979201;
DI NCIt; C4911; Gastric carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID IT-26R21
AC CVCL_7676
DR IFO; IFO50078
RX PubMed=517453;
CC Breed/subspecies: Wistar.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Spontaneously immortalized cell line
//
ID IT-45R1
AC CVCL_7677
SY IT-45 R1; IT45-R1
DR BCRJ; 0282
DR IFO; IFO50076
RX CelloPub=CLPUB00358;
RX PubMed=6602403;
RX PubMed=6977896;
CC Doubling time: 60 hours (CelloPub=CLPUB00358).
CC Caution: Erroneously indicated as originating from mouse in BCRJ 0282.
CC Breed/subspecies: Wistar.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Spontaneously immortalized cell line
//
ID IT-45R91
AC CVCL_7678
SY IT45R91
DR IFO; IFO50077
CC Breed/subspecies: Wistar.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Spontaneously immortalized cell line
//
ID IT-79MTNC3
AC CVCL_U233
SY IT79M1
DR BCRJ; 0120
DR IFO; IFO50248
RX PubMed=3259930;
CC Discontinued: BCRJ; 0120; probable.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Finite cell line
//
ID IT832
AC CVCL_F945
DR TKG; TKG 0586
ST Source(s): TKG
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 9,11
ST D16S539: 10,11
ST D5S818: 12,13
ST D7S820: 10,13
ST TH01: 6,7
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C7464; Acute leukemia of ambiguous lineage
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ITAC-3
AC CVCL_A015
RX PubMed=21360264;
DI NCIt; C116316; Intestinal type sinonasal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ITC-1
AC CVCL_F644
RX PubMed=1311428;
OX NCBI_TaxID=10029; ! Cricetulus griseus
CA Cancer cell line
//
ID ITM
AC CVCL_U244
DR EFO; EFO_0002061
DR GEO; GSM42104
DR GEO; GSM42170
RX PubMed=16079833;
CC Transfected with: HGNC; 6840; MAP2K1.
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U243 ! ITV
SX Female
CA Telomerase immortalized cell line
//
ID ITM-E6/E7
AC CVCL_U245
SY ITM-E6E7; ITME6E7
DR EFO; EFO_0002062
DR GEO; GSM42176
DR GEO; GSM42177
RX PubMed=16079833;
CC Transfected with: HGNC; 6840; MAP2K1.
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E7].
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U244 ! ITM
SX Female
CA Transformed cell line
//
ID ITM-E6/E7-ST
AC CVCL_U246
SY ITM-E6E7-ST; ITME6E7ST
DR EFO; EFO_0002063
DR GEO; GSM42178
DR GEO; GSM42179
RX PubMed=16079833;
CC Transfected with: HGNC; 6840; MAP2K1.
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E7].
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U244 ! ITM
SX Female
CA Transformed cell line
//
ID ITM-ST
AC CVCL_U247
SY ITMST
DR EFO; EFO_0002064
DR GEO; GSM42172
DR GEO; GSM42175
RX PubMed=16079833;
CC Transfected with: HGNC; 6840; MAP2K1.
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U244 ! ITM
SX Female
CA Transformed cell line
//
ID ITO-II
AC CVCL_1315
DR BioSample; SAMN03471634
DR Cosmic; 924164
DR JCRB; JCRB0613
RX CelloPub=CLPUB00056;
RX PubMed=2445169;
RX PubMed=3618218;
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8
ST D16S539: 9
ST D5S818: 12
ST D7S820: 11
ST TH01: 9
ST TPOX: 9
ST vWA: 16,21
DI NCIt; C6341; Testicular embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ITO-II cl-5
AC CVCL_IW42
SY ITO-II clone-5
RX PubMed=2445169;
DI NCIt; C6341; Testicular embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1315 ! ITO-II
SX Male
CA Cancer cell line
//
ID ITPD-iPSC
AC CVCL_0H83
SY Infantile-type-PD-iPSC
DR SKIP; SKIP000577
RX PubMed=24642446;
DI NCIt; C84734; Glycogen storage disease type II
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0H82 ! GM20124
SX Male
CA Induced pluripotent stem cell
//
ID iTS1
AC CVCL_T799
SY A000056#1
DR RCB; HPS0149
DR SKIP; SKIP000055
DR SKIP; SKIP000246
DI NCIt; C85184; Tay-Sachs disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_K263 ! GM2-1TKB
SX Female
CA Induced pluripotent stem cell
//
ID iTS2
AC CVCL_T800
SY A000056#2
DR RCB; HPS0150
DR SKIP; SKIP000056
DR SKIP; SKIP000247
DI NCIt; C85184; Tay-Sachs disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_K263 ! GM2-1TKB
SX Female
CA Induced pluripotent stem cell
//
ID iTS3
AC CVCL_T801
SY A000056#3
DR RCB; HPS0151
DR SKIP; SKIP000057
DR SKIP; SKIP000248
DI NCIt; C85184; Tay-Sachs disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_K263 ! GM2-1TKB
SX Female
CA Induced pluripotent stem cell
//
ID ITV
AC CVCL_U243
DR EFO; EFO_0002065
DR GEO; GSM42080
DR GEO; GSM42103
RX PubMed=16079833;
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0347 ! IMR-90
SX Female
CA Telomerase immortalized cell line
//
ID IU-TAB-1
AC CVCL_D551
SY IU-TAB1
RX PubMed=22926645;
CC Doubling time: 48 hours (PubMed=22926645).
CC Omics: Transcriptome analysis.
DI NCIt; C3411; Thymoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID IV.3
AC CVCL_J831
DR CLO; CLO_0006976
DR ATCC; HB-217
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID IVA12
AC CVCL_G223
DR CLO; CLO_0006978
DR ATCC; HB-145
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID IVD12
AC CVCL_G224
DR CLO; CLO_0006979
DR ATCC; HB-144
RX PubMed=6189938;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID IVG-BF/LXSN
AC CVCL_4417
SY IVG-BF.LXSN
RX PubMed=22829774;
CC Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-0058 but was never intended to be distributed.
DI NCIt; C3476; Li-Fraumeni syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Spontaneously immortalized cell line
//
ID IWB
AC CVCL_1M72
SY GM06825
DR CLO; CLO_0036523
DR Coriell; GM06825
RX PubMed=6417008;
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID iWS229
AC CVCL_EQ35
SY WS iPSC from AG05229
DR GEO; GSM1184284
DR GEO; GSM1184285
RX PubMed=24749076;
CC Omics: Transcriptome analysis.
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X835 ! AG05229
SX Male
CA Induced pluripotent stem cell
//
ID iWS229-p53i-2.1
AC CVCL_EQ36
SY WS iPSC iWS229 p53i
DR GEO; GSM1184294
DR GEO; GSM1184295
RX PubMed=24749076;
CC Knockout cell: Method=shRNA knockdown; HGNC; 11998; TP53.
CC Omics: Transcriptome analysis.
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_EQ35 ! iWS229
SX Male
CA Induced pluripotent stem cell
//
ID iWS229T-13
AC CVCL_EQ37
SY WS iPSC iWS229 TERT (clone 13)
DR GEO; GSM1184296
DR GEO; GSM1184297
RX PubMed=24749076;
CC Transfected with: HGNC; 11730; TERT.
CC Omics: Transcriptome analysis.
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_EQ35 ! iWS229
SX Male
CA Induced pluripotent stem cell
//
ID iWS229T-21
AC CVCL_EQ38
SY WS iPSC iWS229 TERT (clone 21)
DR GEO; GSM1184298
DR GEO; GSM1184299
RX PubMed=24749076;
CC Transfected with: HGNC; 11730; TERT.
CC Omics: Transcriptome analysis.
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_EQ35 ! iWS229
SX Male
CA Induced pluripotent stem cell
//
ID iWS300
AC CVCL_EQ39
SY WS iPSC from AG06300
DR GEO; GSM1184286
DR GEO; GSM1184287
RX PubMed=24749076;
CC Omics: Transcriptome analysis.
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0J91 ! AG06300
SX Male
CA Induced pluripotent stem cell
//
ID iWS780-1.9
AC CVCL_EQ40
SY WS iPSC from AG00780 (clone 1.9)
DR GEO; GSM1184288
DR GEO; GSM1184289
RX PubMed=24749076;
CC Omics: Transcriptome analysis.
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U282 ! AG00780
SX Male
CA Induced pluripotent stem cell
//
ID iWS780-2.10
AC CVCL_EQ41
SY WS iPSC from AG00780 (clone 2.10)
DR GEO; GSM1184290
DR GEO; GSM1184291
RX PubMed=24749076;
CC Omics: Transcriptome analysis.
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U282 ! AG00780
SX Male
CA Induced pluripotent stem cell
//
ID iWS797
AC CVCL_EQ42
SY WS iPSC from AG12797
DR GEO; GSM1184292
DR GEO; GSM1184293
RX PubMed=24749076;
CC Omics: Transcriptome analysis.
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X769 ! AG12797
SX Male
CA Induced pluripotent stem cell
//
ID iWS797T
AC CVCL_EQ43
SY WS iPSC iWS797 TERT
DR GEO; GSM1184300
DR GEO; GSM1184301
RX PubMed=24749076;
CC Omics: Transcriptome analysis.
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_EQ42 ! iWS797
SX Male
CA Induced pluripotent stem cell
//
ID IX-2H7-E10
AC CVCL_U035
SY M-2
DR ECACC; 08041722
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID IX-5H9-C10
AC CVCL_U046
SY M-3; M3
RX PubMed=8734946;
CC Monoclonal antibody target: Leishmania amazonensis.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID IZD-MB-0503
AC CVCL_C411
SY IZD-MB0503; IZD-Mb0503; MB-0503; Mb-0503; Mb 0503; MB0503
DR CLO; CLO_0006980
DR ATCC; CRL-8003
DR ECACC; 93090714
RX DOI=10.1111/j.1439-0418.1976.tb03417.x;
RX PubMed=1367489;
RX PubMed=8314732;
RX PubMed=8799737;
CC Group: Insect cell line.
CC Group: Recombinant protein production insect cell line.
CC Discontinued: ATCC; CRL-8003; probable.
CC Discontinued: ECACC; 93090714; probable.
OX NCBI_TaxID=55057; ! Mamestra brassicae
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IZD-MB-1203
AC CVCL_AR80
SY IZD-MB1203; IZD-Mb 1203; Mb 1203
RX DOI=10.1111/j.1439-0418.1976.tb03417.x;
CC Group: Insect cell line.
OX NCBI_TaxID=55057; ! Mamestra brassicae
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IZD-MB-2006
AC CVCL_AR81
SY IZD-MB2006; IZD-Mb 2006; Mb 2006
RX DOI=10.1111/j.1439-0418.1976.tb03417.x;
CC Group: Insect cell line.
OX NCBI_TaxID=55057; ! Mamestra brassicae
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IZD-MB-2007
AC CVCL_AR82
SY IZD-MB2007; Mb 2007
RX DOI=10.1111/j.1439-0418.1976.tb03417.x;
CC Group: Insect cell line.
OX NCBI_TaxID=55057; ! Mamestra brassicae
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID IZD-MB-2506
AC CVCL_AR83
SY IZD-MB2506; Mb 2506
RX DOI=10.1111/j.1439-0418.1976.tb03417.x;
CC Group: Insect cell line.
OX NCBI_TaxID=55057; ! Mamestra brassicae
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID J 3
AC CVCL_C334
SY J3; TE07; TECHe004-A
DR hPSCreg; TECHe004-A
DR ISCR; 126
CC From: Technion - Israel Institute of Technology; Haifa; Israel.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID J 3.2
AC CVCL_C335
SY J3.2; TE72; TECHe004-A-1
DR hPSCreg; TECHe004-A-1
DR ISCR; 125
CC From: Technion - Israel Institute of Technology; Haifa; Israel.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_C334 ! J 3
SX Male
CA Embryonic stem cell
//
ID J-111
AC CVCL_2965
SY J 111; J111; JIII; Oregon J-111
DR CLO; CLO_0006981
DR CLO; CLO_0007024
DR CLDB; cl2915
DR CLDB; cl2916
DR ATCC; CCL-24
DR BioSample; SAMN03151724
DR CCRID; 3111C0002000000054
DR Cosmic; 919124
DR Cosmic; 998751
DR Cosmic; 1037668
DR ECACC; 93120824
DR IFO; IFO50005
DR IZSLER; BS TCL 30
DR JCRB; JCRB0073
RX PubMed=566722;
RX PubMed=1246601;
RX PubMed=9290701;
RX PubMed=12592342;
RX PubMed=13260360;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=566722, PubMed=1246601, PubMed=12592342, PubMed=20143388).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Discontinued: ATCC; CCL-24; true.
ST Source(s): JCRB; PubMed=11416159
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 12,13.3
ST D16S539: 9,10
ST D18S51: 16
ST D21S11: 27,28
ST D5S818: 11,12
ST D7S820: 8,12
ST D8S1179: 12
ST FGA: 18,21
ST TH01: 7
ST TPOX: 8,12
ST vWA: 16,18
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID J-87
AC CVCL_5297
SY J87
RX PubMed=2624778;
CC Characteristics: IL3 or IL5 dependent.
CC Characteristics: Requires feeder cells. Maintenance of J-87 depends on the presence of cell line ST-2 (CVCL_2205).
CC Breed/subspecies: DBA/2J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Factor-dependent cell line
//
ID J-96
AC CVCL_3990
SY J96; Oregon J-96
DR BTO; BTO:0002028
DR CLO; CLO_0007007
DR CLDB; cl2914
DR BioSample; SAMN03151725
RX PubMed=1246601;
RX PubMed=4472134;
RX PubMed=13260360;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601, PubMed=4472134, PubMed=20143388).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID J-A1886
AC CVCL_U324
DR ATCC; CRL-8130
RX Patent=US5795777;
CC Discontinued: ATCC; CRL-8130; probable.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0065 ! Jurkat
SX Male
CA Cancer cell line
//
ID J-beta2.7
AC CVCL_J124
SY J-(beta2).7; Jurkat-beta2.7; Jurkat B2.7; B2.7
RX PubMed=8977199;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0367 ! Jurkat E6.1
SX Male
CA Cancer cell line
//
ID J-Jhan
AC CVCL_1H08
SY J-JHAN; J.Jhan; J Jhan; J JHAN; JJhan; JJHAN
DR NIH-ARP; 12186-350
RX PubMed=2886841;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0065 ! Jurkat
SX Male
CA Cancer cell line
//
ID J-Jhan/U1102
AC CVCL_1H09
WW http://hhv-6foundation.org/wp-content/uploads/2011/08/J-Jhan-U1102.pdf
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1H08 ! J-Jhan
SX Male
CA Cancer cell line
//
ID J-Lat 10.6
AC CVCL_8281
SY J-Lat clone 10.6; J-Lat full length clone 10.6
DR NIH-ARP; 9849-437
RX PubMed=12682019;
CC Transfected with: UniProtKB; P42212; GFP.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0065 ! Jurkat
SX Male
CA Cancer cell line
//
ID J-Lat 15.4
AC CVCL_8282
SY J-Lat clone 15.4; J-Lat full length clone 15.4
DR NIH-ARP; 9850-417
RX PubMed=12682019;
CC Transfected with: UniProtKB; P42212; GFP.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0065 ! Jurkat
SX Male
CA Cancer cell line
//
ID J-Lat 6.3
AC CVCL_8280
SY J-Lat clone 6.3; J-Lat full length clone 6.3
DR Lonza; 1300
DR NIH-ARP; 9846-446
RX PubMed=12682019;
CC Transfected with: UniProtKB; P42212; GFP.
CC Misspelling: 'J-Lat 6.2' in Lonza 1300.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0065 ! Jurkat
SX Male
CA Cancer cell line
//
ID J-Lat 8.4
AC CVCL_8284
SY J-Lat clone 8.4; J-Lat full length clone 8.4
DR NIH-ARP; 9847-427
RX PubMed=12682019;
CC Transfected with: UniProtKB; P42212; GFP.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0065 ! Jurkat
SX Male
CA Cancer cell line
//
ID J-Lat 9.2
AC CVCL_8285
SY J-Lat clone 9.2; J-Lat full length clone 9.2
DR NIH-ARP; 9848-69
RX PubMed=12682019;
CC Transfected with: UniProtKB; P42212; GFP.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0065 ! Jurkat
SX Male
CA Cancer cell line
//
ID J-Lat GFP Clone A72
AC CVCL_1H28
DR NIH-ARP; 9856-389
RX PubMed=12682019;
CC Transfected with: UniProtKB; P42212; GFP.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0065 ! Jurkat
SX Male
CA Cancer cell line
//
ID J-Lat Tat-GFP Clone 82
AC CVCL_1G41
DR NIH-ARP; 9851-423
RX PubMed=12682019;
CC Transfected with: UniProtKB; P42212; GFP.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0065 ! Jurkat
SX Male
CA Cancer cell line
//
ID J-Lat Tat-GFP Clone A1
AC CVCL_1G42
DR NIH-ARP; 9852-431
RX PubMed=12682019;
CC Transfected with: UniProtKB; P42212; GFP.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0065 ! Jurkat
SX Male
CA Cancer cell line
//
ID J-Lat Tat-GFP Clone A2
AC CVCL_1G43
DR NIH-ARP; 9854-453
RX PubMed=12682019;
CC Transfected with: UniProtKB; P42212; GFP.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0065 ! Jurkat
SX Male
CA Cancer cell line
//
ID J-Lat Tat-GFP Clone A7
AC CVCL_1G44
DR NIH-ARP; 9853-256
RX PubMed=12682019;
CC Transfected with: UniProtKB; P42212; GFP.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0065 ! Jurkat
SX Male
CA Cancer cell line
//
ID J-Lat Tat-GFP Clone H2
AC CVCL_1G45
DR NIH-ARP; 9855-258
RX PubMed=12682019;
CC Transfected with: UniProtKB; P42212; GFP.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0065 ! Jurkat
SX Male
CA Cancer cell line
//
ID J.CaM1.6
AC CVCL_0354
SY J CaM 1.6; J-CaM-1.6; JCam-1.6; JCaM 1.6; JCAM 1.6; JCaM1.6; Jcam clone 1.6; J.CaM1; JCaM1; JCAM1; Jurkat-derived Ca2+ mutant no. 1
DR BTO; BTO:0003314
DR CLO; CLO_0006983
DR MCCL; MCC:0000248
DR CLDB; cl2934
DR ATCC; CRL-2063
DR BioSample; SAMN03471427
DR ECACC; 96060401
RX PubMed=3263650;
RX PubMed=3309950;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/j/cell-lines-detail-80.html
CC Characteristics: Deficient for LCK activity due to a deletion of exon 7.
ST Source(s): ATCC; ECACC
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 8,12
ST D16S539: 10,11
ST D5S818: 9
ST D7S820: 8,10
ST TH01: 6,9.3
ST TPOX: 8,10
ST vWA: 18,19
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0367 ! Jurkat E6.1
SX Male
CA Cancer cell line
//
ID J.CaM2
AC CVCL_R862
SY JCaM2; JCam2; Jurkat-derived Ca2+ mutant no. 2
RX PubMed=3263650;
RX PubMed=9846483;
CC Transformant: NCIt; C129643; Cesium-137 gamma radiation.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0367 ! Jurkat E6.1
SX Male
CA Cancer cell line
//
ID J.CaM2.5
AC CVCL_DR61
SY JCam2.5; JCAM2.5
DR PRIDE; PXD000341
CC Transformant: NCIt; C129643; Cesium-137 gamma radiation.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_R862 ! J.CaM2
SX Male
CA Cancer cell line
//
ID J.gamma1
AC CVCL_6410
SY Jgamma1; Jurkat Gamma1
DR CLO; CLO_0006985
DR ATCC; CRL-2678
DR BioSample; SAMN03471763
DR GEO; GSM827148
DR PRIDE; PXD002871
RX PubMed=11094067;
RX PubMed=26546556;
CC Transformant: ChEBI; CHEBI:132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC Omics: Deep phosphoproteome analysis.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,12
ST D16S539: 11
ST D5S818: 9
ST D7S820: 8,12
ST TH01: 6,9.3
ST TPOX: 8,10
ST vWA: 18,19
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0367 ! Jurkat E6.1
SX Male
CA Cancer cell line
//
ID J.gamma1.WT
AC CVCL_6411
SY J.gamma1.WT-1; J.gamma1.wt
DR CLO; CLO_0006986
DR ATCC; CRL-2679
DR BioSample; SAMN03471764
RX PubMed=11094067;
CC Transfected with: HGNC; 9065; PLCG1.
CC Transformant: ChEBI; CHEBI:132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,12
ST D16S539: 11
ST D5S818: 9
ST D7S820: 8,12
ST TH01: 6,9.3
ST TPOX: 8,9,10
ST vWA: 18,19
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6410 ! J.gamma1
SX Male
CA Cancer cell line
//
ID J.RT3-T3.5
AC CVCL_1316
AS CVCL_9725
SY J.RT3/T3.5; J-RT3-T3-5; JRT3-T3.5; JRT3T3.5; JRT3T35; Jurkat RT3-T3.5; Jurkat/RT3-T3.5
DR CLO; CLO_0006984
DR EFO; EFO_0002213
DR ATCC; TIB-153
DR BioSample; SAMN03471939
DR ChEMBL-Cells; CHEMBL3308326
DR ChEMBL-Targets; CHEMBL2366219
DR Cosmic; 683538
DR Cosmic; 907391
DR Cosmic; 1151780
DR GDSC; 907391
DR GEO; GSM1669963
DR IGRhCellID; JRT3T35
RX PubMed=6208306;
CC Characteristics: Does not express the beta chain of the T cell antigen receptor.
CC Omics: DNA methylation analysis.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,12
ST D16S539: 11
ST D5S818: 10
ST D7S820: 8,10
ST TH01: 6,9.3
ST TPOX: 8,10
ST vWA: 18
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0367 ! Jurkat E6.1
SX Male
CA Cancer cell line
//
ID J#176-3.2
AC CVCL_U127
DR CLO; CLO_0050352
DR RCB; RCB1918
CC Monoclonal antibody target: UniProtKB; P97875; Mouse Jdp2.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID J#214.2-2
AC CVCL_U128
DR CLO; CLO_0050395
DR RCB; RCB1919
CC Monoclonal antibody target: UniProtKB; P97875; Mouse Jdp2.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID J#249.1-1
AC CVCL_U129
DR CLO; CLO_0050396
DR RCB; RCB1920
CC Monoclonal antibody target: UniProtKB; P97875; Mouse Jdp2.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID J0528239
AC CVCL_E713
SY JO528239
DR dbMHC; 48910
DR ECACC; 88052041
DR IHW; IHW9041
DR IMGT/HLA; 11636
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl41.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID J1
AC CVCL_6412
DR CLO; CLO_0006987
DR EFO; EFO_0004990
DR ATCC; SCRC-1010
DR PRIDE; PXD000589
RX PubMed=1606615;
RX PubMed=9353641;
RX PubMed=25894527;
CC Omics: Cell surface proteome.
CC Breed/subspecies: 129S4/SvJae.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID J1-31
AC CVCL_C555
DR CLO; CLO_0006989
DR ATCC; CRL-2253
RX PubMed=2421799;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID J1.1
AC CVCL_8279
DR NIH-ARP; 1340-401
RX PubMed=1833465;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0065 ! Jurkat
SX Male
CA Cancer cell line
//
ID J11d.2
AC CVCL_9185
DR CLO; CLO_0006988
DR ATCC; TIB-183
DR KCLB; 40183
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID J14
AC CVCL_R861
SY Jurkat J14
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0065 ! Jurkat
SX Male
CA Cancer cell line
//
ID J143
AC CVCL_N324
DR ATCC; HB-8276
RX Patent=US4643971;
RX Patent=US4935344;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID J185a
AC CVCL_Y501
DR EFO; EFO_0005486
DR ENCODE; ENCBS181ENC
DR GEO; GSM450293
RX PubMed=19952138;
CC Part of: ENCODE project mouse cell lines.
OX NCBI_TaxID=10090; ! Mus musculus
SX Sex undetermined
CA Undefined cell line type
//
ID J1j.10
AC CVCL_9186
DR CLO; CLO_0006990
DR ATCC; TIB-184
DR KCLB; 40184
CC Monoclonal antibody target: UniProtKB; P01831; Mouse Thy1/Cd90 (allotype 1.2).
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID J2-BM
AC CVCL_S484
RX PubMed=4079980;
WW http://www.infarktforschung.de/macrophages_cell_lines.html
CC Transformant: Recombinant retrovirus J2.
CC Breed/subspecies: C3H/HeJ.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID J206L
AC CVCL_U110
RX PubMed=16651449;
DI NCIt; C5672; Large cell lung neuroendocrine carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID J233
AC CVCL_N325
DR ATCC; HB-8272
RX Patent=US4643971;
CC Discontinued: ATCC; HB-8272; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID J26
AC CVCL_6487
DR CLO; CLO_0006991
DR ATCC; CRL-1802
RX PubMed=6188154;
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Transfected with: HGNC; 914; B2M.
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4536 ! L-M(TK-)
SX Male
CA Spontaneously immortalized cell line
//
ID J26Cw3
AC CVCL_V081
DR CLO; CLO_0006992
DR CLDB; cl2917
DR IHW; IHW8041
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Transfected with: HGNC; 914; B2M.
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6487 ! J26
SX Male
CA Spontaneously immortalized cell line
//
ID J27-B7
AC CVCL_6488
SY J27.2-B7
DR CLO; CLO_0006996
DR ATCC; CRL-2374
RX PubMed=7960968;
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Transfected with: HGNC; 914; B2M.
CC Transfected with: HGNC; 4932; HLA-B (allele HLB-B7).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_K237 ! J27.2
SX Male
CA Spontaneously immortalized cell line
//
ID J27-neo
AC CVCL_6489
SY J27.2-neo
DR CLO; CLO_0006997
DR ATCC; CRL-2372
RX PubMed=7960968;
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Transfected with: HGNC; 914; B2M.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_K237 ! J27.2
SX Male
CA Spontaneously immortalized cell line
//
ID J27-sB7
AC CVCL_V057
SY J27.2-sB7
DR ATCC; CRL-2373
RX PubMed=7960968;
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Transfected with: HGNC; 914; B2M.
CC Transfected with: HGNC; 4932; HLA-B (allele HLB-B7).
CC Discontinued: ATCC; CRL-2373; true.
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_K237 ! J27.2
SX Male
CA Spontaneously immortalized cell line
//
ID J27.2
AC CVCL_K237
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Transfected with: HGNC; 914; B2M.
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4536 ! L-M(TK-)
SX Male
CA Spontaneously immortalized cell line
//
ID J27.2 43R
AC CVCL_V082
DR CLO; CLO_0006993
DR CLDB; cl2918
DR IHW; IHW8027
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Transfected with: HGNC; 914; B2M.
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_K237 ! J27.2
SX Male
CA Spontaneously immortalized cell line
//
ID J27.2 Cw7neo
AC CVCL_V083
DR CLO; CLO_0006994
DR CLDB; cl2919
DR IHW; IHW8044
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Transfected with: HGNC; 914; B2M.
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_K237 ! J27.2
SX Male
CA Spontaneously immortalized cell line
//
ID J27.2 neoB7
AC CVCL_V084
DR CLO; CLO_0006995
DR CLDB; cl2920
DR IHW; IHW8024
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Transfected with: HGNC; 914; B2M.
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_K237 ! J27.2
SX Male
CA Spontaneously immortalized cell line
//
ID J2E
AC CVCL_0355
SY J2E-1
DR MCCL; MCC:0000249
RX PubMed=1688637;
RX PubMed=2847163;
RX PubMed=8631947;
CC Breed/subspecies: CBA.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID J2E-NR
AC CVCL_5984
RX PubMed=1688637;
RX PubMed=8631947;
CC Breed/subspecies: CBA.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0355 ! J2E
CA Transformed cell line
//
ID J31.13
AC CVCL_HE55
RX PubMed=2901344;
CC Characteristics: Does not express CD3.
CC Transformant: NCIt; C129643; Cesium-137 gamma radiation.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_HE54 ! Jurkat clone 77-6.8
SX Male
CA Cancer cell line
//
ID J3K
AC CVCL_F762
RX PubMed=12513117;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9543; ! Macaca fuscata fuscata
SX Male
CA Spontaneously immortalized cell line
//
ID J3T
AC CVCL_W822
RX PubMed=10901232;
DI NCIt; C129297; Canine glioma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID J3T-1
AC CVCL_W823
RX PubMed=22120277;
DI NCIt; C129297; Canine glioma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_W822 ! J3T
CA Cancer cell line
//
ID J3T-2
AC CVCL_W824
RX PubMed=22120277;
DI NCIt; C129297; Canine glioma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_W822 ! J3T
CA Cancer cell line
//
ID J45.01
AC CVCL_2530
DR CLO; CLO_0006998
DR CLDB; cl2921
DR ATCC; CRL-1990
DR BCRC; 60255
DR BioSample; SAMN03470881
DR ECACC; 93031145
RX PubMed=1672451;
ST Source(s): ATCC; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,11,12
ST D16S539: 11
ST D18S51: 13,21,22
ST D21S11: 31.2,33.2,34.2
ST D3S1358: 14,17
ST D5S818: 9
ST D7S820: 8,9.3,10.3
ST D8S1179: 14,15
ST FGA: 20,21
ST Penta D: 11,13
ST Penta E: 10,12
ST TH01: 6,9.3
ST TPOX: 8,10
ST vWA: 18
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0367 ! Jurkat E6.1
SX Male
CA Cancer cell line
//
ID J5 [Human hepatocellular carcinoma]
AC CVCL_4Z68
DR BTO; BTO:0005057
RX PubMed=1847999;
RX PubMed=9774996;
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID J5 [Mouse hybridoma]
AC CVCL_G198
DR ECACC; 91072536
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID J5 [Mouse Sertoli cells]
AC CVCL_U456
RX PubMed=12514093;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID J5-1
AC CVCL_G194
DR CLO; CLO_0006999
DR ATCC; HB-8297
RX Patent=US5057598;
CC Monoclonal antibody target: Escherichia coli J5 endotoxin core.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID J5-2
AC CVCL_G195
DR CLO; CLO_0007000
DR ATCC; HB-8298
RX Patent=US5057598;
CC Monoclonal antibody target: Escherichia coli J5 endotoxin core.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID J53Z1
AC CVCL_HF88
RX PubMed=25036984;
CC Doubling time: ~18 hours (PubMed=25036984).
CC Breed/subspecies: C57BL/6 JAK2V617F/Trp53-/- transgenic.
DI NCIt; C21895; Mouse erythroid leukemia
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID J558
AC CVCL_3529
DR CLO; CLO_0007001
DR ATCC; TIB-6
DR Wikidata; Q28243888
RX PubMed=5483159;
CC Breed/subspecies: BALB/c.
DI NCIt; C125417; Mouse plasma cell myeloma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID J558L
AC CVCL_3949
SY J 558L; J.558 L
DR BTO; BTO:0002898
DR CLO; CLO_0007002
DR CLDB; cl2922
DR ECACC; 88032902
DR Lonza; 14
DR Wikidata; Q6107580
RX PubMed=6402777;
WW https://en.wikipedia.org/wiki/J558L_cells
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/j/cell-lines-detail-45.html
CC Group: Hybridoma fusion partner cell line.
CC Breed/subspecies: BALB/c.
DI NCIt; C125417; Mouse plasma cell myeloma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3529 ! J558
CA Cancer cell line
//
ID J6
AC CVCL_W797
DR Cosmic; 706113
RX PubMed=9692547;
RX PubMed=10766161;
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID J618
AC CVCL_C943
WW http://grants.nih.gov/stem_cells/registry/not_approved.htm
WW http://acd.od.nih.gov/reports/Stem-Cell-Working-Group-Reports-June-2011.pdf
CC From: VistaGen Therapeutics, Inc.
CC Registration: NIH Human Embryonic Stem Cell Registry; not approved.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID J7
AC CVCL_4Z69
DR BTO; BTO:0005056
RX PubMed=8828459;
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID J7.DEF.3
AC CVCL_0356
DR MCCL; MCC:0000250
RX PubMed=7689615;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4770 ! J774.1
SX Female
CA Cancer cell line
//
ID J713
AC CVCL_C944
WW http://grants.nih.gov/stem_cells/registry/not_approved.htm
WW http://acd.od.nih.gov/reports/Stem-Cell-Working-Group-Reports-June-2011.pdf
CC From: VistaGen Therapeutics, Inc.
CC Registration: NIH Human Embryonic Stem Cell Registry; not approved.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID J774
AC CVCL_4692
SY J-774
DR BTO; BTO:0002279
DR CLO; CLO_0007003
DR CLDB; cl2911
DR CLDB; cl2913
DR ChEMBL-Cells; CHEMBL3307540
DR ChEMBL-Targets; CHEMBL614123
DR Lonza; 15
RX PubMed=1101071;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=J774
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/j/cell-lines-detail-500.html
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID J774-Dual
AC CVCL_5I75
WW http://www.invivogen.com/j774-dual
CC Transfected with: HGNC; 439; ALPP.
CC Transfected with: Lucia luciferase; a synthetic gene designed on natural secreted luciferase genes from marine copepods.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4770 ! J774.1
SX Female
CA Cancer cell line
//
ID J774.1
AC CVCL_4770
SY J-774.1; J774-1
DR BTO; BTO:0003042
DR CLO; CLO_0050192
DR CLO; CLO_0050193
DR JCRB; JCRB0018
DR RCB; RCB0434
DR RCB; RCB2652
DR TKG; TKG 0208
RX DOI=10.4051/ibc.2010.2.4.0014;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4692 ! J774
SX Female
CA Cancer cell line
//
ID J774.16
AC CVCL_HA24
SY J774 1.6; J774-1.6
DR BCRJ; 0273
RX PubMed=3792703;
RX PubMed=6252274;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4692 ! J774
SX Female
CA Cancer cell line
//
ID J774.2
AC CVCL_0357
DR BTO; BTO:0001030
DR CLO; CLO_0007004
DR MCCL; MCC:0000251
DR CLDB; cl2923
DR ChEMBL-Cells; CHEMBL3307942
DR ChEMBL-Targets; CHEMBL614484
DR ECACC; 85011428
DR PRIDE; PXD000589
RX PubMed=25894527;
CC Omics: Cell surface proteome.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4770 ! J774.1
SX Female
CA Cancer cell line
//
ID J774.G8
AC CVCL_HA26
SY J774-G8
DR BCRJ; 0122
RX PubMed=286323;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4692 ! J774
SX Female
CA Cancer cell line
//
ID J774A1
AC CVCL_0358
SY J-774A.1; J774.A1; J774 A1; J774A.1; J 774A.1; J774 A.1
DR BTO; BTO:0000804
DR CLO; CLO_0006982
DR CLO; CLO_0007005
DR MCCL; MCC:0000252
DR CLDB; cl2924
DR CLDB; cl2925
DR CLDB; cl2926
DR CLDB; cl2927
DR CLDB; cl2928
DR CLDB; cl4914
DR ATCC; TIB-67
DR BCRC; 60140
DR BCRJ; 0121
DR CCRID; 3111C0001CCC000222
DR CCRID; 3111C0002000000043
DR CCRID; 3142C0001000000144
DR ChEMBL-Cells; CHEMBL3307516
DR ChEMBL-Targets; CHEMBL614040
DR CLS; 400220/p1684_J-774A1
DR DSMZ; ACC-170
DR ECACC; 91051511
DR ICLC; ATL98011
DR IZSLER; BS TCL 83
DR JCRB; JCRB9108
DR KCB; KCB 2010167
DR KCLB; 40067
DR Lonza; 645
DR NCBI_Iran; C483
WW http://www.infarktforschung.de/macrophages_cell_lines.html
CC Doubling time: ~35 hours (DSMZ).
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4692 ! J774
SX Female
CA Cancer cell line
//
ID J82
AC CVCL_0359
SY J-82; J 82; J82COT
DR BTO; BTO:0001671
DR CLO; CLO_0007006
DR EFO; EFO_0002210
DR MCCL; MCC:0000253
DR ATCC; HTB-1
DR BioSample; SAMN03471085
DR CCLE; J82_URINARY_TRACT
DR CCRID; 3111C0001CCC000346
DR CCRID; 3131C0001001200024
DR ChEMBL-Cells; CHEMBL3308508
DR ChEMBL-Targets; CHEMBL614586
DR Cosmic; 753566
DR Cosmic; 755399
DR Cosmic; 760474
DR Cosmic; 808517
DR Cosmic; 809378
DR Cosmic; 845571
DR Cosmic; 846276
DR Cosmic; 867838
DR Cosmic; 943731
DR Cosmic; 1016887
DR Cosmic; 1046674
DR Cosmic; 1093984
DR Cosmic; 1175827
DR Cosmic; 1285119
DR Cosmic; 1285996
DR Cosmic; 1302362
DR Cosmic; 1927308
DR Cosmic; 1995459
DR Cosmic; 2050445
DR Cosmic; 2057450
DR Cosmic; 2444229
DR Cosmic-CLP; 753566
DR GDSC; 753566
DR GEO; GSM492491
DR GEO; GSM827204
DR GEO; GSM887167
DR GEO; GSM888239
DR GEO; GSM1374575
DR GEO; GSM1574579
DR GEO; GSM1669946
DR IGRhCellID; J82
DR KCB; KCB 2014052YJ
DR KCLB; 30001
RX PubMed=833871;
RX PubMed=864752;
RX PubMed=3413074;
RX PubMed=3708594;
RX PubMed=6244232;
RX PubMed=6582512;
RX PubMed=12127398;
RX PubMed=14762065;
RX PubMed=16885334;
RX PubMed=22460905;
RX PubMed=23401075;
RX PubMed=24367658;
RX PubMed=25997541;
RX PubMed=27397505;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/j/cell-lines-detail-250.html
CC Part of: BLA-40 bladder carcinoma cell line panel.
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: PTEN genetic alteration cell panel (ATCC TCP-1030).
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=11416159
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 10,12
ST D16S539: 11,12
ST D18S51: 12
ST D21S11: 30,31
ST D3S1358: 16,18
ST D5S818: 12,13
ST D7S820: 9,11
ST D8S1179: 8,13
ST FGA: 20,24
ST TH01: 9.3
ST TPOX: 11,12
ST vWA: 17,18
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5H97 ! J82-EBV
SX Male
CA Cancer cell line
//
ID J82-EBV
AC CVCL_5H97
SY J82EBV
DR Cosmic; 760488
RX PubMed=14762065;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0359 ! J82
SX Male
CA Transformed cell line
//
ID J82-NVB
AC CVCL_4V98
RX PubMed=7981063;
CC Selected for resistance to: ChEBI; CHEBI:480999; Vinorelbine (Navelbine; NVB).
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0359 ! J82
SX Male
CA Cancer cell line
//
ID JA
AC CVCL_W874
DR Cosmic; 889004
DR GEO; GSM219029
RX PubMed=15048078;
RX PubMed=17363583;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Ja Bos
AC CVCL_3304
DR CLO; CLO_0007008
DR CLDB; cl2930
DR ATCC; CRL-1176
DI NCIt; C125697; Ehlers-Danlos syndrome, type II
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID Ja Coo
AC CVCL_3305
DR CLO; CLO_0007009
DR ATCC; CRL-1294
DI NCIt; C26837; Osteogenesis imperfecta
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID Ja Lin
AC CVCL_U778
DR ATCC; CRL-1380
CC Discontinued: ATCC; CRL-1380; true.
DI NCIt; C34568; Ehlers-Danlos syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID JA-1
AC CVCL_B411
RX PubMed=3804493;
DI NCIt; C5228; Ovarian cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID JA-M
AC CVCL_S855
DR Cosmic; 928738
RX PubMed=9354451;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID JA2/R7Hyg
AC CVCL_X704
DR NIH-ARP; 2682-59
RX PubMed=7523570;
CC Transfected with: HGNC; 4931; HLA-A (allele HLA-A2).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X703 ! Jurkat-A2
SX Male
CA Cancer cell line
//
ID JAA-F11
AC CVCL_G196
DR CLO; CLO_0007010
DR ATCC; CRL-2381
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID JAC
AC CVCL_F562
SY 30089; TER233
DR IMGT/HLA; 10818
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID Jada-BL
AC CVCL_7197
SY Jada
RX PubMed=9882297;
RX PubMed=16051863;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID JAG020
AC CVCL_2H88
SY NOD.CBALs-Tyr+ JAG020
WW http://jaxmice.jax.org/strain/017313.html
CC Breed/subspecies: NOD.CBALs-Tyr+/LtJ.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID JAM
AC CVCL_D239
DR ChEMBL-Cells; CHEMBL3307834
DR ChEMBL-Targets; CHEMBL613987
DR Cosmic; 991318
DR Cosmic; 1524363
RX PubMed=3567897;
DI NCIt; C5228; Ovarian cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B411 ! JA-1
CA Cancer cell line
//
ID JAMA-2
AC CVCL_A593
SY JAMA2
DR Cosmic; 1175881
DR GEO; GSM313694
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID JAP-NF
AC CVCL_E714
DR dbMHC; 48911
DR ECACC; 94022531
DR IHW; IHW9227
DR IMGT/HLA; 10819
WW http://bioinformatics.hsanmartino.it/ecbr/cl227.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID JAR
AC CVCL_0360
SY Jar; JAr; JaR
DR BTO; BTO:0001585
DR CLO; CLO_0007011
DR EFO; EFO_0002211
DR MCCL; MCC:0000254
DR ATCC; HTB-144
DR BCRC; 60491
DR BioSample; SAMN01821568
DR BioSample; SAMN01821637
DR BioSample; SAMN03472717
DR CCRID; 3131C0001000700028
DR CCRID; 3131C0001000700156
DR ChEMBL-Cells; CHEMBL3307657
DR ChEMBL-Targets; CHEMBL614587
DR CLS; 300221/p449_JAR
DR Cosmic; 907175
DR Cosmic; 2077193
DR Cosmic-CLP; 907175
DR DSMZ; ACC-462
DR GDSC; 907175
DR GEO; GSM827264
DR GEO; GSM1669947
DR IGRhCellID; JAR
DR IZSLER; BS TCL 182
DR KCLB; 30144
DR TOKU-E; 2064
RX DOI=10.1007/BF02619074;
RX PubMed=2720636;
RX PubMed=4038916;
RX PubMed=7153601;
RX PubMed=7716126;
RX PubMed=7937597;
RX PubMed=27397505;
CC Doubling time: ~20-30 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; KCLB
ST Amelogenin: X,Y
ST CSF1PO: 7,10
ST D13S317: 11
ST D16S539: 9,10
ST D18S51: 13,17
ST D21S11: 30
ST D3S1358: 14 (CLS)
ST D3S1358: 16,17 (KCLB)
ST D5S818: 10,11
ST D7S820: 10,11
ST D8S1179: 14,16
ST FGA: 22
ST Penta D: 9,11
ST Penta E: 10,12
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 16,18
DI NCIt; C4646; Gestational choriocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Jari
AC CVCL_6F63
RX PubMed=1690682;
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9600; ! Pongo pygmaeus
SX Female
CA Transformed cell line
//
ID Jarques
AC CVCL_L359
DR BTO; BTO:0005358
RX PubMed=21552385;
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID JAWSII
AC CVCL_3727
SY JAWS II
DR CLO; CLO_0007012
DR ATCC; CRL-11904
DR BCRJ; 0347
RX Patent=US5648219;
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID Jay Sen
AC CVCL_3319
DR CLO; CLO_0007013
DR CLDB; cl2933
DR ATCC; CRL-1215
DI NCIt; C125696; Ehlers-Danlos syndrome, type I
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID Jay Ver
AC CVCL_Y124
DR ATCC; CRL-1127
CC Discontinued: ATCC; CRL-1127; true.
DI NCIt; C125696; Ehlers-Danlos syndrome, type I
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID JB
AC CVCL_Y434
RX PubMed=17760811;
CC Doubling time: ~4-6 days (PubMed=17760811).
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID JB/MS
AC CVCL_E093
RX PubMed=3698017;
CC Transformant: ChEBI; CHEBI:59032; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC Breed/subspecies: C57BL/6.
DI NCIt; C21790; Mouse melanoma
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID JB/RH
AC CVCL_E094
SY JB-RH; JBRH
RX PubMed=3698017;
CC Transformant: ChEBI; CHEBI:59032; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC Breed/subspecies: C57BL/6.
DI NCIt; C21790; Mouse melanoma
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID JB1 [Mouse hybridoma]
AC CVCL_U053
DR ECACC; 01091808
CC Monoclonal antibody target: UniProtKB; Q30201; Human HFE.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID JB1 [Rat hepatocellular carcinoma]
AC CVCL_HA75
RX PubMed=3675628;
RX PubMed=6132685;
RX PubMed=6150901;
CC Transformant: ChEBI; CHEBI:2504; Aflatoxin B1 (AFB1).
CC Breed/subspecies: Fischer 344.
DI NCIt; C60416; Rat hepatocellular carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID JB6 [Human anaplastic large cell lymphoma]
AC CVCL_H633
SY JB-6
DR Cosmic; 850200
DR Cosmic; 1086363
DR GEO; GSM1217150
RX CelloPub=CLPUB00058;
RX PubMed=11021758;
RX PubMed=15356658;
DI NCIt; C3720; Anaplastic large cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID JB6 [Mouse]
AC CVCL_B230
SY JB-6; JB 6
DR BTO; BTO:0004831
RX PubMed=2985973;
RX PubMed=6119803;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID JB6 Cl 25
AC CVCL_5U34
SY JB-6 Cl 25; JB6Cl25
RX PubMed=6119803;
RX PubMed=6947266;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_B230 ! JB6 [Mouse]
CA Spontaneously immortalized cell line
//
ID JB6 Cl 30-7b
AC CVCL_0361
SY JB6 clone 30, subclone 7b; JB6 Cl 30; JB-6 Cl 30; JB6Cl30
DR CLO; CLO_0007014
DR MCCL; MCC:0000255
DR ATCC; CRL-2007
RX PubMed=6119803;
RX PubMed=6947266;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_B230 ! JB6 [Mouse]
CA Spontaneously immortalized cell line
//
ID JB6 Cl 41-5a
AC CVCL_0362
SY JB6 clone 41, subclone 5a; JB6 Cl41; JB6 Cl 41; JB-6 Cl 41; JB6Cl41
DR BTO; BTO:0003316
DR CLO; CLO_0007015
DR MCCL; MCC:0000256
DR ATCC; CRL-2010
DR TOKU-E; 2068
RX PubMed=2985973;
RX PubMed=6119803;
RX PubMed=6947266;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/j/cell-lines-detail-218.html
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_B230 ! JB6 [Mouse]
CA Spontaneously immortalized cell line
//
ID JBL-1
AC CVCL_IW32
SY JBL1; JBL; Japanese Burkitt's Lymphoma
RX PubMed=201360;
RX PubMed=7064731;
RX PubMed=7464876;
CC Characteristics: EBV-negative.
CC Doubling time: 30 hours (PubMed=201360).
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID JBL-2
AC CVCL_A630
SY JBL2; Japanese Burkitt's Lymphoma 2
DR Cosmic; 931123
RX PubMed=467575;
RX PubMed=2847931;
RX PubMed=3024964;
RX PubMed=3027441;
RX PubMed=6327071;
RX PubMed=7064731;
RX PubMed=7464876;
RX PubMed=9473234;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID JBL-3
AC CVCL_IW51
SY JBL3; Japanese Burkitt's Lymphoma 3
RX PubMed=7064731;
RX PubMed=7464876;
CC Characteristics: EBV-negative.
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID JBL-4
AC CVCL_IW53
SY JBL4; Japanese Burkitt's Lymphoma 4
RX PubMed=7064731;
RX PubMed=7464876;
CC Characteristics: EBV-negative.
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID JBL-5
AC CVCL_IW52
SY JBL5; Japanese Burkitt's Lymphoma 5
RX PubMed=7064731;
RX PubMed=7464876;
CC Characteristics: EBV-negative.
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID JBL-6
AC CVCL_IW54
SY JBL6; Japanese Burkitt's Lymphoma 6
RX PubMed=7064731;
CC Characteristics: EBV-negative.
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID JBUSH
AC CVCL_E715
SY JBush
DR dbMHC; 48912
DR ECACC; 88052035
DR IHW; IHW9035
DR IMGT/HLA; 10825
WW http://bioinformatics.hsanmartino.it/ecbr/cl35.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID JC
AC CVCL_3530
DR CLO; CLO_0007016
DR ATCC; CRL-2116
DR BCRC; 60347
DR Cosmic; 1661882
DR KCLB; 22116
CC Breed/subspecies: BALB/cRos.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID JC-410
AC CVCL_6660
SY jc-410; JC410
RX PubMed=9584843;
RX PubMed=15541573;
OX NCBI_TaxID=9823; ! Sus scrofa
SX Female
CA Spontaneously immortalized cell line
//
ID JCA-1
AC CVCL_4015
SY JCA1
DR BioSample; SAMN03151947
RX PubMed=2195744;
RX PubMed=11522622;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a T24 derivative (PubMed=11522622, PubMed=20143388). Originally thought to originate from a prostate carcinoma.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0554 ! T24
SX Female
CA Cancer cell line
//
ID JCK
AC CVCL_M270
RX CelloPub=CLPUB00275;
RX PubMed=1312890;
DI NCIt; C4436; Cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID JD-MEL
AC CVCL_GR47
RX PubMed=7453182;
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID JD13D
AC CVCL_E299
SY Pa04C
DR Cosmic; 1473011
DR Cosmic; 1509851
RX PubMed=17912029;
RX PubMed=22753594;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC Derived from metastatic site: Lung.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID JD38
AC CVCL_A631
SY JD 38
DR Cosmic; 850209
DR Cosmic; 931124
RX PubMed=1325212;
RX PubMed=2052620;
RX PubMed=6286763;
RX PubMed=8344493;
RX PubMed=9473234;
RX PubMed=9973220;
CC Characteristics: EBV-negative.
DI NCIt; C3457; B-cell non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID JD39
AC CVCL_W743
SY JD 39
RX PubMed=1325212;
RX PubMed=6286763;
RX PubMed=8515068;
DI NCIt; C3457; B-cell non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID JD40
AC CVCL_W744
SY JD 40
RX PubMed=6286763;
DI NCIt; C3457; B-cell non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID JDB1
AC CVCL_U321
DR ATCC; HB-8143
RX Patent=US4724211;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Hybridoma
//
ID JDM-iPS1
AC CVCL_B350
SY JDM-IPS1
DR ISCR; 6
RX PubMed=18691744;
CC From: Children's Hospital Boston; Boston; USA.
DI NCIt; C2985; Diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8518 ! GM02416
SX Female
CA Induced pluripotent stem cell
//
ID JDM-iPS10
AC CVCL_B351
SY JDM-IPS10
DR ISCR; 1241
CC From: Children's Hospital Boston; Boston; USA.
DI NCIt; C2985; Diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8518 ! GM02416
SX Female
CA Induced pluripotent stem cell
//
ID JDM-iPS2
AC CVCL_B352
SY JDM-IPS2
DR ISCR; 7
RX Patent=US20110151447;
RX PubMed=18691744;
CC From: Children's Hospital Boston; Boston; USA.
DI NCIt; C2985; Diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8518 ! GM02416
SX Female
CA Induced pluripotent stem cell
//
ID JDM-iPS4
AC CVCL_B353
SY JDM-IPS4
DR ISCR; 8
RX Patent=US20110151447;
RX PubMed=18691744;
CC From: Children's Hospital Boston; Boston; USA.
DI NCIt; C2985; Diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8518 ! GM02416
SX Female
CA Induced pluripotent stem cell
//
ID JDU
AC CVCL_T280
DR ATCC; CCL-118
RX PubMed=13754521;
CC Discontinued: ATCC; CCL-118; true.
DI NCIt; C84723; Galactosemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID Je Kin
AC CVCL_Y306
DR ATCC; CRL-1232
RX PubMed=3860870;
CC Discontinued: ATCC; CRL-1232; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID JEG-3
AC CVCL_0363
SY Jeg-3; JEG3; Jeg3; jeg3
DR BTO; BTO:0002269
DR CLO; CLO_0007017
DR EFO; EFO_0002066
DR MCCL; MCC:0000257
DR CLDB; cl2935
DR CLDB; cl2936
DR ATCC; HTB-36
DR BCRC; 60428
DR BCRJ; 0123
DR BioSample; SAMN01821538
DR BioSample; SAMN01821638
DR CCRID; 3111C0001CCC000071
DR ChEMBL-Cells; CHEMBL3308202
DR ChEMBL-Targets; CHEMBL2366348
DR CLS; 300222/p698_JEG-3
DR Cosmic; 683654
DR Cosmic; 907176
DR Cosmic; 1312288
DR Cosmic; 2077192
DR Cosmic-CLP; 907176
DR DSMZ; ACC-463
DR ECACC; 92120308
DR GDSC; 907176
DR GEO; GSM48266
DR GEO; GSM48267
DR GEO; GSM48268
DR GEO; GSM1669948
DR IGRhCellID; JEG3
DR IZSLER; BS TCL 181
DR KCLB; 30036
DR NCBI_Iran; C544
DR TOKU-E; 2070
RX PubMed=62839;
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=5103722;
RX PubMed=7459858;
RX PubMed=7753552;
RX PubMed=7937597;
RX PubMed=11994546;
RX PubMed=12966428;
RX PubMed=16797695;
RX PubMed=27397505;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/j/cell-lines-detail-251.html
CC Doubling time: ~24 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Brain.
ST Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; KCLB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 9,11
ST D16S539: 13,14
ST D18S51: 14
ST D21S11: 30
ST D3S1358: 15 (CLS)
ST D3S1358: 15,16 (KCLB)
ST D5S818: 10,11
ST D7S820: 10,12
ST D8S1179: 12
ST FGA: 23,24
ST Penta D: 9,12
ST Penta E: 8,12
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 16
DI NCIt; C4646; Gestational choriocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0044 ! BeWo
SX Male
CA Cancer cell line
//
ID JEG-3/A3-1A7
AC CVCL_IV65
SY A3-1A7
RX PubMed=6683274;
CC Selected for resistance to: ChEBI; CHEBI:45327; Adenine arabinoside (Vidarabine; 9-beta-D-arabinofuranosyladenine; ara-A).
CC Selected for resistance to: ChEBI; CHEBI:46515; 9-beta-D-xylofuranosyl adenine (xyl-A).
CC Derived from metastatic site: Brain.
DI NCIt; C4646; Gestational choriocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0363 ! JEG-3
SX Male
CA Cancer cell line
//
ID JEG-3/VP16
AC CVCL_6922
SY jeg3/vp16
DR CCRID; 3111C0001CCC000072
RX PubMed=17884151;
CC Selected for resistance to: ChEBI; CHEBI:4911; Etoposide (VP-16).
CC Derived from metastatic site: Brain.
DI NCIt; C4646; Gestational choriocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0363 ! JEG-3
SX Male
CA Cancer cell line
//
ID JEG-3/VP16-IL-2
AC CVCL_6923
DR CCRID; 3111C0001CCC000073
CC Selected for resistance to: ChEBI; CHEBI:4911; Etoposide (VP-16).
CC Transfected with: HGNC; 6001; IL2.
CC Derived from metastatic site: Brain.
DI NCIt; C4646; Gestational choriocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6922 ! JEG-3/VP16
SX Male
CA Cancer cell line
//
ID JEG-3/VP16-TNFa
AC CVCL_6924
SY JEG-3-VP16-TNFa
DR CCRID; 3111C0001CCC000074
CC Selected for resistance to: ChEBI; CHEBI:4911; Etoposide (VP-16).
CC Transfected with: HGNC; 11892; TNF.
CC Derived from metastatic site: Brain.
DI NCIt; C4646; Gestational choriocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6922 ! JEG-3/VP16
SX Male
CA Cancer cell line
//
ID JeKo-1
AC CVCL_1865
SY Jeko-1; JEKO-1; JeKo 1; Jeko1; JEKO1; JEKO
DR EFO; EFO_0005387
DR ATCC; CRL-3006
DR BioSample; SAMN01821569
DR BioSample; SAMN01821639
DR BioSample; SAMN03473289
DR CCLE; JEKO1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 1047110
DR Cosmic; 1881781
DR Cosmic; 2088016
DR Cosmic; 2296999
DR Cosmic-CLP; 1327765
DR DSMZ; ACC-553
DR GDSC; 1327765
DR GEO; GSM95563
DR GEO; GSM104460
DR GEO; GSM119537
DR GEO; GSM887168
DR GEO; GSM888240
DR GEO; GSM907519
DR GEO; GSM1374577
DR GEO; GSM1669949
DR Lonza; 1060
RX PubMed=9753063;
RX PubMed=12683869;
RX PubMed=16448697;
RX PubMed=16960149;
RX PubMed=22460905;
RX PubMed=25315077;
RX PubMed=25355872;
RX PubMed=25485619;
RX PubMed=26439697;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Lymphoma Research Foundation Mantle Cell Lymphoma cell bank (LRF MCL cell bank).
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 26 hours (PubMed=25315077); 26.1 +- 1.1 hours (PubMed=26439697); ~50 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Omics: Virome analysis using RNAseq.
ST Source(s): ATCC; Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 9,12
ST D13S317: 8,9
ST D16S539: 12
ST D18S51: 13,15
ST D21S11: 30,33.2
ST D3S1358: 15,16
ST D5S818: 10,13
ST D7S820: 10,11
ST D8S1179: 11,14
ST FGA: 21,24
ST Penta D: 12
ST Penta E: 17,21
ST TH01: 7
ST TPOX: 8
ST vWA: 14
DI NCIt; C4337; Mantle cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID JEKO-1 R
AC CVCL_HF56
RX PubMed=26439697;
CC Doubling time: 20.5 +- 1.2 hours (PubMed=26439697).
CC Selected for resistance to: ChEBI; CHEBI:91385; PF-00477736.
DI NCIt; C4337; Mantle cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1865 ! JeKo-1
SX Female
CA Cancer cell line
//
ID Jenny
AC CVCL_0D15
SY JENNY; JEN
RX PubMed=11467477;
RX PubMed=12944992;
DI NCIt; C120298; Canine melanoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID Jensen sarcoma
AC CVCL_3531
SY Jensen Sarcoma; Jensen
DR CLO; CLO_0007018
DR CLDB; cl2938
DR CLDB; cl2939
DR ATCC; CCL-45
DR ChEMBL-Cells; CHEMBL3307260
DR ChEMBL-Targets; CHEMBL613511
DR ECACC; 90111913
DR IZSLER; BS TCL 31
DI NCIt; C60505; Rat sarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID JES3-19F1.1.1
AC CVCL_9187
DR CLO; CLO_0007019
DR ATCC; HB-10487
RX Patent=US5231012;
CC Monoclonal antibody target: UniProtKB; P22301; Human IL10.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID JESTHOM
AC CVCL_E716
SY JThom
DR dbMHC; 48915
DR ECACC; 88052004
DR IHW; IHW9004
DR IMGT/HLA; 11635
WW http://bioinformatics.hsanmartino.it/ecbr/cl4.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID JF
AC CVCL_R878
SY Jarbua Fin
RX CelloPub=CLPUB00059;
CC Group: Fish cell line.
OX NCBI_TaxID=163131; ! Terapon jarbua
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID JF1
AC CVCL_L879
DR CLO; CLO_0007020
DR CLDB; cl2940
DI NCIt; C60505; Rat sarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_3531 ! Jensen sarcoma
CA Cancer cell line
//
ID JF5
AC CVCL_V085
DR CLO; CLO_0007021
DR CLDB; cl2941
DR IHW; IHW8005
RX PubMed=3894226;
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Transfected with: HGNC; 914; B2M.
CC Transfected with: HGNC; 4931; HLA-A (allele HLA-A11).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_K237 ! J27.2
SX Male
CA Spontaneously immortalized cell line
//
ID JFCF-6
AC CVCL_4418
SY JFCF6
RX PubMed=20143388;
RX PubMed=22829774;
ST Source(s): PubMed=20143388
ST Amelogenin: X,Y
ST CSF1PO: 10,13
ST D13S317: 8,12
ST D16S539: 11,13
ST D18S51: 12,19
ST D19S433: 14,15
ST D21S11: 29,31
ST D2S1338: 17,20
ST D3S1358: 14,16
ST D5S818: 9,11
ST D7S820: 11
ST D8S1179: 10,13
ST TH01: 9.3
ST TPOX: 11
ST vWA: 16,17
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID JFCF-6/T.1D
AC CVCL_4419
SY JFCF-6/T1.D
RX PubMed=20143388;
RX PubMed=22829774;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-0044 but was never intended to be distributed.
ST Source(s): PubMed=20143388
ST Amelogenin: X,Y
ST CSF1PO: 10,13
ST D13S317: 8
ST D16S539: 13
ST D18S51: 12,19
ST D19S433: 14,15
ST D21S11: 29,31
ST D2S1338: 17,20
ST D3S1358: 14
ST D5S818: 9,11
ST D7S820: 11
ST D8S1179: 13
ST TH01: 9.3
ST TPOX: 11
ST vWA: 16,17
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4418 ! JFCF-6
SX Male
CA Transformed cell line
//
ID JFCF-6/T.1J/1.3C
AC CVCL_4420
SY JFCF-6/T.1J/1-3C; JFCF-6/T1.J/1.3C; JFCF6/T.1J/1.3C; JFCF6-3C
RX PubMed=20143388;
RX PubMed=22829774;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-0042 but was never intended to be distributed.
ST Source(s): PubMed=20143388
ST Amelogenin: X,Y
ST CSF1PO: 10,13
ST D13S317: 8,12
ST D16S539: 11
ST D18S51: 12,19
ST D19S433: 14,15
ST D21S11: 29,31
ST D2S1338: 17,20
ST D3S1358: 14,16
ST D5S818: 9,11
ST D7S820: 11
ST D8S1179: 10,13
ST TH01: 9.3
ST TPOX: 11
ST vWA: 16,17
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4418 ! JFCF-6
SX Male
CA Transformed cell line
//
ID JFCF-6/T.1J/11E
AC CVCL_4422
SY JFCF6-T.1J/11E
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4418 ! JFCF-6
SX Male
CA Transformed cell line
//
ID JFCF-6/T.1J/1D
AC CVCL_4421
RX PubMed=19468068;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4418 ! JFCF-6
SX Male
CA Transformed cell line
//
ID JFCF-6/T.1J/5H
AC CVCL_4423
RX PubMed=22829774;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-0043 but was never intended to be distributed.
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4418 ! JFCF-6
SX Male
CA Transformed cell line
//
ID JFCF-6/T.1J/6B
AC CVCL_4424
SY JFCF-6/T1.J/6B; JFCF6/T1.J/6B; JFCF6-6B
RX PubMed=19468068;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4418 ! JFCF-6
SX Male
CA Transformed cell line
//
ID JFCF-6/T.1L
AC CVCL_4425
RX PubMed=22829774;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-0045 but was never intended to be distributed.
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4418 ! JFCF-6
SX Male
CA Transformed cell line
//
ID JFCF-6/T.1M
AC CVCL_4426
RX PubMed=22829774;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-0046 but was never intended to be distributed.
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4418 ! JFCF-6
SX Male
CA Transformed cell line
//
ID JFCF-6/T.1Q
AC CVCL_4427
SY JFCF-6/T1.Q
RX PubMed=20143388;
RX PubMed=22829774;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-0047 but was never intended to be distributed.
ST Source(s): PubMed=20143388
ST Amelogenin: X,Y
ST CSF1PO: 10,13
ST D13S317: 8,12
ST D16S539: 11,13
ST D18S51: 19
ST D19S433: 14,15
ST D21S11: 29,31
ST D2S1338: 17,20
ST D3S1358: 14,16
ST D5S818: 9,11
ST D7S820: 11
ST D8S1179: 10,13
ST TH01: 9.3
ST TPOX: 11
ST vWA: 16,17
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4418 ! JFCF-6
SX Male
CA Transformed cell line
//
ID JFCF-6/T.1R
AC CVCL_4428
RX PubMed=22829774;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-0041 but was never intended to be distributed.
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4418 ! JFCF-6
SX Male
CA Transformed cell line
//
ID JFCF-6/T.5B
AC CVCL_4430
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4418 ! JFCF-6
SX Male
CA Transformed cell line
//
ID JFCF-6/T22.5M
AC CVCL_4429
SY JFCF6/T22.5M
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C2975; Cystic fibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4418 ! JFCF-6
SX Male
CA Transformed cell line
//
ID JFEN
AC CVCL_X151
SY CB-JFEN
RX PubMed=2841669;
RX PubMed=8577710;
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 11,12
ST D16S539: 9,12
ST D18S51: 12,18
ST D19S433: 14,15
ST D21S11: 28,30
ST D2S1338: 20,24
ST D3S1358: 16,18
ST D5S818: 11,12
ST D7S820: 8,10
ST D8S1179: 11,14
ST FGA: 20,25
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C3789; Olfactory neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID JFF07-1
AC CVCL_R909
RX DOI=10.3147/jsfp.46.11;
CC Group: Fish cell line.
OX NCBI_TaxID=8255; ! Paralichthys olivaceus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID JFHZ1
AC CVCL_AS33
SY JF10
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/jfhz1.cmsx
WW http://shared.eagle-i.net/i/00000155-2b9c-9ff7-e5e2-249880000000
CC From: Jain Foundation; Seattle; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AS34 ! JFHZ2
OI CVCL_AS35 ! JFHZ3
SX Male
CA Induced pluripotent stem cell
//
ID JFHZ2
AC CVCL_AS34
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/jfhz2.cmsx
WW http://shared.eagle-i.net/i/00000155-2be8-58f9-e5e2-249880000000
CC From: Jain Foundation; Seattle; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AS33 ! JFHZ1
OI CVCL_AS35 ! JFHZ3
SX Male
CA Induced pluripotent stem cell
//
ID JFHZ3
AC CVCL_AS35
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/jfhz3.cmsx
WW http://shared.eagle-i.net/i/00000155-2bfa-93b7-e5e2-249880000000
CC From: Jain Foundation; Seattle; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AS33 ! JFHZ1
OI CVCL_AS34 ! JFHZ2
SX Male
CA Induced pluripotent stem cell
//
ID JFMD1
AC CVCL_AS36
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/jfmd1.cmsx
WW http://shared.eagle-i.net/i/00000155-2c35-85d5-e5e2-249880000000
CC From: Jain Foundation; Seattle; USA.
DI NCIt; C84828; Limb-girdle muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AS37 ! JFMD2
OI CVCL_AS38 ! JFMD3
OI CVCL_AS39 ! JFMD4
OI CVCL_AS40 ! JFMD5
SX Male
CA Induced pluripotent stem cell
//
ID JFMD2
AC CVCL_AS37
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/jfmd2.cmsx
WW http://shared.eagle-i.net/i/00000155-2c51-5071-e5e2-249880000000
CC From: Jain Foundation; Seattle; USA.
DI NCIt; C84828; Limb-girdle muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AS36 ! JFMD1
OI CVCL_AS38 ! JFMD3
OI CVCL_AS39 ! JFMD4
OI CVCL_AS40 ! JFMD5
SX Male
CA Induced pluripotent stem cell
//
ID JFMD3
AC CVCL_AS38
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/jfmd3.cmsx
WW http://shared.eagle-i.net/i/00000155-2c53-c584-e5e2-249880000000
CC From: Jain Foundation; Seattle; USA.
DI NCIt; C84828; Limb-girdle muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AS36 ! JFMD1
OI CVCL_AS37 ! JFMD2
OI CVCL_AS39 ! JFMD4
OI CVCL_AS40 ! JFMD5
SX Male
CA Induced pluripotent stem cell
//
ID JFMD4
AC CVCL_AS39
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/jfmd4.cmsx
WW http://shared.eagle-i.net/i/00000155-2c55-898b-e5e2-249880000000
CC From: Jain Foundation; Seattle; USA.
DI NCIt; C84828; Limb-girdle muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AS36 ! JFMD1
OI CVCL_AS37 ! JFMD2
OI CVCL_AS38 ! JFMD3
OI CVCL_AS40 ! JFMD5
SX Male
CA Induced pluripotent stem cell
//
ID JFMD5
AC CVCL_AS40
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/jfmd5.cmsx
WW http://shared.eagle-i.net/i/00000155-2c57-7f58-e5e2-249880000000
CC From: Jain Foundation; Seattle; USA.
DI NCIt; C84828; Limb-girdle muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AS36 ! JFMD1
OI CVCL_AS37 ! JFMD2
OI CVCL_AS38 ! JFMD3
OI CVCL_AS39 ! JFMD4
SX Male
CA Induced pluripotent stem cell
//
ID JFNY1
AC CVCL_AS41
SY JF25
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/jfny1.cmsx
WW http://shared.eagle-i.net/i/00000155-2c0f-8b45-e5e2-249880000000
CC From: Jain Foundation; Seattle; USA.
DI NCIt; C84828; Limb-girdle muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID JFP-J1
AC CVCL_C478
DR CLO; CLO_0050521
DR RCB; RCB2309
CC Monoclonal antibody target: UniProtKB; P42212; GFP.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID JFP-J5
AC CVCL_C479
DR CLO; CLO_0050524
DR RCB; RCB2310
CC Monoclonal antibody target: UniProtKB; P42212; GFP.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID JFP-K2
AC CVCL_C480
DR CLO; CLO_0050522
DR RCB; RCB2311
CC Monoclonal antibody target: UniProtKB; P42212; GFP.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID JFRBi1
AC CVCL_AS42
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/jfrbi1.cmsx
WW http://shared.eagle-i.net/i/00000155-2c5f-af77-e5e2-249880000000
CC From: Jain Foundation; Seattle; USA.
DI NCIt; C84828; Limb-girdle muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AS43 ! JFRBi2
OI CVCL_AS44 ! JFRBi3
OI CVCL_AS45 ! JFRBi4
SX Male
CA Induced pluripotent stem cell
//
ID JFRBi2
AC CVCL_AS43
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/jfrbi2.cmsx
WW http://shared.eagle-i.net/i/00000155-2c68-56ab-e5e2-249880000000
CC From: Jain Foundation; Seattle; USA.
DI NCIt; C84828; Limb-girdle muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AS42 ! JFRBi1
OI CVCL_AS44 ! JFRBi3
OI CVCL_AS45 ! JFRBi4
SX Male
CA Induced pluripotent stem cell
//
ID JFRBi3
AC CVCL_AS44
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/jfrbi3.cmsx
WW http://shared.eagle-i.net/i/00000155-2c6a-258c-e5e2-249880000000
CC From: Jain Foundation; Seattle; USA.
DI NCIt; C84828; Limb-girdle muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AS42 ! JFRBi1
OI CVCL_AS43 ! JFRBi2
OI CVCL_AS45 ! JFRBi4
SX Male
CA Induced pluripotent stem cell
//
ID JFRBi4
AC CVCL_AS45
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/jfrbi4.cmsx
WW http://shared.eagle-i.net/i/00000155-2c6b-832c-e5e2-249880000000
CC From: Jain Foundation; Seattle; USA.
DI NCIt; C84828; Limb-girdle muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AS42 ! JFRBi1
OI CVCL_AS43 ! JFRBi2
OI CVCL_AS44 ! JFRBi3
SX Male
CA Induced pluripotent stem cell
//
ID JFWT1
AC CVCL_AS46
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/jfwt1.cmsx
WW http://shared.eagle-i.net/i/00000155-2c75-eb14-e5e2-249880000000
CC From: Jain Foundation; Seattle; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AS47 ! JFWT2
OI CVCL_AS48 ! JFWT3
SX Male
CA Induced pluripotent stem cell
//
ID JFWT2
AC CVCL_AS47
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/jfwt2.cmsx
WW http://shared.eagle-i.net/i/00000155-2c7a-968b-e5e2-249880000000
CC From: Jain Foundation; Seattle; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AS46 ! JFWT1
OI CVCL_AS48 ! JFWT3
SX Male
CA Induced pluripotent stem cell
//
ID JFWT3
AC CVCL_AS48
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/jfwt3.cmsx
WW http://shared.eagle-i.net/i/00000155-2c7c-104e-e5e2-249880000000
CC From: Jain Foundation; Seattle; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AS46 ! JFWT1
OI CVCL_AS47 ! JFWT2
SX Male
CA Induced pluripotent stem cell
//
ID JG2/1
AC CVCL_T960
SY JG2.1; IO/JG2/1
RX Patent=US6878544;
RX PubMed=8982103;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Lewis.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Transformed cell line
//
ID JGG
AC CVCL_GU02
SY Jining Grey Goat
RX DOI=10.3906/vet-1106-15;
CC Doubling time: ~48 hours (DOI=10.3906/vet-1106-15).
CC Breed/subspecies: Jining Grey.
OX NCBI_TaxID=9925; ! Capra hircus
SX Mixed sex
CA Finite cell line
//
ID JH
AC CVCL_S102
RX PubMed=7073944;
CC Doubling time: 35.7 hours (PubMed=7073944).
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID JH-2/TPA
AC CVCL_V634
SY JH-2
DR CCRID; 3142C0001000000548
RX Patent=US7632677;
CC Registration: International Depositary Authority, China Center for Type Culture Collection (CCTCC); C200006.
CC Characteristics: Heterozygous for the IDH1 p.Arg132Cys mutation.
CC Transfected with: HGNC; 9051; PLAT.
DI NCIt; C3043; Fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0317 ! HT-1080
SX Male
CA Cancer cell line
//
ID JH-EsoAd1
AC CVCL_8098
SY JHEsoAD1; JHesoAD1; JHESOAD1
DR CCLE; JHESOAD1_OESOPHAGUS
DR Cosmic; 1599340
RX PubMed=18787394;
RX PubMed=20075370;
RX PubMed=23795680;
RX PubMed=25984343;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 29 hours (PubMed=25984343).
CC Omics: shRNA library screening.
DI NCIt; C7027; Barrett adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID JH024
AC CVCL_E279
SY Pa43C
RX PubMed=22753594;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID JH029
AC CVCL_E280
SY Pa11C
RX PubMed=22753594;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID JH4 clone 1
AC CVCL_4229
SY JH 4 clone 1
DR CLO; CLO_0007022
DR CLDB; cl2942
DR CLDB; cl2943
DR ATCC; CCL-158
DR ECACC; 86070201
DR ECACC; 93120825
DR IZSLER; BS CL 54
RX PubMed=7065527;
CC Discontinued: ECACC; 93120825; probable.
OX NCBI_TaxID=10141; ! Cavia porcellus
SX Female
CA Spontaneously immortalized cell line
//
ID JHAF
AC CVCL_E717
SY JHF; JHA
DR dbMHC; 48913
DR ECACC; 88052030
DR IHW; IHW9030
DR IMGT/HLA; 10845
WW http://bioinformatics.hsanmartino.it/ecbr/cl30.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID JHC
AC CVCL_M093
DR BioSample; SAMN03151726
RX PubMed=6451928;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=6451928, PubMed=20143388).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID JHC-2
AC CVCL_M097
RX PubMed=9168447;
DI NCIt; C7402; Hairy cell leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID JHC7
AC CVCL_L154
SY Johns Hopkins Chordoma line 7
DR ATCC; CRL-3267
RX PubMed=21699479;
RX PubMed=27102572;
WW https://www.chordomafoundation.org/reagents-data/cell-line-repository/jhc7/
CC Doubling time: ~5 days (PubMed=21699479).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Genome sequenced.
ST Source(s): ATCC; PubMed=27102572
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 11
ST D18S51: 12
ST D19S433: 13,13.2
ST D21S11: 27,31.2
ST D2S1338: 18,20
ST D3S1358: 17
ST D5S818: 13
ST D7S820: 7,10
ST D8S1179: 13,14
ST FGA: 21,23
ST Penta D: 6,11
ST Penta E: 15
ST TH01: 6,8
ST TPOX: 10,11
ST vWA: 17
DI NCIt; C129927; Sacral chordoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID JHCA-ov
AC CVCL_E075
DR CLO; CLO_0050631
DR BioSample; SAMN03472065
DR RCB; RCB1705
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8
ST D16S539: 12
ST D5S818: 10
ST D7S820: 11
ST TH01: 9
ST TPOX: 11
ST vWA: 14,18
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID JHCOLOYI
AC CVCL_E076
DR CLO; CLO_0051400
DR BioSample; SAMN03472066
DR RCB; RCB1706
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 9,11
ST D13S317: 11,12
ST D16S539: 9
ST D5S818: 12,13
ST D7S820: 10,12
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID JHE
AC CVCL_5I40
RX PubMed=24582862;
WW https://www.kerafast.com/product/2409/canine-hemangiosarcoma-cell-line-jhe
CC Doubling time: ~72 hours (Kerafast).
CC Breed/subspecies: Golden Retriever.
DI NCIt; C122783; Canine hemangiosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_5I41 ! JLI
OI CVCL_5I42 ! JLU
SX Male
CA Cancer cell line
//
ID JHH-1
AC CVCL_2785
SY Jhh-1; JHH1
DR EFO; EFO_0006599
DR BioSample; SAMN03473248
DR CCLE; JHH1_LIVER
DR Cosmic; 1187334
DR Cosmic; 1995460
DR Cosmic; 2009536
DR Cosmic; 2023872
DR Cosmic-CLP; 1298151
DR GDSC; 1298151
DR GEO; GSM827297
DR GEO; GSM887169
DR GEO; GSM888241
DR GEO; GSM936764
DR GEO; GSM1669950
DR JCRB; JCRB1062
DR JCRB; NIHS0056
DR JCRB; NIHS0329
RX PubMed=1701409;
RX PubMed=15767549;
RX PubMed=20143388;
RX PubMed=22460905;
RX PubMed=23505090;
RX PubMed=25485619;
RX PubMed=27397505;
CC Problematic cell line: Misidentified. Originally thought to be of human origin but found to be from mouse (PubMed=20143388).
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: JFCR45 cancer cell line panel.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: JCRB; NIHS0056; true.
CC Discontinued: JCRB; NIHS0329; true.
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID JHH-2
AC CVCL_2786
SY Jhh-2; JHH2
DR EFO; EFO_0006600
DR BioSample; SAMN03473249
DR CCLE; JHH2_LIVER
DR Cosmic; 1995461
DR Cosmic; 2023873
DR Cosmic-CLP; 1240157
DR GDSC; 1240157
DR GEO; GSM827249
DR GEO; GSM887170
DR GEO; GSM888242
DR GEO; GSM936765
DR GEO; GSM1669951
DR JCRB; JCRB1028
DR JCRB; NIHS0058
RX PubMed=1701409;
RX PubMed=22460905;
RX PubMed=23505090;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: JCRB; NIHS0058; true.
ST Source(s): Cosmic-CLP; JCRB; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 12
ST D16S539: 10,13
ST D18S51: 13
ST D21S11: 29,32.2
ST D3S1358: 17
ST D5S818: 9,13
ST D7S820: 10
ST D8S1179: 11,16
ST FGA: 21,24
ST Penta D: 10,13
ST Penta E: 21
ST TH01: 6,7
ST TPOX: 8
ST vWA: 14
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID JHH-4
AC CVCL_2787
SY Jhh-4; JHH4
DR EFO; EFO_0006601
DR BioSample; SAMN03473220
DR CCLE; JHH4_LIVER
DR Cosmic; 1187335
DR Cosmic; 1995462
DR Cosmic; 2009537
DR Cosmic; 2023874
DR Cosmic-CLP; 1240158
DR GDSC; 1240158
DR GEO; GSM827207
DR GEO; GSM887171
DR GEO; GSM888243
DR GEO; GSM936766
DR GEO; GSM1669952
DR JCRB; JCRB0435
DR JCRB; NIHS0057
RX PubMed=1701409;
RX PubMed=2856444;
RX PubMed=22460905;
RX PubMed=23505090;
RX PubMed=25485619;
RX PubMed=25574106;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Caution: FLC-4 (CVCL_D204) is often stated to be synonymous with JHH-4, but a FLC-4 patent reference (Patent=US5804441) seems to indicate that it is derived from JHH-4 and has a different karyotype.
CC Discontinued: JCRB; NIHS0057; true.
ST Source(s): Cosmic-CLP; JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 12,13
ST D18S51: 13,16
ST D21S11: 31.2,32.2
ST D3S1358: 15,16
ST D5S818: 9,13
ST D7S820: 10,12
ST D8S1179: 17
ST FGA: 22
ST Penta D: 9,12
ST Penta E: 5,12
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 14,17
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID JHH-5
AC CVCL_0364
AS CVCL_0263
SY Jhh-5; JHH5; FLC-5; FLC5; Functional Liver Cell-5
DR EFO; EFO_0006602
DR MCCL; MCC:0000154
DR MCCL; MCC:0000258
DR BioSample; SAMN03473192
DR CCLE; JHH5_LIVER
DR Cosmic; 2023875
DR GEO; GSM887172
DR GEO; GSM888244
DR GEO; GSM936767
DR JCRB; JCRB1029
DR JCRB; NIHS0279
RX PubMed=1701409;
RX PubMed=10933057;
RX PubMed=17241388;
RX PubMed=22460905;
RX PubMed=23505090;
RX PubMed=25485619;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: JCRB; NIHS0279; true.
ST Source(s): JCRB; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 9
ST D13S317: 9
ST D16S539: 9,10
ST D18S51: 13
ST D21S11: 31.2
ST D3S1358: 15,17
ST D5S818: 13
ST D7S820: 10,12
ST D8S1179: 12
ST FGA: 19
ST Penta D: 11
ST Penta E: 17,20
ST TH01: 9
ST TPOX: 11
ST vWA: 17,19
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID JHH-6
AC CVCL_2788
SY Jhh-6; JHH6
DR BioSample; SAMN03472917
DR CCLE; JHH6_LIVER
DR Cosmic; 1995463
DR Cosmic; 2023876
DR Cosmic-CLP; 1240159
DR GDSC; 1240159
DR GEO; GSM827199
DR GEO; GSM887173
DR GEO; GSM888245
DR GEO; GSM936768
DR GEO; GSM1669953
DR JCRB; JCRB1030
DR JCRB; NIHS0280
DR LINCS; 50021
RX PubMed=1701409;
RX PubMed=10933057;
RX PubMed=22460905;
RX PubMed=23505090;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: JCRB; NIHS0280; true.
ST Source(s): Cosmic-CLP; JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11,12,13
ST D16S539: 10
ST D18S51: 20
ST D19S433: 13
ST D21S11: 31,32.2
ST D2S1338: 19,24
ST D3S1358: 17
ST D5S818: 10,11
ST D7S820: 11
ST D8S1179: 12,13
ST FGA: 22
ST Penta D: 10,13
ST Penta E: 15
ST TH01: 7,9
ST TPOX: 8,9
ST vWA: 14,18
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID JHH-7
AC CVCL_2805
SY Jhh-7; JHH7; FLC-7; FLC7; Functional Liver Cell-7
DR EFO; EFO_0006603
DR BioSample; SAMN03471923
DR CCLE; JHH7_LIVER
DR Cosmic; 1187336
DR Cosmic; 1995464
DR Cosmic; 2023877
DR Cosmic-CLP; 1240160
DR GDSC; 1240160
DR GEO; GSM887174
DR GEO; GSM888246
DR GEO; GSM936769
DR GEO; GSM1669954
DR JCRB; JCRB1031
DR JCRB; NIHS0281
DR PRIDE; PXD002486
RX PubMed=1701409;
RX PubMed=1707654;
RX PubMed=10933057;
RX PubMed=17241388;
RX PubMed=22460905;
RX PubMed=23505090;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: JCRB; NIHS0281; true.
ST Source(s): Cosmic-CLP; JCRB; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 13,14
ST D13S317: 12
ST D16S539: 13
ST D18S51: 17
ST D21S11: 29,33.2
ST D3S1358: 15,17
ST D5S818: 13
ST D7S820: 8,11
ST D8S1179: 10,11
ST FGA: 22
ST Penta D: 12
ST Penta E: 10,11
ST TH01: 6
ST TPOX: 9,11
ST vWA: 16,18
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID JHH-DIPG-1
AC CVCL_IT47
SY JHH-DIPG1; JHH DIPG1; JHH DIPG; Johns Hopkins Hospital - Diffuse Intrinsic Pontine Glioma-1
RX PubMed=25939062;
RX PubMed=26115193;
CC Characteristics: Has a H3F3A p.Lys28Met mutation (H3.3K27M).
CC Omics: Deep RNAseq analysis.
ST Source(s): PubMed=25939062
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 11
ST D21S11: 30
ST D5S818: 12,13
ST D7S820: 11,12
ST TH01: 6
ST TPOX: 8,12
ST vWA: 18,19
DI NCIt; C94764; Diffuse intrinsic pontine glioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID JHK-3
AC CVCL_0U23
SY JHK3
DR ATCC; CRL-10991
DR BioSample; SAMN03471325
RX Patent=US5545550;
RX PubMed=9201810;
RX PubMed=24159361;
CC Characteristics: Infected by the JHK retrovirus (JHKV), a murine leukemia-related retrovirus.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 10,13
ST D16S539: 11,13
ST D5S818: 9,11
ST D7S820: 9,11
ST TH01: 9,9.3
ST TPOX: 8,10
ST vWA: 15,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID JHOC-5
AC CVCL_4640
SY JHOC5
DR CLO; CLO_0051439
DR BioSample; SAMN03472149
DR CCLE; JHOC5_OVARY
DR Cosmic; 1066214
DR Cosmic; 1223321
DR Cosmic; 1328070
DR Cosmic; 1708381
DR Cosmic; 2074241
DR Cosmic; 2582800
DR GEO; GSM887175
DR GEO; GSM888247
DR GEO; GSM1176277
DR RCB; RCB1520
RX PubMed=10695020;
RX PubMed=22460905;
RX PubMed=23839242;
RX PubMed=24023729;
RX PubMed=25984343;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 52 hours (PubMed=10695020); 30 hours (PubMed=25984343).
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 9,12
ST D16S539: 11,13
ST D5S818: 10
ST D7S820: 12
ST TH01: 7
ST TPOX: 11
ST vWA: 14,16
DI NCIt; C40078; Ovarian clear cell adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID JHOC-6
AC CVCL_M712
SY JHOC6
RX PubMed=10695020;
CC Doubling time: 70 hours (PubMed=10695020).
DI NCIt; C40078; Ovarian clear cell adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID JHOC-7
AC CVCL_4641
SY JHOC7
DR CLO; CLO_0051445
DR BioSample; SAMN03472120
DR Cosmic; 1707562
DR Cosmic; 2582797
DR GEO; GSM1176278
DR RCB; RCB1688
RX PubMed=24023729;
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,10
ST D16S539: 9
ST D5S818: 9,12
ST D7S820: 11,12
ST TH01: 9
ST TPOX: 8,11
ST vWA: 14,17
DI NCIt; C40078; Ovarian clear cell adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID JHOC-8
AC CVCL_4642
SY JHOC8
DR CLO; CLO_0051446
DR BioSample; SAMN03472070
DR Cosmic; 2582798
DR RCB; RCB1723
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 14
ST D13S317: 8
ST D16S539: 9
ST D5S818: 11
ST D7S820: 8,11
ST TH01: 7,9
ST TPOX: 8,9
ST vWA: 14,17
DI NCIt; C40078; Ovarian clear cell adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID JHOC-9
AC CVCL_4643
SY JHOC9
DR CLO; CLO_0051447
DR BioSample; SAMN03472024
DR Cosmic; 1708380
DR Cosmic; 2582796
DR GEO; GSM1176279
DR RCB; RCB2226
RX PubMed=24023729;
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 10
ST D16S539: 12
ST D5S818: 10
ST D7S820: 8,12
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C40078; Ovarian clear cell adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID JHOM-1
AC CVCL_4644
SY JHOM1
DR CLO; CLO_0051441
DR BioSample; SAMN03472113
DR CCLE; JHOM1_OVARY
DR Cosmic; 1707566
DR Cosmic; 2429299
DR GEO; GSM887176
DR GEO; GSM888248
DR RCB; RCB1676
RX PubMed=22460905;
RX PubMed=23839242;
RX PubMed=25984343;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 60 hours (PubMed=25984343).
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,12
ST D16S539: 10,11
ST D5S818: 10
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 14,18
DI NCIt; C5243; Ovarian mucinous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID JHOM-2B
AC CVCL_4645
SY JHOM2B
DR CLO; CLO_0051444
DR BioSample; SAMN03472119
DR CCLE; JHOM2B_OVARY
DR Cosmic; 2429300
DR GEO; GSM887177
DR GEO; GSM888249
DR RCB; RCB1682
RX PubMed=22460905;
RX PubMed=23839242;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 9,13
ST D5S818: 10,11
ST D7S820: 10,11
ST TH01: 7
ST TPOX: 8,10
ST vWA: 16,17
DI NCIt; C5243; Ovarian mucinous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID JHONA
AC CVCL_4646
DR CLO; CLO_0051449
DR BioSample; SAMN03471916
DR RCB; RCB2365
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9,11
ST D16S539: 9,11
ST D5S818: 12,13
ST D7S820: 10
ST TH01: 6,9
ST TPOX: 8
ST vWA: 15,17
DI NCIt; C40093; Ovarian squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID JHOS-2
AC CVCL_4647
SY JHOS2
DR CLO; CLO_0051440
DR BioSample; SAMN03472150
DR CCLE; JHOS2_OVARY
DR Cosmic; 1066215
DR Cosmic-CLP; 1479995
DR GDSC; 1479995
DR GEO; GSM887178
DR GEO; GSM888250
DR GEO; GSM1669955
DR RCB; RCB1521
RX PubMed=10695020;
RX PubMed=22460905;
RX PubMed=23839242;
RX PubMed=27397505;
RX PubMed=27561551;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Deep proteome analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; RCB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 8,9
ST D16S539: 13
ST D5S818: 10
ST D7S820: 11
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 14,17
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID JHOS-3
AC CVCL_4648
SY JHOS3
DR CLO; CLO_0051450
DR BioSample; SAMN03472097
DR RCB; RCB1546
DR Cosmic-CLP; 1480358
DR GDSC; 1480358
DR GEO; GSM1669956
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; RCB
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 10
ST D16S539: 9,12
ST D5S818: 13
ST D7S820: 10
ST TH01: 6
ST TPOX: 9,11
ST vWA: 18
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID JHOS-4
AC CVCL_4649
SY JHOS4
DR CLO; CLO_0051443
DR BioSample; SAMN03472117
DR CCLE; JHOS4_OVARY
DR Cosmic-CLP; 1480359
DR GDSC; 1480359
DR GEO; GSM887179
DR GEO; GSM888251
DR GEO; GSM1669957
DR RCB; RCB1678
RX PubMed=22460905;
RX PubMed=23839242;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=27561551;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 70 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; RCB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 9,10
ST D5S818: 11
ST D7S820: 10
ST TH01: 7
ST TPOX: 8,12
ST vWA: 14
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID JHP-1
AC CVCL_W523
RX PubMed=2979202;
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID JHPI-1 clone-16
AC CVCL_1T11
SY Clone-16
DR BioSample; SAMN03152006
RX PubMed=2903855;
RX PubMed=6125140;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Misidentified. Originally thought to be of human origin but found to be from hamster (PubMed=2903855, PubMed=20143388). Originally thought to originate from fetal pancreatic islets.
OX NCBI_TaxID=10036; ! Mesocricetus auratus
SX Sex undetermined
CA Undefined cell line type
//
ID JHSK-rec
AC CVCL_6661
DR CLO; CLO_0051399
DR BioSample; SAMN03472071
DR RCB; RCB1724
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 9
ST D16S539: 11,13
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 6,7
ST TPOX: 8,12
ST vWA: 14,16
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID JHT
AC CVCL_M620
DR BioSample; SAMN03151727
RX PubMed=1246601;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Parent cell line (JHC) has been shown to be a HeLa derivative (PubMed=1246601, PubMed=20143388).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M093 ! JHC
SX Female
CA Cancer cell line
//
ID JHTK-1
AC CVCL_S903
RX PubMed=2556605;
RX PubMed=3820395;
DI NCIt; C7733; Testicular choriocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID JHTKI-col-L
AC CVCL_H734
DR CLO; CLO_0051048
DR BioSample; SAMN03472094
DR RCB; RCB1543
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 9,12
ST D13S317: 8,12
ST D16S539: 11,12
ST D5S818: 9,10,11
ST D7S820: 10,11,12
ST TH01: 6
ST TPOX: 11,13
ST vWA: 14,16,17
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID JHTSK-col-L
AC CVCL_E077
DR CLO; CLO_0051049
DR BioSample; SAMN03472067
DR RCB; RCB1708
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 8,12
ST D16S539: 9
ST D5S818: 9,10
ST D7S820: 11
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID JHU-011
AC CVCL_5986
SY JHU 011; JHU-011-SCC; JHU-O11; JHU011; HNSCC 011; O11; 011; 11
DR BTO; BTO:0003891
DR ATCC; CRL-2719
DR BioSample; SAMN03471775
DR Cosmic-CLP; 1240161
DR GDSC; 1240161
DR GEO; GSM1669958
RX PubMed=12925955;
RX PubMed=21868764;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Discontinued: ATCC; CRL-2719; true.
ST Source(s): ATCC; Cosmic-CLP; PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 9,14
ST D5S818: 9,12
ST D7S820: 11
ST TH01: 6,9
ST TPOX: 8,9
ST vWA: 16,17
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID JHU-012
AC CVCL_5987
SY JHU 012; JHU-O12; JHU012; SCC012; HNSCC 012; O12; 012
DR ATCC; CRL-2720
DR BioSample; SAMN03151804
DR Cosmic; 1122669
DR Cosmic; 1530746
RX PubMed=12925955;
RX PubMed=21868764;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a JHU-022 derivative (PubMed=21868764).
CC Misspelling: 'JHU-112' in Cosmic 1530746.
CC Discontinued: ATCC; CRL-2720; true.
ST Source(s): ATCC; PubMed=21868764
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 12
ST D5S818: 12,13
ST D7S820: 9,10
ST TH01: 6
ST TPOX: 8
ST vWA: 14,16
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5991 ! JHU-022
SX Male
CA Cancer cell line
//
ID JHU-013
AC CVCL_5988
SY JHU 013; JHU013; JHU-O13; JHU-13; O13
DR BTO; BTO:0003890
DR BioSample; SAMN03151639
DR Cosmic; 1122670
DR Cosmic; 1530747
DR GDSC; 1298152
RX PubMed=12925955;
RX PubMed=21868764;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a FaDu derivative (PubMed=21868764).
ST Source(s): PubMed=21868764
ST Amelogenin: Not_detected
ST CSF1PO: 12
ST D13S317: 8,9
ST D16S539: 11
ST D5S818: 12
ST D7S820: 11,12
ST TH01: 8
ST TPOX: 11
ST vWA: 15,17
DI NCIt; C4043; Hypopharyngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1218 ! FaDu
SX Male
CA Cancer cell line
//
ID JHU-019
AC CVCL_5989
SY JHU 019; JHU-O19; JHU019; O19; 019; 19
DR BTO; BTO:0003889
DR ATCC; CRL-2721
DR BioSample; SAMN03151893
DR BioSample; SAMN03471776
DR GDSC; 1298153
RX PubMed=12925955;
RX PubMed=21868764;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a PC-3 derivative (PubMed=21868764). Originally thought to originate from a oropharyngeal squamous cell carcinoma.
CC Discontinued: ATCC; CRL-2721; true.
CC Derived from metastatic site: Bone.
ST Source(s): ATCC; PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 11
ST D5S818: 9,13 (ATCC)
ST D5S818: 13 (PubMed=21868764)
ST D7S820: 8,11
ST TH01: 6,7
ST TPOX: 8,9
ST vWA: 17
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0035 ! PC-3
SX Male
CA Cancer cell line
//
ID JHU-020
AC CVCL_5990
SY JHU-020-SCC; JHU020
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID JHU-022
AC CVCL_5991
SY JHU-022-SCC; JHU022; JHU-O22; JHU-22; HNSCC 022; O22; 022
DR BTO; BTO:0003887
DR ATCC; CRL-2722
DR Cosmic; 1122671
DR Cosmic; 1530748
DR Cosmic; 2131848
DR Cosmic-CLP; 1240162
DR GDSC; 1240162
DR GEO; GSM1669959
RX PubMed=12925955;
RX PubMed=21868764;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Misspelling: 'JUH022' in Cosmic 2131848.
CC Discontinued: ATCC; CRL-2722; true.
ST Source(s): ATCC; Cosmic-CLP; PubMed=21868764
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 12
ST D5S818: 12,13
ST D7S820: 9,10
ST TH01: 6
ST TPOX: 8
ST vWA: 14,16
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID JHU-028
AC CVCL_5992
SY JHU 028; JHU028; SCC028; HNSCC 028; O28
DR BioSample; SAMN03151610
DR GDSC; 1298154
RX PubMed=12925955;
RX PubMed=21868764;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a A-549 derivative (PubMed=21868764).
ST Source(s): PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 11,12
ST D5S818: 13
ST D7S820: 8,11
ST TH01: 8
ST TPOX: 8,11
ST vWA: 14
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0023 ! A-549
SX Male
CA Cancer cell line
//
ID JHU-029
AC CVCL_5993
SY JHU-O29; JHU029; HNSCC 029; 029
DR BTO; BTO:0003888
DR ATCC; CRL-2723
DR Cosmic-CLP; 1298156
DR GDSC; 1298156
RX PubMed=21868764;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Discontinued: ATCC; CRL-2723; true.
ST Source(s): Cosmic-CLP; PubMed=21868764
ST Amelogenin: X,Y
ST CSF1PO: 8,12
ST D13S317: 12,13
ST D16S539: 10,13
ST D5S818: 13,15
ST D7S820: 10,11
ST TH01: 8
ST TPOX: 9,11
ST vWA: 15
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID JHU-06
AC CVCL_5985
SY JHU006; HNSCC 06; 006; 6
DR ATCC; CRL-2718
DR BioSample; SAMN03471774
CC Discontinued: ATCC; CRL-2718; true.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 12
ST D5S818: 12,13
ST D7S820: 9,10
ST TH01: 6
ST TPOX: 8
ST vWA: 14,16
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID JHU-ESS1
AC CVCL_S824
DR Cosmic; 2008738
RX PubMed=1591708;
RX PubMed=18722875;
DI NCIt; C8973; Endometrioid stromal sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID JHUAS-1
AC CVCL_4650
DR CLO; CLO_0050878
DR BioSample; SAMN03472095
DR RCB; RCB1544
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 7,13
ST D13S317: 11,13
ST D16S539: 9,12
ST D5S818: 11,12
ST D7S820: 12
ST TH01: 9
ST TPOX: 8,10
ST vWA: 14
DI NCIt; C4519; Cervical adenosquamous carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID JHUAS-2-L
AC CVCL_4651
DR CLO; CLO_0051047
DR BioSample; SAMN03472096
DR RCB; RCB1545
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,14
ST D16S539: 9,10
ST D5S818: 12
ST D7S820: 12
ST TH01: 7,9
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C4519; Cervical adenosquamous carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID JHUCS-1
AC CVCL_4652
DR CLO; CLO_0050879
DR BioSample; SAMN03472098
DR RCB; RCB1547
RX PubMed=15859159;
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 8,12
ST D16S539: 12
ST D5S818: 10,11
ST D7S820: 8,13
ST TH01: 7,9
ST TPOX: 11,12
ST vWA: 18
DI NCIt; C42700; Uterine carcinosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID JHUCS-3
AC CVCL_4653
DR CLO; CLO_0050926
DR BioSample; SAMN03472069
DR RCB; RCB1721
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 9,12
ST D13S317: 8,11
ST D16S539: 9,10
ST D5S818: 11
ST D7S820: 8
ST TH01: 6,9
ST TPOX: 8,9
ST vWA: 16,19
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID JHUEM-1
AC CVCL_4655
SY JHUEM1
DR CLO; CLO_0050873
DR BioSample; SAMN03472099
DR CCLE; JHUEM1_ENDOMETRIUM
DR GEO; GSM887180
DR GEO; GSM888252
DR RCB; RCB1548
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,14
ST D13S317: 8
ST D16S539: 9,10
ST D5S818: 11,12
ST D7S820: 12,13
ST TH01: 6
ST TPOX: 7,8
ST vWA: 17,18,19
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID JHUEM-14
AC CVCL_4654
DR CLO; CLO_0050877
DR BioSample; SAMN03472023
DR RCB; RCB2225
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12,13,14
ST D13S317: 8,10
ST D16S539: 10
ST D5S818: 11
ST D7S820: 10
ST TH01: 6,10
ST TPOX: 10,11
ST vWA: 17
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID JHUEM-2
AC CVCL_4656
SY JHUEM2
DR CLO; CLO_0050874
DR BioSample; SAMN03472101
DR CCLE; JHUEM2_ENDOMETRIUM
DR GEO; GSM887181
DR GEO; GSM888253
DR RCB; RCB1551
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9
ST D16S539: 9,10
ST D5S818: 11,14
ST D7S820: 11
ST TH01: 7,9
ST TPOX: 8,9,11
ST vWA: 14
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID JHUEM-3
AC CVCL_4657
SY JHUEM3
DR CLO; CLO_0050875
DR BioSample; SAMN03472102
DR CCLE; JHUEM3_ENDOMETRIUM
DR Cosmic; 2030476
DR GEO; GSM887182
DR GEO; GSM888254
DR RCB; RCB1552
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,13
ST D16S539: 9,11
ST D5S818: 11
ST D7S820: 9,11
ST TH01: 7
ST TPOX: 8,11
ST vWA: 14,19,20
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID JHUEM-7
AC CVCL_4658
SY JHUEM7
DR CLO; CLO_0050876
DR BioSample; SAMN03472114
DR CCLE; JHUEM7_ENDOMETRIUM
DR GEO; GSM888255
DR RCB; RCB1677
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 10,11
ST D16S539: 9,13
ST D5S818: 11
ST D7S820: 10
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 15,17
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID JHUS-nk1
AC CVCL_3729
DR CLO; CLO_0050925
DR BioSample; SAMN03472103
DR RCB; RCB1558
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 9,10
ST D5S818: 9
ST D7S820: 10,13
ST TH01: 7
ST TPOX: 8,12
ST vWA: 16,18
DI NCIt; C4028; Cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID JI
AC CVCL_W934
DR Cosmic; 931125
RX PubMed=3027441;
RX PubMed=9473234;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID JIH-3
AC CVCL_8884
RX PubMed=22340903;
DI NCIt; C7463; Acute myelomonocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID JIH-4
AC CVCL_A454
RX PubMed=21536242;
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID JIH-5
AC CVCL_EQ76
DR DSMZ; ACC-788
RX PubMed=26293203;
CC Doubling time: ~5-7 days.
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 9,12
ST D13S317: 8
ST D16S539: 9,11
ST D5S818: 11
ST D7S820: 10,12
ST TH01: 9,10
ST TPOX: 8
ST vWA: 14,18
DI NCIt; C4673; Acute biphenotypic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID JII1
AC CVCL_V086
DR CLO; CLO_0007023
DR CLDB; cl2944
DR IHW; IHW8031
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4536 ! L-M(TK-)
SX Male
CA Spontaneously immortalized cell line
//
ID JIM1
AC CVCL_2532
SY JIM-1
DR Cosmic; 888015
DR ECACC; 10032303
DR Ximbio; 151449
RX PubMed=1943229;
RX PubMed=10087940;
RX PubMed=10936422;
RX PubMed=11021758;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2533 ! JIM3
SX Female
CA Cancer cell line
//
ID JIM3
AC CVCL_2533
SY JIM-3; Jim3
DR Cosmic; 720770
DR Cosmic; 850217
DR Cosmic; 888016
DR Cosmic; 2081384
DR Cosmic; 2367268
DR ECACC; 10081204
DR Ximbio; 151450
RX PubMed=1943229;
RX PubMed=8943038;
RX PubMed=10087940;
RX PubMed=10936422;
RX PubMed=16956823;
RX PubMed=21173094;
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2532 ! JIM1
SX Female
CA Cancer cell line
//
ID JIMT-1
AC CVCL_2077
SY JIMT1; JIMT
DR BTO; BTO:0004312
DR EFO; EFO_0005388
DR BioSample; SAMN03473040
DR CCLE; JIMT1_BREAST
DR Cosmic; 1348959
DR Cosmic; 2165010
DR Cosmic-CLP; 1298157
DR DSMZ; ACC-589
DR GDSC; 1298157
DR GEO; GSM155212
DR GEO; GSM783975
DR GEO; GSM827173
DR GEO; GSM847393
DR GEO; GSM847489
DR GEO; GSM887183
DR GEO; GSM888256
DR GEO; GSM1374578
DR PRIDE; PXD000691
RX PubMed=15634652;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=26055192;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.addexbio.com/productdetail?pid=50
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~30-40 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 8,13
ST D16S539: 11
ST D18S51: 10
ST D21S11: 27,31.2
ST D3S1358: 18
ST D5S818: 12,13,14
ST D7S820: 12
ST D8S1179: 10,13
ST FGA: 21,23
ST Penta D: 9,12
ST Penta E: 7,19
ST TH01: 7
ST TPOX: 8
ST vWA: 18
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID JinB8
AC CVCL_1Y74
SY JINB8
DR EFO; EFO_0006281
RX PubMed=10330276;
CC Characteristics: CD47-deficient.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0065 ! Jurkat
SX Male
CA Cancer cell line
//
ID Jiyoye
AC CVCL_1317
SY JIYOYE; Jijoye; JIJOYE; P-2003; P3 (Jiyoye); P3-Jiyoye; P-3J; P3J; Jiyoye(P-2003); Jiyoye (P-2003); JiyoyeP-2003; GM04678
DR CLO; CLO_0007025
DR CLO; CLO_0019011
DR EFO; EFO_0002215
DR CLDB; cl2945
DR CLDB; cl2946
DR ATCC; CCL-87
DR ATCC; CRL-7933
DR BioSample; SAMN01821570
DR BioSample; SAMN01821640
DR BioSample; SAMN03471289
DR ChEMBL-Cells; CHEMBL3307658
DR ChEMBL-Cells; CHEMBL3308338
DR ChEMBL-Targets; CHEMBL614588
DR ChEMBL-Targets; CHEMBL2366129
DR Coriell; GM04678
DR Cosmic; 687846
DR Cosmic; 907268
DR Cosmic; 931105
DR Cosmic; 1818344
DR Cosmic-CLP; 907268
DR DSMZ; ACC-590
DR ECACC; 88071302
DR GDSC; 907268
DR GEO; GSM1669960
DR IZSLER; BS TCL 32
DR IGRhCellID; Jiyoye
DR KCLB; 10087
DR NCBI_Iran; C117
RX PubMed=1915267;
RX PubMed=4321974;
RX PubMed=4736620;
RX PubMed=5786183;
RX PubMed=6018567;
RX PubMed=6500159;
RX PubMed=7316467;
RX PubMed=8515068;
RX PubMed=9473234;
RX PubMed=17254797;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Doubling time: ~30-60 hours (DSMZ).
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Discontinued: ATCC; CRL-7933; true.
ST Source(s): ATCC; Cosmic-CLP; DSMZ; ECACC; KCLB; PubMed=17254797
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 12
ST D16S539: 10,11 (ATCC; Cosmic-CLP; DSMZ; ECACC; KCLB)
ST D16S539: 9,10 (PubMed=17254797)
ST D18S51: 12
ST D21S11: 27
ST D3S1358: 16,17
ST D5S818: 12
ST D7S820: 8,10
ST D8S1179: 14,15
ST FGA: 23,24
ST TH01: 7,9
ST TPOX: 6,8
ST vWA: 15,19
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID JJ0016
AC CVCL_8X72
DR ECACC; 90091401
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID JJ0035
AC CVCL_8X73
DR ECACC; 91071906
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID JJ0038
AC CVCL_8X74
DR ECACC; 91080806
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID JJ0039
AC CVCL_8X75
DR ECACC; 91082130
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID JJ0040
AC CVCL_8X76
DR ECACC; 91091106
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID JJ0042
AC CVCL_8X77
DR ECACC; 91102601
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C125488; Seckel syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID JJ0048
AC CVCL_8X78
DR ECACC; 92012303
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID JJ0049
AC CVCL_8X79
DR ECACC; 92012304
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID JJ0051
AC CVCL_8X80
DR ECACC; 92012306
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID JJ0052
AC CVCL_8X81
DR ECACC; 92012307
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID JJ0053
AC CVCL_8X82
DR ECACC; 92020605
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID JJ0054
AC CVCL_8X83
DR ECACC; 92041013
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID JJ0055
AC CVCL_8X84
DR ECACC; 92041014
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID JJ0056
AC CVCL_8X85
DR ECACC; 92072312
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID JJ0057
AC CVCL_8X86
DR ECACC; 92080607
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID JJ0060
AC CVCL_8X87
DR ECACC; 92080610
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID JJ0061
AC CVCL_8X88
DR ECACC; 92080611
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84717; Fragile X syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID JJ012
AC CVCL_D605
SY JJO12; JJ
DR BTO; BTO:0005168
DR EFO; EFO_0006604
DR BioSample; SAMN03470880
DR Cosmic; 1602476
DR Cosmic; 1992323
DR GEO; GSM1676351
DR GEO; GSM1701681
RX PubMed=8689637;
RX PubMed=10906887;
RX PubMed=12168675;
RX PubMed=22057234;
RX PubMed=25485619;
RX PubMed=26368816;
CC Characteristics: Heterozygous for the IDH1 p.Arg132Gly mutation.
CC Doubling time: 0.9 days (PubMed=12168675).
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 11,12
ST D18S51: 15
ST D21S11: 28,29
ST D3S1358: 15,16,17,18
ST D5S818: 11,12
ST D7S820: 8,10
ST D8S1179: 13
ST FGA: 21,22
ST Penta D: 11,13
ST Penta E: 7,15
ST TH01: 6,8
ST TPOX: 8,9
ST vWA: 15,16
DI NCIt; C2946; Chondrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID JJ012-TS4
AC CVCL_D901
DR BTO; BTO:0003043
RX PubMed=11796708;
RX PubMed=14701864;
CC Characteristics: Heterozygous for the IDH1 p.Arg132Gly mutation.
CC Transfected with: HGNC; 220; ADAMTS4.
DI NCIt; C2946; Chondrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D605 ! JJ012
SX Male
CA Cancer cell line
//
ID JJN-1
AC CVCL_L066
SY JJN1
RX PubMed=2495201;
RX PubMed=10936422;
CC Characteristics: IL6 dependent.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID JJN-2
AC CVCL_L067
SY JJN2
RX PubMed=2495201;
RX PubMed=10936422;
CC Characteristics: IL6 dependent.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L066 ! JJN-1
SX Female
CA Cancer cell line
//
ID JJN-3
AC CVCL_2078
SY JJN3
DR EFO; EFO_0006605
DR BioSample; SAMN03472931
DR CCLE; JJN3_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 720788
DR Cosmic; 742956
DR Cosmic; 888017
DR Cosmic; 1483076
DR Cosmic; 1889516
DR Cosmic; 2081385
DR Cosmic; 2131563
DR Cosmic; 2302418
DR Cosmic; 2367283
DR Cosmic; 2391793
DR Cosmic-CLP; 1327766
DR DSMZ; ACC-541
DR GDSC; 1327766
DR GEO; GSM143339
DR GEO; GSM290291
DR GEO; GSM1374579
DR GEO; GSM1669961
RX PubMed=1943229;
RX PubMed=8943038;
RX PubMed=10087940;
RX PubMed=10557056;
RX PubMed=10583232;
RX PubMed=10936422;
RX PubMed=11429052;
RX PubMed=16956823;
RX PubMed=17171682;
RX PubMed=18700954;
RX PubMed=19306352;
RX PubMed=21173094;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=JJN-3
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 24 hours (PubMed=25984343); ~20-35 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9
ST D16S539: 11,12
ST D18S51: 12,13
ST D21S11: 28,33.2
ST D3S1358: 14,16
ST D5S818: 11,12
ST D7S820: 8,9
ST D8S1179: 14,15
ST FGA: 20,21
ST Penta D: 11,12
ST Penta E: 11
ST TH01: 9
ST TPOX: 8,10
ST vWA: 15
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L066 ! JJN-1
SX Female
CA Cancer cell line
//
ID JK [Boa]
AC CVCL_T683
SY Juliet's Kidneys
RX PubMed=22893382;
WW https://www.ucsf.edu/news/2012/08/12545/mysterious-snake-disease-decoded
CC Group: Reptilian cell line.
OX NCBI_TaxID=8574; ! Boa constrictor
SX Female
CA Spontaneously immortalized cell line
//
ID JK [Human anaplastic large cell lymphoma]
AC CVCL_H635
RX PubMed=10515889;
RX PubMed=15356658;
DI NCIt; C3720; Anaplastic large cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID JK-1
AC CVCL_2079
SY JK1
DR CLO; CLO_0007026
DR BioSample; SAMN03473358
DR CCLE; JK1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 787494
DR Cosmic; 924046
DR Cosmic; 1012071
DR DSMZ; ACC-347
DR GEO; GSM887184
DR GEO; GSM888257
RX PubMed=2169992;
RX PubMed=15843827;
RX PubMed=16408098;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~50 hours (DSMZ).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 9,13
ST D16S539: 9,13
ST D5S818: 11
ST D7S820: 13
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID JK-6
AC CVCL_M534
RX CelloPub=CLPUB00060;
RX PubMed=10936422;
CC Characteristics: IL6 dependent.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID JK-6L
AC CVCL_0C41
SY JK6L
DR Cosmic; 2081386
RX PubMed=19621390;
CC Characteristics: Compared to the parent cell line, it is no longer IL6 dependent.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M534 ! JK-6
SX Male
CA Cancer cell line
//
ID JK-GMS
AC CVCL_T755
RX PubMed=11850535;
RX PubMed=14694527;
DI NCIt; C7542; Askin tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID JK-NB1
AC CVCL_W474
RX PubMed=8148311;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID JK-T1
AC CVCL_DD43
RX PubMed=1333881;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID JKT-beta-del
AC CVCL_2966
DR BioSample; SAMN03470812
DR JCRB; JCRB0147
DR JCRB; NIHS0224
CC Discontinued: JCRB; NIHS0224; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 8,10,11
ST D16S539: 11,12
ST D5S818: 9
ST D7S820: 8,10
ST TH01: 6,10
ST TPOX: 8,10
ST vWA: 18,19
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0065 ! Jurkat
SX Male
CA Cancer cell line
//
ID JKT-1
AC CVCL_T011
SY JKT1
RX PubMed=9624562;
RX PubMed=10210573;
RX PubMed=17705808;
RX PubMed=18008088;
CC Problematic cell line: Misidentified. Originally thought to be a seminoma cell line but shown not to be from germ cells. Its real nature is not clear (PubMed=17705808, PubMed=18008088).
CC Doubling time: 28.5 hours (PubMed=10210573).
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID JKT-HM
AC CVCL_T014
RX PubMed=10210573;
RX PubMed=17705808;
RX PubMed=18008088;
CC Problematic cell line: Misidentified. Parent line (JKT-1) was originally thought to be a seminoma cell line but shown not to be from germ cells. Its real nature is not clear (PubMed=17705808, PubMed=18008088).
CC Doubling time: 27.9 hours (PubMed=10210573).
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_T011 ! JKT-1
SX Male
CA Cancer cell line
//
ID JL
AC CVCL_F563
SY TER316
DR IMGT/HLA; 10850
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID JL-1
AC CVCL_2080
SY JL1
DR EFO; EFO_0006448
DR BioSample; SAMN03473060
DR CCLE; JL1_PLEURA
DR DSMZ; ACC-596
DR GEO; GSM887185
DR GEO; GSM888258
RX PubMed=15372243;
RX PubMed=22460905;
RX PubMed=25485619;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~70-80 hours (DSMZ).
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): DSMZ; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 9
ST D16S539: 9,12
ST D18S51: 14,15
ST D21S11: 30
ST D3S1358: 18
ST D5S818: 12,13
ST D7S820: 9,11
ST D8S1179: 15
ST FGA: 22,23
ST Penta D: 11,12
ST Penta E: 11,13
ST TH01: 8,9.3
ST TPOX: 9,11
ST vWA: 18
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID JL/AMSA
AC CVCL_4V24
SY JL AMSA
RX PubMed=1989661;
CC Selected for resistance to: ChEBI; CHEBI:2687; Amsacrine.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0065 ! Jurkat
SX Male
CA Cancer cell line
//
ID JLI
AC CVCL_5I41
DR GEO; GSM1122232
RX PubMed=24582862;
CC Breed/subspecies: Golden Retriever.
DI NCIt; C122783; Canine hemangiosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_5I40 ! JHE
OI CVCL_5I42 ! JLU
SX Male
CA Cancer cell line
//
ID JLO
AC CVCL_S858
DR Cosmic; 928739
RX PubMed=9354451;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID JLP
AC CVCL_N703
RX PubMed=6243721;
RX PubMed=6243722;
RX PubMed=6286763;
RX PubMed=8515068;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID JLPC119
AC CVCL_W748
SY JLPC 119; JLPc119; JLP119
RX PubMed=6286763;
RX PubMed=8515068;
RX PubMed=9973220;
CC Characteristics: EBV-negative.
DI NCIt; C3457; B-cell non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID JLS-V5
AC CVCL_2534
SY JLS V5; JLSV5
DR CLO; CLO_0007027
DR ATCC; CRL-6359
RX PubMed=58965;
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6359; true.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID JLS-V9
AC CVCL_2535
SY JLSV-9; JLSV9
DR CLO; CLO_0007028
DR CLO; CLO_0051026
DR CLDB; cl2947
DR ATCC; CRL-6360
DR RCB; RCB2651
DR TKG; TKG 0355
RX PubMed=4129475;
RX PubMed=6057678;
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6360; true.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID JLS-V9 6TG
AC CVCL_B949
DR CLO; CLO_0050197
DR RCB; RCB2896
DR TKG; TKG 0350
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2535 ! JLS-V9
CA Spontaneously immortalized cell line
//
ID JLS-V9 BudR
AC CVCL_F944
DR CLO; CLO_0051027
DR RCB; RCB2644
DR RCB; RCB3515
DR TKG; TKG 0356
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Discontinued: RCB; RCB2644; true.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2535 ! JLS-V9
CA Spontaneously immortalized cell line
//
ID JLS-V9R
AC CVCL_HA49
SY JLS-V10
RX PubMed=58965;
RX PubMed=6057678;
CC Characteristics: In vitro infected by R-MuLV.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2535 ! JLS-V9
CA Spontaneously immortalized cell line
//
ID JLTRG
AC CVCL_1E01
SY JLTR-RS
DR NIH-ARP; 11587-286
RX PubMed=15105117;
CC Doubling time: 24-48 hours (NIH-ARP).
CC Transfected with: UniProtKB; P42212; GFP.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0065 ! Jurkat
SX Male
CA Cancer cell line
//
ID JLTRG-R5
AC CVCL_1E02
DR NIH-ARP; 11586-287
RX PubMed=16454046;
CC Transfected with: UniProtKB; P42212; GFP.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1E01 ! JLTRG
SX Male
CA Cancer cell line
//
ID JLU
AC CVCL_5I42
DR GEO; GSM1122230
RX PubMed=24582862;
CC Breed/subspecies: Golden Retriever.
DI NCIt; C122783; Canine hemangiosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_5I40 ! JHE
OI CVCL_5I41 ! JLI
SX Male
CA Cancer cell line
//
ID JM
AC CVCL_S103
RX PubMed=7073944;
CC Doubling time: 35.2 hours (PubMed=7073944).
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID JM-1
AC CVCL_3532
SY JM1
DR CLO; CLO_0007030
DR EFO; EFO_0002212
DR ATCC; CRL-10423
DR BCRC; 60513
DR BioSample; SAMN03471300
DR CCLE; JM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR ChEMBL-Cells; CHEMBL3308496
DR ChEMBL-Targets; CHEMBL614589
DR Cosmic; 2491096
DR Cosmic-CLP; 1327768
DR GDSC; 1327768
DR GEO; GSM887186
DR GEO; GSM888259
DR GEO; GSM1669962
DR IGRhCellID; JM1
RX PubMed=2647717;
RX PubMed=9067587;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 9
ST D5S818: 12
ST D7S820: 8,10
ST TH01: 6
ST TPOX: 10,11
ST vWA: 17
DI NCIt; C3183; T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID JM1
AC CVCL_F242
RX PubMed=6131863;
CC Breed/subspecies: Fischer 344.
DI NCIt; C60416; Rat hepatocellular carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID JM2
AC CVCL_3384
DR CLO; CLO_0007031
DR CLDB; cl4959
DR ICLC; ATL99009
RX PubMed=6131863;
CC Breed/subspecies: Fischer 344.
DI NCIt; C60416; Rat hepatocellular carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID JM8
AC CVCL_J957
RX PubMed=19525957;
WW https://www.komp.org/pdf.php?cloneID=140302
WW https://www.komp.org/pdf/Culturing_and_media_conditions_for_KOMP_CSD_JM8_and_JM8_F6_ES_cell_clones_Protocol.pdf
CC Breed/subspecies: C57BL/6N.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID JM86
AC CVCL_X916
SY JM-86; Japanese Monkey 86
RX PubMed=2579038;
RX PubMed=6093374;
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 33747; Simian T-lymphotropic virus 1 (STLV-1).
OX NCBI_TaxID=9543; ! Macaca fuscata fuscata
CA Transformed cell line
- 公告/新闻
